data_2mhp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mhp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.541 ' N ' ' SD ' ' A' ' 10' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.46 0.066 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.62 124.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.256 0.55 . . . . 0.0 110.81 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 6.5 ttpt . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -137.12 156.65 48.1 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.6 t -46.46 -17.05 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.33 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 30' ' ' THR . 12.6 pt20 -84.97 -42.75 14.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.4 m-20 -109.31 -2.44 17.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.284 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.5 t80 -44.27 -53.0 7.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -105.74 -3.63 21.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASN . 31.4 mt . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.087 0.47 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 p . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.699 0.285 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.0 mt -123.73 -174.59 3.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 50' ' ' PRO . 69.1 m -92.48 149.76 38.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.301 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 99.6 Cg_exo -38.47 165.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.745 2.297 . . . . 0.0 112.62 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' C ' ' HZ2' ' A' ' 29' ' ' LYS . 53.2 Cg_exo -53.87 -48.17 23.2 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.052 1.835 . . . . 0.0 112.926 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.15 -6.24 82.61 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.539 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.9 mtp -112.83 154.38 26.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 111.023 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.91 152.25 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -86.72 117.61 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.289 0.566 . . . . 0.0 110.887 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -138.55 126.45 22.44 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.349 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 46.83 45.56 15.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.261 0.553 . . . . 0.0 110.352 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER 63.04 8.44 3.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.978 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -120.43 149.24 42.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -97.34 128.08 43.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.516 . . . . 0.0 110.385 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.59 155.17 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.582 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 148.33 47.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.588 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.01 -52.22 52.15 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.024 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.62 -15.58 29.69 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.533 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -104.25 -4.9 22.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.473 0.177 . . . . 0.0 111.45 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -53.79 151.78 11.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.438 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 92.4 Cg_endo -74.51 156.66 45.2 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 110.99 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -116.25 151.69 35.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.069 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 3.5 m-85 -120.94 130.85 54.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.087 0.47 . . . . 0.0 110.58 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.506 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.5 t60 -152.79 98.54 2.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.033 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 30.8 tt0 87.81 36.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.963 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.17 -5.59 48.78 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.0 148.45 26.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 110.522 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.88 125.39 41.28 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.988 0.423 . . . . 0.0 110.966 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 26.5 m-85 -114.53 177.06 4.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.8 173.58 3.15 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.695 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.56 139.12 62.6 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.248 1.965 . . . . 0.0 111.472 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.7 0.16 67.36 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -81.73 129.22 34.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.35 145.07 30.77 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.112 0.958 . . . . 0.0 112.313 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' OG1' ' A' ' 87' ' ' THR . 22.2 m -138.08 153.78 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.17 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.72 130.42 48.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.756 0.312 . . . . 0.0 110.159 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.14 98.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.3 -116.68 7.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 3.6 40.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.115 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.75 159.01 35.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 81' ' ' VAL . 1.1 t -123.25 153.29 40.36 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -134.51 151.1 50.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.432 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.26 138.86 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.36 116.01 12.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.346 0.593 . . . . 0.0 111.124 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -144.0 118.78 9.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.325 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.29 51.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 54.23 12.24 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 157.54 44.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.68 133.48 36.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.8 m-80 -112.86 109.36 18.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.609 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 65.2 m -89.21 134.6 33.97 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.384 0.612 . . . . 0.0 111.792 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.597 HG21 ' H ' ' A' ' 100' ' ' HIS . 0.8 OUTLIER -71.68 -37.04 70.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.913 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.52 32.65 19.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.597 ' H ' HG21 ' A' ' 98' ' ' THR . 15.0 p80 -61.04 171.26 1.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.576 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.305 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.439 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 44.5 mtm . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.549 0.214 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.06 115.36 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp . . . . . 0 C--N 1.319 -0.748 0 CA-C-O 121.181 0.515 . . . . 0.0 111.026 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 3.7 tttp . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -135.64 156.08 49.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.991 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.465 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 1.5 t -52.12 -4.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.9 pt20 -100.4 -42.36 6.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.302 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.2 m-20 -113.74 -2.8 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.027 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' THR . 15.1 t80 -51.88 -45.47 64.14 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -102.17 -3.8 26.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.636 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 33' ' ' ASN . 50.5 mt . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.944 0.402 . . . . 0.0 111.052 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.947 0.403 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.08 -172.96 2.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -103.28 173.39 3.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.12 157.11 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.544 2.163 . . . . 0.0 112.344 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 32.1 Cg_endo -62.15 -27.97 79.28 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.602 2.201 . . . . 0.0 112.198 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 -8.79 75.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.11 153.0 31.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.002 0.429 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.96 135.05 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.945 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -73.84 129.75 38.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' ARG . 3.5 t60 -139.11 130.33 26.78 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.052 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 22.1 tp10 45.72 26.64 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 40.9 t30 88.56 10.27 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.916 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' HIS . 2.1 ptm180 -126.92 151.94 47.78 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.8 m -99.42 131.56 45.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.301 0.572 . . . . 0.0 110.539 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.03 157.17 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.574 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.04 148.8 48.37 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.456 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.8 mm? -52.17 -46.21 65.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.176 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.75 -13.42 62.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.441 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -102.07 -6.9 22.79 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 110.987 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.15 148.9 49.44 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.34 162.26 40.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.624 2.216 . . . . 0.0 111.83 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.6 m -103.41 166.19 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 17.8 m-85 -132.23 123.12 26.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.948 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.463 ' NE2' ' CD1' ' A' ' 83' ' ' ILE . 13.4 t60 -142.67 126.92 17.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 110.049 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.6 42.15 29.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.62 -3.38 49.47 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.353 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -104.31 151.33 23.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.975 0.417 . . . . 0.0 110.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -104.63 129.14 52.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.654 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 10.4 m-85 -117.53 176.51 5.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.486 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.74 162.55 24.73 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.765 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.6 136.06 68.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.411 2.074 . . . . 0.0 111.522 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.42 -2.62 86.9 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' C ' ' OE1' ' A' ' 79' ' ' GLU . 9.5 tm-20 -82.78 137.46 34.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -104.9 149.69 25.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.789 0.804 . . . . 0.0 111.966 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.437 ' O ' ' OG1' ' A' ' 87' ' ' THR . 18.4 m -140.16 146.07 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.399 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 84' ' ' GLY . 6.0 tmtt? -101.82 129.43 48.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 70' ' ' HIS . 81.4 mt -129.52 117.31 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . . . 56.41 -117.83 10.12 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.443 ' C ' ' HZ3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -102.19 1.98 36.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.328 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 6.7 p30 -125.81 162.38 25.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.397 0.617 . . . . 0.0 111.044 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 81' ' ' VAL . 1.3 t -127.88 157.57 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.909 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.38 163.01 33.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.29 142.41 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.19 105.55 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.426 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -137.7 122.42 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.593 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 60.14 51.94 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.37 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 62.7 mtp180 54.47 12.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.157 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -132.91 158.07 43.52 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -92.86 133.73 35.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -105.53 94.21 5.08 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.7 m -82.0 135.03 35.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.187 0.518 . . . . 0.0 111.226 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.583 ' CG2' ' H ' ' A' ' 99' ' ' ASP . 8.0 t -63.46 -52.57 60.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.281 1.039 . . . . 0.0 110.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.583 ' H ' ' CG2' ' A' ' 98' ' ' THR . 27.7 t0 68.74 18.76 8.64 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.929 -1.941 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 3.6 p80 -59.6 171.27 0.88 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 62.0 t . . . . . 0 CA--C 1.52 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.248 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.555 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.52 107.58 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 121.285 0.564 . . . . 0.0 111.241 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 35.0 mtpt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 32' ' ' GLN . 36.4 p -131.25 152.57 50.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.832 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -50.42 -4.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.742 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.592 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.6 pt20 -104.31 -54.43 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.655 0.264 . . . . 0.0 111.618 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.49 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 27.7 p30 -93.3 -7.11 45.85 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.687 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -44.29 -47.5 9.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.248 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 17.1 p-10 -102.02 -0.63 33.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 32' ' ' GLN . 4.5 mt . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.29 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.726 0.298 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' O ' ' SD ' ' A' ' 10' ' ' MET . 95.6 mt -136.68 -173.41 3.42 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.172 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 50' ' ' PRO . 93.2 m -96.35 150.6 37.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.944 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 49' ' ' CYS . 84.4 Cg_exo -34.2 158.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.568 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.3 Cg_endo -58.14 -26.68 77.02 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.791 2.327 . . . . 0.0 112.179 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.5 -1.32 60.59 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtp -122.95 164.34 18.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.31 -0.445 . . . . 0.0 111.23 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.11 148.79 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -76.26 123.05 25.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.153 0.501 . . . . 0.0 110.712 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.95 127.95 22.19 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 55.2 tt0 47.42 35.07 3.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.6 m-20 76.31 9.39 3.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.745 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -127.1 152.1 47.76 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.66 126.95 40.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 0.0 109.992 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.42 156.98 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.942 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.97 41.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.464 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 4.3 mm? -48.05 -50.24 28.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.111 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -59.67 -14.34 13.48 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.188 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -99.95 -6.58 26.38 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.471 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.9 m -55.11 138.87 65.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.197 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.79 159.99 47.2 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.593 2.195 . . . . 0.0 112.138 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.76 167.07 10.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.812 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.98 129.71 32.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -142.72 122.73 13.62 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 58.86 42.8 19.17 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.617 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.09 -3.98 34.65 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.119 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -101.79 142.02 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -96.23 129.08 43.63 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.194 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 39.0 m-85 -118.95 176.91 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.003 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.89 164.51 16.44 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.34 133.96 55.76 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.519 2.146 . . . . 0.0 111.529 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.92 86.51 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 80' ' ' THR . 11.1 tm-20 -80.74 138.67 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.423 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -110.66 154.9 23.17 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.622 0.725 . . . . 0.0 111.696 -177.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.9 150.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.61 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -99.71 131.55 45.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 86' ' ' ASN . 55.6 mt -135.26 99.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.687 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 41.34 78.23 0.07 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 63.35 -29.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.667 0.27 . . . . 0.0 110.918 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.654 ' H ' ' C ' ' A' ' 84' ' ' GLY . 23.4 t-20 -89.92 128.62 36.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.229 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.493 ' H ' ' HE2' ' A' ' 100' ' ' HIS . 0.6 OUTLIER -111.28 148.02 33.8 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.804 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.61 153.55 51.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.168 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.93 146.27 29.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.515 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.649 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 77.1 m -71.31 108.66 4.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -139.84 114.63 9.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.363 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 68.92 50.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.407 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 55.99 11.93 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.53 161.02 34.84 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.649 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 95.3 m95 -93.34 130.41 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.115 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.0 t-20 -105.88 105.41 15.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.728 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 53.3 m -87.92 132.62 34.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.627 0.727 . . . . 0.0 112.808 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 52.5 m -61.58 -47.9 83.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.359 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' THR . 14.6 t0 79.04 11.06 1.51 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.952 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.549 ' N ' ' CD2' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.91 151.38 45.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.032 0.444 . . . . 0.0 110.486 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.578 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 58.9 mtm . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.63 120.29 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.551 -179.466 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.669 ' NZ ' ' H ' ' A' ' 52' ' ' GLY . 77.6 tttt . . . . . 0 CA--C 1.515 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 32' ' ' GLN . 6.4 m -136.78 155.84 49.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.872 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 3.7 t -59.15 1.37 0.07 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.017 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.0 pt20 -104.06 -44.0 5.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.622 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' LEU . 96.5 m-20 -111.81 -7.14 14.21 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.9 t80 -48.52 -47.13 39.24 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.935 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 48.8 t0 -101.45 -5.2 25.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 110.463 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 33' ' ' ASN . 45.0 mt . . . . . 0 N--CA 1.468 0.443 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.603 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -120.23 -172.66 2.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -90.44 171.75 7.97 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.617 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' CD ' ' SG ' ' A' ' 49' ' ' CYS . 25.6 Cg_exo -61.55 -179.84 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.298 1.999 . . . . 0.0 112.673 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.53 151.43 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.791 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.669 ' H ' ' NZ ' ' A' ' 29' ' ' LYS . . . 79.76 -9.57 43.58 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mtp -116.68 152.23 34.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.214 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.8 139.6 50.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.257 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -73.55 126.35 30.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.385 0.612 . . . . 0.0 110.516 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' ARG . 1.9 t60 -133.88 122.83 23.73 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.905 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 80.9 mt-10 46.99 31.68 1.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.788 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.4 m120 83.71 11.43 0.43 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.553 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 3.1 ptm180 -125.79 149.02 48.92 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.0 m -97.5 133.44 42.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.899 -0.5 . . . . 0.0 110.589 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.62 157.73 24.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.288 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.31 150.45 45.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.297 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.9 mm? -49.16 -46.61 45.54 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.52 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.99 -14.38 61.52 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.868 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -101.39 -8.98 21.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.801 0.334 . . . . 0.0 110.952 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 147.02 30.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.615 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.55 163.73 37.7 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.692 2.262 . . . . 0.0 111.582 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.41 158.48 22.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.921 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -127.89 128.11 44.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.398 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -144.82 126.18 14.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 59.24 37.88 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.502 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.95 -5.2 50.2 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.096 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -102.2 145.7 29.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 0.0 109.875 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -100.73 129.31 46.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 29.0 m-85 -118.96 177.31 4.91 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.316 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.79 175.11 2.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.736 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.37 138.75 67.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.429 2.086 . . . . 0.0 111.605 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.97 -0.86 61.19 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.29 134.0 36.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.85 151.6 24.32 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.029 0.443 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.72 148.52 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.656 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -96.52 129.14 43.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 86' ' ' ASN . 97.9 mt -136.78 127.06 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.961 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 86' ' ' ASN . . . 32.52 83.97 0.01 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 1.6 p 41.48 13.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.627 0.251 . . . . 0.0 111.441 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 84' ' ' GLY . 8.8 m120 -128.04 161.1 29.97 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.97 149.68 52.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.165 0.507 . . . . 0.0 111.006 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 m -137.33 157.65 46.13 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.707 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.86 144.09 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.658 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 71.2 m -67.01 107.11 2.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -137.71 118.61 14.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 63.48 50.73 2.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.584 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 58.1 mtp180 55.92 11.95 0.8 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.3 160.86 35.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 110.054 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.658 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 93.5 m95 -93.1 131.94 37.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.101 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -106.26 94.29 5.07 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 95.2 m -78.26 135.24 37.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.605 0.717 . . . . 0.0 111.576 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 m -59.62 -45.48 91.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 59.47 28.0 17.28 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.559 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.589 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -76.78 170.53 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.827 177.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.647 -179.416 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' ' SG ' ' A' ' 49' ' ' CYS . 64.7 mtm . . . . . 0 C--O 1.234 0.246 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.44 118.98 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 pttm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.504 179.363 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' TYR . 10.6 m -128.27 165.28 20.82 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.9 m -55.08 -13.11 1.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.154 -0.341 . . . . 0.0 110.663 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -96.87 -38.01 10.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.492 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 36' ' ' LEU . 6.2 m120 -106.0 -4.96 19.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 30' ' ' THR . 22.2 t80 -44.36 -53.88 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.228 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 20.2 p-10 -102.8 -0.2 31.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.421 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' ASN . 55.4 mt . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.694 0.283 . . . . 0.0 110.681 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 121.0 0.429 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -118.68 -174.58 2.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.73 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' SG ' ' CE ' ' A' ' 10' ' ' MET . 0.4 OUTLIER -86.98 161.41 47.04 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.064 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.42 168.11 23.37 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.651 2.234 . . . . 0.0 112.622 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.39 145.99 53.86 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.035 1.824 . . . . 0.0 112.163 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.54 -23.02 24.51 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 96.2 mmm -116.43 155.71 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 109.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.21 -167.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.85 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -120.7 118.07 29.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.54 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -135.97 126.53 27.0 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 44.74 45.07 8.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.213 0.53 . . . . 0.0 110.102 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.9 m120 68.21 10.41 7.82 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -126.46 152.95 45.75 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -100.26 134.04 43.77 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.704 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.84 155.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.18 153.11 44.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.473 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -52.46 -50.81 61.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.41 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -56.62 -15.57 4.66 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.88 -1.52 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.091 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -55.22 115.61 9.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.45 159.47 2.07 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.737 1.625 . . . . 0.0 112.406 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.01 166.62 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -136.39 130.75 33.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.416 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.4 t60 -150.94 104.21 3.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.247 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 32.0 tt0 83.1 37.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.34 48.67 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -104.07 145.45 30.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -97.83 127.22 43.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 37.9 m-85 -115.11 177.24 4.73 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.127 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.73 170.12 6.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.37 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.34 138.28 65.19 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.969 1.779 . . . . 0.0 111.306 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.25 -1.23 76.8 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.51 128.47 34.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.48 145.74 29.85 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.688 0.756 . . . . 0.0 111.886 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.22 154.37 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -101.08 130.24 47.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 77.2 mt -128.45 106.61 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.87 -116.78 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' NE2' ' A' ' 100' ' ' HIS . 7.6 p -103.99 3.94 33.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.03 0.443 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 17.3 p30 -126.27 164.72 20.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.393 0.615 . . . . 0.0 110.61 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.32 152.07 41.81 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.879 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.76 150.62 52.14 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.2 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.55 140.85 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.52 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 t -71.11 110.26 5.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.74 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -140.9 118.93 11.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.794 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 94' ' ' LYS . 34.5 t0 63.96 50.52 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.317 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 55.59 9.27 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.296 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 92' ' ' ASP . 64.2 tttp -129.71 155.91 45.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -94.63 134.42 37.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.437 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 98.5 m-20 -111.67 104.44 12.8 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.632 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 78.4 m -86.94 137.92 31.96 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.913 0.863 . . . . 0.0 112.175 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 100' ' ' HIS . 2.8 m -61.03 -44.78 96.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t0 55.0 29.61 12.63 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.074 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.469 ' NE2' ' O ' ' A' ' 85' ' ' CYS . 0.3 OUTLIER -70.6 172.21 8.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.705 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.39 117.01 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.029 0.443 . . . . 0.0 110.843 179.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.733 ' HG1' HE21 ' A' ' 32' ' ' GLN . 0.5 OUTLIER -140.82 162.56 35.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.105 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.0 t -59.26 6.45 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.081 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.733 HE21 ' HG1' ' A' ' 30' ' ' THR . 5.9 pt20 -105.13 -46.14 4.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.057 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.449 ' N ' ' CG ' ' A' ' 32' ' ' GLN . 99.2 m-20 -115.83 -3.16 12.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.014 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -50.46 -46.59 56.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.926 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 58.2 t0 -106.82 -8.51 16.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ASN . 52.8 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.538 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 20.0 p . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 62.3 mt -123.75 -177.17 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.972 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -98.07 159.09 31.61 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' CYS . 87.5 Cg_exo -42.11 173.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.754 2.303 . . . . 0.0 112.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.03 154.72 57.72 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.507 2.138 . . . . 0.0 111.974 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 -4.37 58.71 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.1 mtp -110.54 150.22 29.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.061 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.59 137.3 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -72.31 118.59 15.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.262 0.553 . . . . 0.0 110.442 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.24 117.88 20.52 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 56.4 mm-40 53.19 35.1 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.0 m-80 77.94 10.79 2.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.745 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -123.01 151.89 41.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.7 m -98.98 128.25 45.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 0.0 110.644 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.699 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.09 143.83 57.58 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.398 0.618 . . . . 0.0 109.86 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.2 tp -51.27 -52.34 45.9 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.43 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.16 -12.92 31.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.01 0.434 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -103.29 -3.72 25.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.403 0.621 . . . . 0.0 110.464 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -54.2 149.02 20.45 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.143 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 67.4 Cg_endo -71.41 159.38 51.7 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.452 2.101 . . . . 0.0 111.132 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.06 148.98 29.97 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.188 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 7.3 m-85 -114.48 122.87 47.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.25 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -137.07 121.08 17.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 58.84 43.02 18.88 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.798 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.63 -4.79 33.76 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.699 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.12 150.52 24.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.2 mp0 -103.2 129.72 50.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.794 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 12.8 m-85 -118.16 175.53 5.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.096 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.11 167.77 9.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.201 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.19 128.29 23.52 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.561 2.174 . . . . 0.0 111.869 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.28 83.89 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -78.14 132.81 37.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.58 152.37 21.81 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.444 0.64 . . . . 0.0 110.931 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.44 150.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.179 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 14.9 tptp -98.72 131.48 44.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 86' ' ' ASN . 56.6 mt -135.01 114.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 34.68 66.09 0.34 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.56 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 70.78 -29.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.958 0.409 . . . . 0.0 110.909 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.597 ' H ' ' C ' ' A' ' 84' ' ' GLY . 59.8 t-20 -87.58 133.82 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.358 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.643 ' H ' ' HE2' ' A' ' 100' ' ' HIS . 0.6 OUTLIER -108.78 148.92 29.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.63 151.76 50.56 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.53 144.29 35.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.4 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.628 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 87.2 m -70.37 111.48 5.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -142.15 121.35 13.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.348 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 61.74 50.62 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.263 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 57.63 10.14 0.97 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.285 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -133.89 152.78 51.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.326 0.584 . . . . 0.0 110.055 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.628 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 94.9 m95 -83.39 133.5 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.108 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.442 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.2 t-20 -108.58 104.53 13.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.781 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 55.8 m -86.97 132.88 33.66 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.014 0.911 . . . . 0.0 112.235 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.1 m -58.07 -45.63 86.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.86 13.55 3.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.047 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.643 ' HE2' ' H ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -64.03 141.93 58.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.374 178.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.639 179.74 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 10' ' ' MET . 5.1 mpp? . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.54 120.31 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 0.0 110.904 179.562 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 11.6 ttpt . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.494 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -132.14 152.05 51.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 1.3 m -49.45 -13.22 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.263 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.0 pt20 -82.33 -38.63 23.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.265 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' LEU . 99.3 m-20 -113.17 -4.39 13.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.581 0.353 . . . . 0.0 111.016 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' THR . 11.9 t80 -48.56 -48.25 38.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -105.18 -7.27 19.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.021 0.438 . . . . 0.0 110.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.04 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 21.8 p . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 120.577 0.227 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.9 mt -130.47 162.19 29.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.21 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -73.64 156.6 88.43 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.333 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.14 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.655 2.237 . . . . 0.0 112.16 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.516 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.7 Cg_endo -56.06 -37.74 95.84 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.518 2.145 . . . . 0.0 112.546 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.01 -0.72 86.33 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.3 mmm -118.51 160.22 22.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.523 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.423 ' O ' ' SG ' ' A' ' 49' ' ' CYS . 16.6 m -130.37 -169.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.719 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -122.13 117.58 26.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.292 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -133.16 124.45 27.51 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 44.47 49.25 8.31 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.269 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' ASN . 29.1 t-20 66.89 5.22 3.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -123.31 151.08 42.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.8 m -103.02 131.69 49.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.337 0.589 . . . . 0.0 110.944 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.48 155.94 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.421 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -65.29 150.1 48.82 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.452 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 4.3 mm? -47.04 -50.65 19.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.862 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -66.89 -14.72 63.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 62' ' ' ALA . 22.1 mmt85 -95.86 -6.18 39.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 110.439 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m -56.38 150.5 33.01 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.34 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.36 157.6 37.04 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.52 2.147 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -109.47 148.25 31.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.739 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.83 127.61 50.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.971 0.415 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -145.44 134.4 22.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.099 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 53.01 33.82 15.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.119 -0.363 . . . . 0.0 111.935 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.25 -5.83 58.59 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.224 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.68 148.85 25.07 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -101.08 127.15 47.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 9.9 m-85 -118.17 178.71 4.34 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.152 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.68 173.58 2.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 137.02 53.12 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.184 1.923 . . . . 0.0 111.737 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.18 82.07 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -81.98 134.37 35.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.63 148.92 24.97 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.846 0.831 . . . . 0.0 112.366 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.434 ' O ' ' OG1' ' A' ' 87' ' ' THR . 15.1 m -141.0 149.83 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 44.1 tptt -106.39 132.2 52.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 86' ' ' ASN . 54.9 mt -130.98 86.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.228 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 51.41 85.95 0.02 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.488 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER 64.76 -37.42 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.771 0.32 . . . . 0.0 111.374 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 84' ' ' GLY . 36.2 t-20 -88.88 140.76 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.123 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 1.3 t -126.99 152.61 46.99 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.042 0.448 . . . . 0.0 110.221 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.19 156.73 46.89 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.007 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 p -128.9 138.33 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.98 112.81 6.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -141.66 123.32 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.029 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 62.03 51.46 3.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.33 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.517 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 77.2 mtp180 53.36 15.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.289 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.25 161.15 35.25 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -98.36 132.09 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.92 95.83 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 86.6 m -80.56 138.74 36.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.052 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.567 ' CG2' ' H ' ' A' ' 99' ' ' ASP . 3.0 t -60.28 -53.17 60.81 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.356 1.074 . . . . 0.0 110.867 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.567 ' H ' ' CG2' ' A' ' 98' ' ' THR . 57.3 t0 60.79 26.44 16.27 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 112.977 -1.92 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.525 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.65 171.39 7.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.53 0.181 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.1 mtm . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.29 115.13 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.1 tttp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 110.195 179.605 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.767 ' H ' HD22 ' A' ' 33' ' ' ASN . 27.7 p -133.06 154.3 50.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.775 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 m -60.27 7.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.715 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.585 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 pt20 -105.72 -43.11 4.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 111.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.767 HD22 ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -108.27 -6.52 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.391 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' N ' HD21 ' A' ' 33' ' ' ASN . 77.8 t80 -44.43 -54.81 5.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.809 0.337 . . . . 0.0 110.588 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.75 -4.87 24.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 33' ' ' ASN . 62.8 mt . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 121.111 0.481 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.2 -173.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.881 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 174.87 4.55 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.18 167.32 17.86 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.014 1.809 . . . . 0.0 112.936 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -54.23 147.47 45.11 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.237 1.958 . . . . 0.0 112.372 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.34 -17.85 40.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.29 148.55 32.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.27 140.27 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.6 122.69 21.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.287 0.565 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.84 117.91 19.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 70.7 mm-40 51.1 35.0 11.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.2 m-80 79.01 11.58 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.624 0.577 . . . . 0.0 110.985 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -122.91 148.91 44.91 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.36 129.98 44.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.676 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.63 154.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.125 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 153.22 41.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.23 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -49.78 -55.64 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.855 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -57.82 -17.4 15.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.47 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.66 -3.48 32.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.9 t -54.4 116.89 11.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.413 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -48.86 153.55 3.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.259 1.973 . . . . 0.0 112.429 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -103.18 163.95 11.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.412 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 21.1 m-85 -137.06 129.3 29.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.071 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -144.48 127.82 16.83 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 55.47 39.57 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.497 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 -5.91 37.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -100.54 144.43 29.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.39 127.18 43.14 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.997 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 31.7 m-85 -120.28 178.41 4.65 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.314 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.04 172.35 3.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.508 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.33 138.79 68.03 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.339 2.026 . . . . 0.0 111.566 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.63 -1.6 71.69 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -79.35 133.25 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.6 144.51 31.6 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.82 0.819 . . . . 0.0 111.993 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.95 152.89 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.53 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -99.18 129.93 45.46 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 59.9 mt -129.17 107.85 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.094 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.64 -115.15 7.62 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.74 1.18 31.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.738 0.304 . . . . 0.0 110.454 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 19.2 p30 -127.16 159.84 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.428 0.632 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.31 151.87 35.0 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.54 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.29 147.92 52.42 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.346 -178.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.33 138.85 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.564 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.22 107.76 3.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.416 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -137.45 121.62 17.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.422 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 94' ' ' LYS . 63.6 m-20 65.34 51.41 1.58 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.654 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 56.61 9.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.621 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 92' ' ' ASP . 68.2 mttm -133.48 163.29 29.7 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -96.96 133.49 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.908 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.436 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.7 m-80 -111.58 106.57 15.45 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.621 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 62.9 m -86.42 137.03 32.88 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 112.063 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.423 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 54.2 m -58.04 -48.8 78.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.116 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 98' ' ' THR . 2.2 m-20 80.02 11.49 1.15 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.286 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.3 OUTLIER -78.76 157.91 28.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.53 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.602 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 40.6 mmm . . . . . 0 CA--C 1.517 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 10' ' ' MET . 0.2 OUTLIER 56.74 128.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.53 178.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.154 0.502 . . . . 0.0 110.05 179.071 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 11.9 ptmt . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -143.12 159.59 41.99 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 67.5 m -40.91 -25.76 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.508 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' THR . 6.6 pt20 -76.62 -44.5 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 36' ' ' LEU . 2.7 p-10 -114.4 0.08 13.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.11 0.481 . . . . 0.0 110.834 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 30' ' ' THR . 64.2 t80 -47.5 -51.85 19.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.012 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -103.43 -2.28 27.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.027 0.441 . . . . 0.0 109.829 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 33' ' ' ASN . 1.7 tp . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 10' ' ' MET . 4.3 pp -119.45 -173.34 2.5 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.421 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.4 t -110.78 128.18 25.73 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.29 171.76 7.41 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.257 1.304 . . . . 0.0 113.197 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 53' ' ' MET . 26.7 Cg_exo -61.21 152.23 73.45 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.392 2.061 . . . . 0.0 112.503 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.75 -21.06 4.87 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.548 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 85.7 mmm -111.86 150.03 30.98 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.44 141.5 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.117 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -72.92 120.14 18.13 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -133.87 120.29 20.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 52.27 37.47 22.21 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.268 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 76.37 10.88 2.88 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.879 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -123.4 153.01 40.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.602 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 18.6 m -103.04 124.7 49.03 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.102 0.477 . . . . 0.0 110.135 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.07 159.74 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.314 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 145.01 51.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.625 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 tp -51.49 -53.48 36.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.66 -20.0 4.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.977 0.417 . . . . 0.0 110.442 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -98.02 -4.25 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 110.27 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.439 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 6.3 t -53.86 126.54 50.69 Favored Pre-proline 0 C--N 1.32 -0.704 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.891 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.03 154.95 9.4 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.914 1.743 . . . . 0.0 112.419 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -99.16 165.63 11.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.133 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 22.1 m-85 -137.1 122.58 19.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -147.26 133.7 19.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.233 0.54 . . . . 0.0 110.426 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 54.11 35.44 22.34 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.708 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.02 -5.65 52.94 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.145 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.8 156.88 17.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -106.48 130.92 54.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.071 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 4.8 m-85 -120.84 177.52 5.06 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.89 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.65 175.46 1.94 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.198 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.66 135.07 43.59 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.235 1.957 . . . . 0.0 111.688 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.56 -2.76 84.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -77.85 136.68 38.11 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.71 152.05 23.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.08 0.466 . . . . 0.0 111.126 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.0 m -145.88 151.2 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.549 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -103.31 135.09 45.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.413 0.625 . . . . 0.0 110.254 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' ASN . 49.6 mt -134.42 84.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 49.97 85.01 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.89 -33.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 99' ' ' ASP . 2.0 t-20 -90.17 136.94 32.74 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.446 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -120.86 152.97 37.77 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.05 0.452 . . . . 0.0 110.973 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.0 m -140.57 154.77 46.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.346 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.88 139.68 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.393 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 24.1 t -71.78 109.64 5.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.288 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -140.07 122.78 16.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.67 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 62.55 51.37 3.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.286 0.565 . . . . 0.0 109.871 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 54.8 ttt-85 51.23 19.11 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.129 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -136.76 153.63 50.78 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 109.978 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -90.18 130.81 36.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.451 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -105.09 94.43 5.23 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.98 133.15 36.15 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.635 0.731 . . . . 0.0 111.79 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.431 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 65.4 m -63.89 -52.53 59.51 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.681 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 95.1 m-20 60.25 31.54 20.5 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.44 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -96.54 170.15 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.047 178.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.5 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 10' ' ' MET . 4.4 mpp? . . . . . 0 CA--C 1.524 -0.037 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.05 122.58 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.071 0.462 . . . . 0.0 111.013 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -132.28 157.32 44.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.93 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.406 ' HB2' ' HE ' ' A' ' 93' ' ' ARG . 1.7 p -47.83 -13.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.54 ' C ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -85.49 -40.95 15.79 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.338 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.54 HD21 ' C ' ' A' ' 32' ' ' GLN . 2.0 m120 -108.9 -5.94 15.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 30' ' ' THR . 18.7 t80 -49.61 -49.71 45.76 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.108 -0.37 . . . . 0.0 110.243 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -99.93 -3.33 32.57 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 33' ' ' ASN . 3.2 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.779 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 12.7 p . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.28 165.41 17.0 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.889 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.78 47.95 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.51 157.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.787 2.325 . . . . 0.0 112.171 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.87 -18.79 63.39 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.602 2.201 . . . . 0.0 111.887 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.92 -17.24 44.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 mtp -111.14 149.71 30.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.909 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.01 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.484 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -74.17 122.5 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.719 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -135.55 124.04 23.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 60.0 tt0 51.97 33.46 11.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.472 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.1 m120 79.51 14.24 1.02 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.019 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -124.77 148.04 48.34 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -103.95 113.81 27.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 0.0 111.176 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 m -123.81 161.02 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.001 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.4 144.6 53.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.46 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.96 -51.11 32.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.273 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -60.74 -17.41 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -102.5 -8.99 20.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.533 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.4 138.45 67.93 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.552 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.76 158.43 53.65 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.147 1.898 . . . . 0.0 112.418 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.03 165.63 11.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.454 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.22 128.39 35.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.932 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -141.3 118.56 11.39 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.416 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 60.55 45.57 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.03 -6.22 28.71 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.256 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -102.78 149.14 24.78 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.849 0.357 . . . . 0.0 110.276 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 74' ' ' GLU . 7.2 tm-20 -103.89 129.64 51.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.652 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 11.4 m-85 -118.53 178.33 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.461 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.66 165.55 13.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.443 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.18 134.56 56.66 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.617 2.212 . . . . 0.0 111.454 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.93 80.79 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -78.64 134.29 37.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.43 151.15 23.87 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.837 0.827 . . . . 0.0 111.645 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 151.79 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.592 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -99.81 131.86 45.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.807 0.337 . . . . 0.0 110.592 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' ASN . 76.8 mt -129.9 119.44 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.866 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.11 -110.53 1.18 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.16 4.09 20.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.047 0.451 . . . . 0.0 110.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ILE . 4.2 p30 -126.02 155.9 40.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.773 0.797 . . . . 0.0 110.306 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -114.95 152.24 32.7 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.235 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -133.57 157.03 46.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.222 -178.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.85 144.72 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.564 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.683 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 76.6 m -69.47 107.55 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.742 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.576 HH21 ' ND2' ' A' ' 96' ' ' ASN . 67.3 ttp85 -139.52 120.73 14.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 94' ' ' LYS . 98.3 m-20 61.94 51.71 3.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.469 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 31' ' ' CYS . 45.0 mtp180 55.68 9.83 0.46 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.008 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 92' ' ' ASP . 72.5 mmtt -133.1 156.49 47.33 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.683 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 96.2 m95 -88.06 132.96 34.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.576 ' ND2' HH21 ' A' ' 91' ' ' ARG . 5.3 t-20 -106.64 102.29 11.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 57.8 m -88.1 134.79 33.68 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.26 0.553 . . . . 0.0 111.61 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.546 ' CG2' ' H ' ' A' ' 99' ' ' ASP . 9.1 t -60.67 -52.47 64.99 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.501 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.546 ' H ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER 77.35 -0.51 2.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.07 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 1.4 p80 -42.6 170.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 14.6 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.127 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.433 ' H1 ' ' H ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . . . 50.42 38.62 18.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.748 0.308 . . . . 0.0 110.661 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.1 ttp -94.36 116.73 29.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 6' ' ' CYS . . . -63.75 -42.34 98.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t 53.12 8.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.524 ' H ' ' C ' ' A' ' 4' ' ' GLY . 7.7 p -84.25 64.37 8.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.665 ' HE ' ' NH2' ' A' ' 55' ' ' ARG . 2.1 mtt-85 49.42 178.05 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.314 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.89 105.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.977 1.785 . . . . 0.0 110.64 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' C ' ' SD ' ' A' ' 10' ' ' MET . 88.3 Cg_endo -83.61 145.72 11.77 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.839 1.693 . . . . 0.0 113.226 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.541 ' N ' ' SD ' ' A' ' 10' ' ' MET . 2.9 mpp? -114.25 -55.78 2.46 Favored 'General case' 0 N--CA 1.46 0.066 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.62 124.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.584 ' HZ1' ' CG1' ' A' ' 14' ' ' VAL . 64.3 tttm -86.8 132.76 33.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.256 0.55 . . . . 0.0 110.81 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 pp -132.42 124.45 28.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.898 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.584 ' CG1' ' HZ1' ' A' ' 12' ' ' LYS . 33.3 m -113.87 159.37 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 1.3 m -107.95 105.29 56.0 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.208 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 15' ' ' CYS . 82.4 Cg_exo -46.0 -179.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.957 1.771 . . . . 0.0 112.475 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.76 78.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -98.55 4.41 48.17 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' GLU . 1.9 m120 64.87 52.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.024 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.83 -40.3 75.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.528 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 63.3 ttm-85 -64.32 -43.3 95.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.531 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 24' ' ' GLY . . . -95.63 -1.64 49.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.998 0.428 . . . . 0.0 110.709 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 19' ' ' ASN . 98.9 mt-10 51.17 11.8 0.11 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.439 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 22' ' ' ALA . . . 73.83 -48.08 1.6 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.96 -43.54 98.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.958 0.409 . . . . 0.0 110.616 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -79.2 145.77 33.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.159 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.16 -48.56 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.606 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 71.5 p -134.14 159.95 39.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.383 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 6.5 ttpt -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.685 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -137.12 156.65 48.1 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.6 t -46.46 -17.05 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.33 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 30' ' ' THR . 12.6 pt20 -84.97 -42.75 14.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.4 m-20 -109.31 -2.44 17.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.284 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.5 t80 -44.27 -53.0 7.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -105.74 -3.63 21.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASN . 31.4 mt -114.33 173.83 6.26 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.087 0.47 . . . . 0.0 110.695 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -48.7 152.94 0.89 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.308 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 39' ' ' MET . 8.0 t -103.91 159.35 15.72 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.956 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.558 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 97.1 mmm -78.78 146.66 33.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.185 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -60.4 -43.01 97.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttp -87.75 129.27 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.23 -36.13 0.96 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -65.51 -39.94 92.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.08 0.467 . . . . 0.0 110.238 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 45' ' ' SER . 26.6 m -84.39 128.46 38.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.664 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 44' ' ' VAL . 5.8 t 20.32 92.57 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.649 1.218 . . . . 0.0 110.949 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.88 160.54 28.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 29.6 p -122.08 119.05 30.23 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.699 0.285 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.0 mt -123.73 -174.59 3.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 50' ' ' PRO . 69.1 m -92.48 149.76 38.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.301 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 99.6 Cg_exo -38.47 165.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.745 2.297 . . . . 0.0 112.62 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' C ' ' HZ2' ' A' ' 29' ' ' LYS . 53.2 Cg_exo -53.87 -48.17 23.2 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.052 1.835 . . . . 0.0 112.926 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.15 -6.24 82.61 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.539 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.9 mtp -112.83 154.38 26.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 111.023 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.91 152.25 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.665 ' NH2' ' HE ' ' A' ' 7' ' ' ARG . 80.1 ttt-85 -86.72 117.61 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.289 0.566 . . . . 0.0 110.887 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -138.55 126.45 22.44 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.349 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 46.83 45.56 15.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.261 0.553 . . . . 0.0 110.352 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER 63.04 8.44 3.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.978 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -120.43 149.24 42.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -97.34 128.08 43.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.516 . . . . 0.0 110.385 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.59 155.17 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.582 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 148.33 47.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.588 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.01 -52.22 52.15 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.024 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.62 -15.58 29.69 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.533 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -104.25 -4.9 22.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.473 0.177 . . . . 0.0 111.45 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -53.79 151.78 11.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.438 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 92.4 Cg_endo -74.51 156.66 45.2 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 110.99 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -116.25 151.69 35.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.069 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 3.5 m-85 -120.94 130.85 54.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.087 0.47 . . . . 0.0 110.58 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.506 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.5 t60 -152.79 98.54 2.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.033 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 30.8 tt0 87.81 36.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.963 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.17 -5.59 48.78 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.0 148.45 26.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 110.522 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.88 125.39 41.28 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.988 0.423 . . . . 0.0 110.966 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 26.5 m-85 -114.53 177.06 4.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.8 173.58 3.15 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.695 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.56 139.12 62.6 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.248 1.965 . . . . 0.0 111.472 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.7 0.16 67.36 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -81.73 129.22 34.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.35 145.07 30.77 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.112 0.958 . . . . 0.0 112.313 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' OG1' ' A' ' 87' ' ' THR . 22.2 m -138.08 153.78 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.17 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.72 130.42 48.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.756 0.312 . . . . 0.0 110.159 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.14 98.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.3 -116.68 7.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 3.6 40.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.115 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.75 159.01 35.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 81' ' ' VAL . 1.1 t -123.25 153.29 40.36 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -134.51 151.1 50.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.432 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.26 138.86 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.36 116.01 12.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.346 0.593 . . . . 0.0 111.124 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -144.0 118.78 9.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.325 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.29 51.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 54.23 12.24 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 157.54 44.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.68 133.48 36.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.8 m-80 -112.86 109.36 18.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.609 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 65.2 m -89.21 134.6 33.97 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.384 0.612 . . . . 0.0 111.792 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.597 HG21 ' H ' ' A' ' 100' ' ' HIS . 0.8 OUTLIER -71.68 -37.04 70.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.913 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.52 32.65 19.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.597 ' H ' HG21 ' A' ' 98' ' ' THR . 15.0 p80 -61.04 171.26 1.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.576 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 103' ' ' ASP . 62.7 t -55.05 135.44 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.305 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 34.8 t -66.82 69.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.665 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 101' ' ' VAL . 68.5 t0 . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.762 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.65 140.54 55.49 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 ttp -123.51 128.98 50.54 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.76 -178.28 39.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 7' ' ' ARG . 63.2 m -79.65 -12.22 59.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.365 . . . . 0.0 110.577 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.541 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 8.3 t -60.24 81.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.241 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.582 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.4 ttm-85 -66.83 -43.96 50.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 7' ' ' ARG . 58.1 Cg_endo -90.86 108.37 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.014 2.476 . . . . 0.0 110.793 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.01 116.79 2.49 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.568 1.512 . . . . 0.0 111.946 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.439 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 44.5 mtm -122.32 -58.79 1.68 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.264 -0.273 . . . . 0.0 110.589 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.06 115.36 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.2 137.05 34.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.181 0.515 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -137.4 128.57 27.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.771 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.77 122.6 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.431 0.634 . . . . 0.0 110.144 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OD1' ' A' ' 19' ' ' ASN . 2.3 t -100.21 105.17 34.28 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' CYS . 86.7 Cg_exo -46.32 179.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.105 1.87 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -47.69 84.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.671 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -95.9 5.41 51.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.42 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.521 ' OD1' ' SG ' ' A' ' 15' ' ' CYS . 52.0 m-20 59.45 57.04 3.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.48 20.0 19.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.77 52.29 0.93 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.045 0.45 . . . . 0.0 110.112 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.88 158.67 23.91 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.08 0.466 . . . . 0.0 110.283 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -64.86 -35.74 82.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.29 -12.85 0.6 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.34 135.1 34.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.837 0.351 . . . . 0.0 110.324 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.74 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 p -154.61 -124.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.38 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' SG ' ' A' ' 38' ' ' CYS . 66.6 p -84.84 168.27 15.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.481 0.182 . . . . 0.0 110.66 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 3.7 tttp -147.05 89.94 1.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -135.64 156.08 49.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.991 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.465 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 1.5 t -52.12 -4.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.9 pt20 -100.4 -42.36 6.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.302 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.2 m-20 -113.74 -2.8 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.027 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' THR . 15.1 t80 -51.88 -45.47 64.14 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -102.17 -3.8 26.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.636 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 33' ' ' ASN . 50.5 mt -120.38 174.88 6.26 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.944 0.402 . . . . 0.0 111.052 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.07 149.16 45.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.012 0.434 . . . . 0.0 110.994 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 90.5 m -82.98 145.86 29.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 41' ' ' MET . 4.7 ptp -66.06 -178.88 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.198 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 m -47.31 88.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.53 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 39' ' ' MET . 7.5 tpp -149.23 124.72 10.32 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.92 37.51 3.78 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t 52.99 100.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.844 0.354 . . . . 0.0 110.143 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.85 159.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.3 t -55.95 134.16 52.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 110.76 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.92 -175.19 45.76 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.541 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 1.6 p -123.16 129.63 51.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.947 0.403 . . . . 0.0 111.134 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.08 -172.96 2.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -103.28 173.39 3.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.12 157.11 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.544 2.163 . . . . 0.0 112.344 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 32.1 Cg_endo -62.15 -27.97 79.28 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.602 2.201 . . . . 0.0 112.198 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 -8.79 75.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.11 153.0 31.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.002 0.429 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.96 135.05 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.945 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -73.84 129.75 38.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' ARG . 3.5 t60 -139.11 130.33 26.78 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.052 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 22.1 tp10 45.72 26.64 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 40.9 t30 88.56 10.27 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.916 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' HIS . 2.1 ptm180 -126.92 151.94 47.78 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.8 m -99.42 131.56 45.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.301 0.572 . . . . 0.0 110.539 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.03 157.17 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.574 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.04 148.8 48.37 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.456 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.8 mm? -52.17 -46.21 65.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.176 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.75 -13.42 62.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.441 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -102.07 -6.9 22.79 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 110.987 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.15 148.9 49.44 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.34 162.26 40.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.624 2.216 . . . . 0.0 111.83 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.6 m -103.41 166.19 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 17.8 m-85 -132.23 123.12 26.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.948 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.463 ' NE2' ' CD1' ' A' ' 83' ' ' ILE . 13.4 t60 -142.67 126.92 17.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 110.049 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.6 42.15 29.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.62 -3.38 49.47 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.353 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -104.31 151.33 23.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.975 0.417 . . . . 0.0 110.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -104.63 129.14 52.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.654 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 10.4 m-85 -117.53 176.51 5.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.486 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.74 162.55 24.73 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.765 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.6 136.06 68.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.411 2.074 . . . . 0.0 111.522 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.42 -2.62 86.9 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' C ' ' OE1' ' A' ' 79' ' ' GLU . 9.5 tm-20 -82.78 137.46 34.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -104.9 149.69 25.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.789 0.804 . . . . 0.0 111.966 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' O ' ' OG1' ' A' ' 87' ' ' THR . 18.4 m -140.16 146.07 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.399 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 84' ' ' GLY . 6.0 tmtt? -101.82 129.43 48.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 70' ' ' HIS . 81.4 mt -129.52 117.31 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . . . 56.41 -117.83 10.12 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.443 ' C ' ' HZ3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -102.19 1.98 36.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.328 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 6.7 p30 -125.81 162.38 25.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.397 0.617 . . . . 0.0 111.044 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 81' ' ' VAL . 1.3 t -127.88 157.57 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.909 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.38 163.01 33.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.29 142.41 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.19 105.55 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.426 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -137.7 122.42 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.593 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 60.14 51.94 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.37 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 62.7 mtp180 54.47 12.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.157 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -132.91 158.07 43.52 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -92.86 133.73 35.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -105.53 94.21 5.08 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.7 m -82.0 135.03 35.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.187 0.518 . . . . 0.0 111.226 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.583 ' CG2' ' H ' ' A' ' 99' ' ' ASP . 8.0 t -63.46 -52.57 60.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.281 1.039 . . . . 0.0 110.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.583 ' H ' ' CG2' ' A' ' 98' ' ' THR . 27.7 t0 68.74 18.76 8.64 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.929 -1.941 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 3.6 p80 -59.6 171.27 0.88 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 62.0 t -55.33 134.94 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 102' ' ' CYS . 28.6 t -63.09 70.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . 67.6 t0 . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.534 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.01 140.53 57.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 110.577 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 ttp -102.2 121.77 42.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.565 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.95 -171.58 42.4 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 m -56.26 -173.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.71 0.29 . . . . 0.0 110.256 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 7.9 t 56.72 96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.664 ' NH2' HH22 ' A' ' 55' ' ' ARG . 2.3 mpp_? -72.41 -64.9 0.86 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.585 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' O ' ' SD ' ' A' ' 10' ' ' MET . 31.7 Cg_endo -62.06 110.73 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.312 2.008 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -83.07 118.86 2.73 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.942 1.761 . . . . 0.0 112.588 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.555 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -128.96 -59.45 1.12 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.52 107.58 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -81.35 141.89 33.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.285 0.564 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.34 122.54 15.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.671 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.98 160.9 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.13 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 26.9 m -108.04 115.06 59.15 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -46.31 177.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.93 1.753 . . . . 0.0 112.845 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.86 90.19 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 94.8 m-20 -104.08 21.46 16.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.003 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 13.4 p30 44.0 62.18 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.235 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.01 21.1 15.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.26 55.52 1.45 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.996 0.427 . . . . 0.0 110.153 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.62 157.25 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.574 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -142.36 173.57 11.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.61 94.09 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.8 mm? -64.51 -39.7 94.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.769 0.319 . . . . 0.0 110.503 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -61.79 -34.42 75.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.9 t -40.32 -76.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.544 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 m -149.77 160.39 43.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.406 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 35.0 mtpt -147.72 91.39 1.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 32' ' ' GLN . 36.4 p -131.25 152.57 50.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.832 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -50.42 -4.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.742 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.592 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.6 pt20 -104.31 -54.43 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.655 0.264 . . . . 0.0 111.618 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.49 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 27.7 p30 -93.3 -7.11 45.85 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.687 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -44.29 -47.5 9.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.248 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 17.1 p-10 -102.02 -0.63 33.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 32' ' ' GLN . 4.5 mt -117.82 174.66 6.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.29 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -77.86 142.64 38.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.748 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.6 p -83.12 165.22 19.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.27 166.01 3.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.313 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -68.3 61.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.806 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 93.2 mmm -63.75 -41.6 97.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 21.39 74.67 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 6.9 t 65.47 96.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.559 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.45 156.88 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.496 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -61.36 132.33 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.375 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.32 175.57 46.69 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.533 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.8 p -117.25 146.48 43.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 110.511 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' O ' ' SD ' ' A' ' 10' ' ' MET . 95.6 mt -136.68 -173.41 3.42 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.172 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 50' ' ' PRO . 93.2 m -96.35 150.6 37.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.944 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 49' ' ' CYS . 84.4 Cg_exo -34.2 158.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.568 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.3 Cg_endo -58.14 -26.68 77.02 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.791 2.327 . . . . 0.0 112.179 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.5 -1.32 60.59 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtp -122.95 164.34 18.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.31 -0.445 . . . . 0.0 111.23 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.11 148.79 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.664 HH22 ' NH2' ' A' ' 7' ' ' ARG . 78.9 ttt-85 -76.26 123.05 25.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.153 0.501 . . . . 0.0 110.712 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.95 127.95 22.19 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 55.2 tt0 47.42 35.07 3.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.6 m-20 76.31 9.39 3.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.745 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -127.1 152.1 47.76 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.66 126.95 40.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 0.0 109.992 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.42 156.98 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.942 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.97 41.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.464 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 4.3 mm? -48.05 -50.24 28.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.111 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -59.67 -14.34 13.48 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.188 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -99.95 -6.58 26.38 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.471 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.9 m -55.11 138.87 65.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.197 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.79 159.99 47.2 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.593 2.195 . . . . 0.0 112.138 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.76 167.07 10.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.812 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.98 129.71 32.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -142.72 122.73 13.62 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 58.86 42.8 19.17 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.617 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.09 -3.98 34.65 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.119 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -101.79 142.02 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -96.23 129.08 43.63 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.194 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 39.0 m-85 -118.95 176.91 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.003 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.89 164.51 16.44 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.34 133.96 55.76 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.519 2.146 . . . . 0.0 111.529 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.92 86.51 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 80' ' ' THR . 11.1 tm-20 -80.74 138.67 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.423 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -110.66 154.9 23.17 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.622 0.725 . . . . 0.0 111.696 -177.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.9 150.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.61 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -99.71 131.55 45.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 86' ' ' ASN . 55.6 mt -135.26 99.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.687 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 41.34 78.23 0.07 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER 63.35 -29.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.667 0.27 . . . . 0.0 110.918 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.654 ' H ' ' C ' ' A' ' 84' ' ' GLY . 23.4 t-20 -89.92 128.62 36.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.229 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.493 ' H ' ' HE2' ' A' ' 100' ' ' HIS . 0.6 OUTLIER -111.28 148.02 33.8 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.804 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.61 153.55 51.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.168 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.93 146.27 29.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.515 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.649 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 77.1 m -71.31 108.66 4.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -139.84 114.63 9.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.363 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 68.92 50.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.407 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 55.99 11.93 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.53 161.02 34.84 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.649 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 95.3 m95 -93.34 130.41 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.115 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.0 t-20 -105.88 105.41 15.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.728 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 53.3 m -87.92 132.62 34.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.627 0.727 . . . . 0.0 112.808 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 52.5 m -61.58 -47.9 83.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.359 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' THR . 14.6 t0 79.04 11.06 1.51 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.952 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.549 ' N ' ' CD2' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.91 151.38 45.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.98 130.42 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.032 0.444 . . . . 0.0 110.486 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -149.49 5.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.444 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' GLY . . . -71.09 145.3 49.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 110.429 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.0 mtt 46.18 21.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.79 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 2' ' ' ALA . . . -72.45 171.18 49.73 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 m -71.38 144.9 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 110.487 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 7' ' ' ARG . 26.4 p -159.95 148.88 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.586 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.553 ' CD ' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -38.83 162.3 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.163 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' C ' ' O ' ' A' ' 7' ' ' ARG . 84.2 Cg_exo -31.51 104.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.769 2.313 . . . . 0.0 111.438 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -55.3 110.97 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.994 1.796 . . . . 0.0 113.68 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.578 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 58.9 mtm -124.06 -46.59 1.94 Allowed 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.63 120.29 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.68 111.23 22.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.551 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pp -110.64 129.62 55.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.604 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' CG2' ' NH2' ' A' ' 21' ' ' ARG . 3.6 m -124.39 164.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' CG ' ' A' ' 19' ' ' ASN . 41.4 t -103.16 104.49 40.78 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.792 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -47.27 178.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.009 1.806 . . . . 0.0 112.692 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.39 94.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.986 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.16 1.4 44.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.17 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 65.42 61.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.978 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.61 21.75 13.71 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' NH2' ' CG2' ' A' ' 14' ' ' VAL . 63.0 ttp85 -150.38 56.07 0.93 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.384 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' GLY . . . -75.16 -13.25 60.45 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 38.4 29.47 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.334 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -170.38 172.48 44.05 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' CYS . 67.9 mt -76.58 80.76 3.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.368 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 57.16 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.598 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LEU . 3.7 m -78.43 -144.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.366 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.5 p -86.69 -157.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.259 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.669 ' NZ ' ' H ' ' A' ' 52' ' ' GLY . 77.6 tttt -147.69 94.45 2.36 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 110.448 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 32' ' ' GLN . 6.4 m -136.78 155.84 49.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.872 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 3.7 t -59.15 1.37 0.07 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.017 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.0 pt20 -104.06 -44.0 5.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.622 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' LEU . 96.5 m-20 -111.81 -7.14 14.21 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.9 t80 -48.52 -47.13 39.24 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.935 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 48.8 t0 -101.45 -5.2 25.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 110.463 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 33' ' ' ASN . 45.0 mt -120.67 130.09 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.603 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 56.1 mp0 -54.05 138.02 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 40' ' ' SER . 26.7 p -67.77 161.42 26.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.614 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.1 ttm -61.31 -40.22 93.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.098 0.475 . . . . 0.0 110.581 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 32.3 t -115.5 104.62 11.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.361 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 27' ' ' CYS . 82.8 mmm -77.84 143.74 37.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.463 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.61 156.71 7.14 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 22.1 p -76.54 112.51 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.085 0.469 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.55 127.17 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.23 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.2 t -62.1 145.55 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.49 172.34 44.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 102.05 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -120.23 -172.66 2.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -90.44 171.75 7.97 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.617 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' CD ' ' SG ' ' A' ' 49' ' ' CYS . 25.6 Cg_exo -61.55 -179.84 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.298 1.999 . . . . 0.0 112.673 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.53 151.43 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.791 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.669 ' H ' ' NZ ' ' A' ' 29' ' ' LYS . . . 79.76 -9.57 43.58 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mtp -116.68 152.23 34.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.214 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.8 139.6 50.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.257 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.474 ' NH1' ' CZ ' ' A' ' 7' ' ' ARG . 36.5 ptt180 -73.55 126.35 30.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.385 0.612 . . . . 0.0 110.516 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' ARG . 1.9 t60 -133.88 122.83 23.73 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.905 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 80.9 mt-10 46.99 31.68 1.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.788 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.4 m120 83.71 11.43 0.43 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.553 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' HIS . 3.1 ptm180 -125.79 149.02 48.92 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.0 m -97.5 133.44 42.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.899 -0.5 . . . . 0.0 110.589 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.62 157.73 24.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.288 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.31 150.45 45.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.297 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.9 mm? -49.16 -46.61 45.54 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.52 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.99 -14.38 61.52 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.868 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -101.39 -8.98 21.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.801 0.334 . . . . 0.0 110.952 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 147.02 30.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.615 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.55 163.73 37.7 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.692 2.262 . . . . 0.0 111.582 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.41 158.48 22.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.921 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -127.89 128.11 44.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.398 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -144.82 126.18 14.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 59.24 37.88 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.502 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.95 -5.2 50.2 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.096 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -102.2 145.7 29.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 0.0 109.875 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -100.73 129.31 46.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 29.0 m-85 -118.96 177.31 4.91 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.316 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.79 175.11 2.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.736 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.37 138.75 67.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.429 2.086 . . . . 0.0 111.605 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.97 -0.86 61.19 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.29 134.0 36.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.85 151.6 24.32 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.029 0.443 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.72 148.52 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.656 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -96.52 129.14 43.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 86' ' ' ASN . 97.9 mt -136.78 127.06 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.961 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 86' ' ' ASN . . . 32.52 83.97 0.01 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 1.6 p 41.48 13.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.627 0.251 . . . . 0.0 111.441 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 84' ' ' GLY . 8.8 m120 -128.04 161.1 29.97 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.97 149.68 52.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.165 0.507 . . . . 0.0 111.006 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 m -137.33 157.65 46.13 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.707 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.86 144.09 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.658 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 71.2 m -67.01 107.11 2.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -137.71 118.61 14.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 63.48 50.73 2.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.584 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 58.1 mtp180 55.92 11.95 0.8 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.3 160.86 35.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 110.054 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.658 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 93.5 m95 -93.1 131.94 37.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.101 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -106.26 94.29 5.07 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 95.2 m -78.26 135.24 37.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.605 0.717 . . . . 0.0 111.576 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 m -59.62 -45.48 91.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 59.47 28.0 17.28 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.559 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.589 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -76.78 170.53 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.827 177.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -40.74 122.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.647 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 102' ' ' CYS . 7.3 t -79.93 74.34 6.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.072 0.463 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.7 t0 . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.519 179.753 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.31 93.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.569 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.6 mtp -95.02 137.34 34.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.0 165.63 38.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 m -83.35 -5.47 59.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 7' ' ' ARG . 19.3 p -40.73 153.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.655 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.584 ' CZ ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -40.04 163.97 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.093 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' A' ' 7' ' ' ARG . 93.2 Cg_exo -31.02 107.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 122.938 2.425 . . . . 0.0 111.464 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.62 121.76 4.77 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.642 1.561 . . . . 0.0 113.325 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' ' SG ' ' A' ' 49' ' ' CYS . 64.7 mtm -128.43 -41.85 1.52 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.44 118.98 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -86.8 133.87 33.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.504 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.52 118.59 18.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.669 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 5.7 m -101.57 116.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.909 0.385 . . . . 0.0 110.476 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.497 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -49.8 123.83 15.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 -179.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 73.5 Cg_exo -45.26 -179.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.845 1.697 . . . . 0.0 112.922 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.15 91.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.383 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -108.59 15.03 24.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.28 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' ALA . 5.5 m120 62.56 58.08 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.785 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' H ' ' HB2' ' A' ' 16' ' ' PRO . 4.4 mm? -65.81 -41.5 91.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.438 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 70.2 ttt180 -66.84 -43.24 84.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.422 . . . . 0.0 110.799 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -95.67 168.38 10.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.804 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 54.3 26.2 6.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -159.48 -85.24 0.05 OUTLIER Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.5 tp -71.58 -88.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -147.88 98.66 2.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.3 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 p -60.44 -25.33 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.438 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' NH2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -138.88 170.26 16.32 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -149.67 90.27 1.69 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' TYR . 10.6 m -128.27 165.28 20.82 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.9 m -55.08 -13.11 1.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.154 -0.341 . . . . 0.0 110.663 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -96.87 -38.01 10.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.492 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 36' ' ' LEU . 6.2 m120 -106.0 -4.96 19.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 30' ' ' THR . 22.2 t80 -44.36 -53.88 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.228 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 20.2 p-10 -102.8 -0.2 31.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.421 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' ASN . 55.4 mt -120.06 165.89 14.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.694 0.283 . . . . 0.0 110.681 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.97 139.13 52.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.773 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 p -88.31 135.25 33.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 41' ' ' MET . 66.9 mtt -79.91 146.81 31.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.197 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -61.82 71.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' MET . 89.9 mmm -65.06 -39.99 94.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 44' ' ' VAL . . . 160.64 92.65 0.09 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 38.7 t -73.59 49.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.082 0.468 . . . . 0.0 110.323 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 45' ' ' SER . 10.3 p -159.39 138.48 3.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 44' ' ' VAL . 29.0 p 20.34 98.82 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.594 1.184 . . . . 0.0 111.228 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.27 145.62 16.18 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 95.51 5.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.917 -0.642 . . . . 0.0 110.142 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -118.68 -174.58 2.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.73 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' SG ' ' CE ' ' A' ' 10' ' ' MET . 0.4 OUTLIER -86.98 161.41 47.04 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.064 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.42 168.11 23.37 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.651 2.234 . . . . 0.0 112.622 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.39 145.99 53.86 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.035 1.824 . . . . 0.0 112.163 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.54 -23.02 24.51 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 96.2 mmm -116.43 155.71 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 109.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.21 -167.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.85 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 7' ' ' ARG . 68.7 mtm180 -120.7 118.07 29.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.54 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -135.97 126.53 27.0 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 44.74 45.07 8.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.213 0.53 . . . . 0.0 110.102 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.9 m120 68.21 10.41 7.82 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -126.46 152.95 45.75 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -100.26 134.04 43.77 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.704 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.84 155.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.18 153.11 44.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.473 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -52.46 -50.81 61.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.41 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -56.62 -15.57 4.66 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.88 -1.52 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.091 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -55.22 115.61 9.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.45 159.47 2.07 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.737 1.625 . . . . 0.0 112.406 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.01 166.62 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -136.39 130.75 33.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.416 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.4 t60 -150.94 104.21 3.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.247 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 32.0 tt0 83.1 37.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.34 48.67 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -104.07 145.45 30.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -97.83 127.22 43.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 37.9 m-85 -115.11 177.24 4.73 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.127 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.73 170.12 6.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.37 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.34 138.28 65.19 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.969 1.779 . . . . 0.0 111.306 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.25 -1.23 76.8 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.51 128.47 34.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.48 145.74 29.85 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.688 0.756 . . . . 0.0 111.886 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.22 154.37 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -101.08 130.24 47.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 77.2 mt -128.45 106.61 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.87 -116.78 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' NE2' ' A' ' 100' ' ' HIS . 7.6 p -103.99 3.94 33.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.03 0.443 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 17.3 p30 -126.27 164.72 20.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.393 0.615 . . . . 0.0 110.61 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.32 152.07 41.81 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.879 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.76 150.62 52.14 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.2 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.55 140.85 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.52 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 t -71.11 110.26 5.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.74 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -140.9 118.93 11.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.794 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 94' ' ' LYS . 34.5 t0 63.96 50.52 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.317 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 55.59 9.27 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.296 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 92' ' ' ASP . 64.2 tttp -129.71 155.91 45.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -94.63 134.42 37.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.437 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 98.5 m-20 -111.67 104.44 12.8 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.632 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 78.4 m -86.94 137.92 31.96 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.913 0.863 . . . . 0.0 112.175 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 100' ' ' HIS . 2.8 m -61.03 -44.78 96.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t0 55.0 29.61 12.63 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.074 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.469 ' NE2' ' O ' ' A' ' 85' ' ' CYS . 0.3 OUTLIER -70.6 172.21 8.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -38.24 126.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.705 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 7.2 t -80.95 72.41 7.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.698 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.429 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' H3 ' ' H ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . . . -69.34 140.45 54.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.476 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -139.15 145.18 39.08 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.67 84.22 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 p 44.2 89.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.705 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 30.3 p -82.87 40.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.623 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 56.26 159.93 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CE ' ' A' ' 10' ' ' MET . 80.1 Cg_exo -31.17 105.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.696 2.264 . . . . 0.0 111.308 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.28 141.47 20.47 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.907 1.738 . . . . 0.0 112.701 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -124.42 -42.91 2.07 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.39 117.01 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.1 131.12 34.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.029 0.443 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.94 122.92 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.776 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.37 162.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.838 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 85.4 m -106.52 102.15 39.69 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.484 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 15' ' ' CYS . 61.7 Cg_exo -46.17 179.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.037 1.825 . . . . 0.0 112.601 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.52 82.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.756 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.42 5.15 48.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.998 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 58.65 63.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.883 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.73 21.58 14.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -100.25 -41.84 6.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.883 0.373 . . . . 0.0 110.012 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.72 138.76 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.732 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 25' ' ' LEU . 22.2 pt-20 -167.86 135.08 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.643 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.43 -30.16 0.58 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' H ' ' C ' ' A' ' 23' ' ' GLU . 91.4 mt -125.13 145.06 50.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 110.282 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 95.6 mt-10 -138.83 153.52 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 28' ' ' THR . 17.1 p 40.0 -138.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.597 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 63.3 p -86.02 167.16 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.95 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -147.24 99.74 3.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.733 ' HG1' HE21 ' A' ' 32' ' ' GLN . 0.5 OUTLIER -140.82 162.56 35.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.105 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.0 t -59.26 6.45 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.081 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.733 HE21 ' HG1' ' A' ' 30' ' ' THR . 5.9 pt20 -105.13 -46.14 4.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.057 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' N ' ' CG ' ' A' ' 32' ' ' GLN . 99.2 m-20 -115.83 -3.16 12.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.014 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -50.46 -46.59 56.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.926 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 58.2 t0 -106.82 -8.51 16.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ASN . 52.8 mt -111.56 172.32 6.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.538 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -41.63 153.41 0.05 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.046 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 t -121.57 168.55 11.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.822 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 78.2 mtm -75.29 144.42 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.554 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.8 m -68.7 62.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 44.7 ttm -64.9 -40.27 94.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.31 31.62 77.61 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.6 t 66.16 92.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.688 0.28 . . . . 0.0 110.475 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.6 154.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -62.16 129.76 42.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.56 168.38 37.45 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 20.0 p -119.38 125.62 49.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 62.3 mt -123.75 -177.17 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.972 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -98.07 159.09 31.61 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' CYS . 87.5 Cg_exo -42.11 173.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.754 2.303 . . . . 0.0 112.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.03 154.72 57.72 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.507 2.138 . . . . 0.0 111.974 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 -4.37 58.71 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.1 mtp -110.54 150.22 29.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.061 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.59 137.3 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -72.31 118.59 15.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.262 0.553 . . . . 0.0 110.442 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.24 117.88 20.52 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 56.4 mm-40 53.19 35.1 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.0 m-80 77.94 10.79 2.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.745 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -123.01 151.89 41.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.7 m -98.98 128.25 45.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 0.0 110.644 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.699 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.09 143.83 57.58 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.398 0.618 . . . . 0.0 109.86 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.2 tp -51.27 -52.34 45.9 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.43 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.16 -12.92 31.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.01 0.434 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -103.29 -3.72 25.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.403 0.621 . . . . 0.0 110.464 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -54.2 149.02 20.45 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.143 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 67.4 Cg_endo -71.41 159.38 51.7 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.452 2.101 . . . . 0.0 111.132 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.06 148.98 29.97 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.188 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 7.3 m-85 -114.48 122.87 47.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.25 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -137.07 121.08 17.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 58.84 43.02 18.88 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.798 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.63 -4.79 33.76 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.699 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.12 150.52 24.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.2 mp0 -103.2 129.72 50.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.794 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 12.8 m-85 -118.16 175.53 5.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.096 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.11 167.77 9.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.201 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.19 128.29 23.52 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.561 2.174 . . . . 0.0 111.869 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.28 83.89 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -78.14 132.81 37.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.58 152.37 21.81 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.444 0.64 . . . . 0.0 110.931 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.44 150.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.179 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 14.9 tptp -98.72 131.48 44.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 86' ' ' ASN . 56.6 mt -135.01 114.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 34.68 66.09 0.34 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.56 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 70.78 -29.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.958 0.409 . . . . 0.0 110.909 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.597 ' H ' ' C ' ' A' ' 84' ' ' GLY . 59.8 t-20 -87.58 133.82 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.358 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.643 ' H ' ' HE2' ' A' ' 100' ' ' HIS . 0.6 OUTLIER -108.78 148.92 29.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.63 151.76 50.56 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.53 144.29 35.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.4 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 87.2 m -70.37 111.48 5.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -142.15 121.35 13.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.348 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 61.74 50.62 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.263 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 57.63 10.14 0.97 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.285 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -133.89 152.78 51.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.326 0.584 . . . . 0.0 110.055 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.628 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 94.9 m95 -83.39 133.5 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.108 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.442 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.2 t-20 -108.58 104.53 13.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.781 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 55.8 m -86.97 132.88 33.66 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.014 0.911 . . . . 0.0 112.235 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.1 m -58.07 -45.63 86.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.86 13.55 3.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.047 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.643 ' HE2' ' H ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -64.03 141.93 58.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.374 178.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -52.2 146.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.639 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.8 m -74.76 92.47 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.506 179.744 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 143.09 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.51 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.7 tpp -97.01 122.54 40.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.391 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.43 175.94 34.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 t -72.79 145.77 46.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 110.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 21.2 p -140.93 37.58 1.78 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' PRO . 30.9 mtm-85 57.96 159.25 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' O ' ' SD ' ' A' ' 10' ' ' MET . 87.4 Cg_exo -30.05 104.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 122.764 2.309 . . . . 0.0 111.174 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.42 134.09 5.62 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.063 1.842 . . . . 0.0 113.1 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 8' ' ' PRO . 5.1 mpp? -116.64 -45.69 2.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.54 120.31 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -84.84 135.32 34.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 0.0 110.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.67 132.7 44.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.351 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.49 160.92 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.588 ' SG ' ' ND2' ' A' ' 19' ' ' ASN . 36.8 t -92.77 111.98 53.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.391 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.424 ' HG2' ' H ' ' A' ' 21' ' ' ARG . 85.2 Cg_exo -46.42 179.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -46.58 86.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.806 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 41.5 t0 -99.74 6.83 45.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.851 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.588 ' ND2' ' SG ' ' A' ' 15' ' ' CYS . 3.4 t-20 61.08 66.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.025 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 1.1 mm? -95.71 -15.72 22.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.246 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 63.4 ttm-85 -70.12 -43.0 71.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 161.43 19.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.949 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -145.12 -35.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.384 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.85 -162.04 36.62 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -79.42 -159.55 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.533 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -69.03 -3.64 13.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' N ' ' OE2' ' A' ' 26' ' ' GLU . 54.4 m -71.7 146.68 48.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.619 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 29' ' ' LYS . 33.5 p -98.72 -122.9 0.14 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 11.6 ttpt -147.63 97.92 2.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.494 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -132.14 152.05 51.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 1.3 m -49.45 -13.22 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.263 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.0 pt20 -82.33 -38.63 23.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.265 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' LEU . 99.3 m-20 -113.17 -4.39 13.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.581 0.353 . . . . 0.0 111.016 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' THR . 11.9 t80 -48.56 -48.25 38.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -105.18 -7.27 19.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.021 0.438 . . . . 0.0 110.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -101.19 139.46 36.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.04 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 97.4 mt-10 -42.49 164.28 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.806 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 1.8 t 78.48 103.05 0.07 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.091 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.3 ptt? -161.35 -167.73 1.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.552 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 39' ' ' MET . 5.5 t 49.77 97.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.915 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 42' ' ' GLY . 5.6 ttt -43.95 125.74 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 44' ' ' VAL . . . -55.4 -160.91 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 53.7 t -71.3 44.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.528 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 42' ' ' GLY . 72.3 t -122.87 127.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.077 0.465 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.5 p -75.34 153.82 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.699 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 -175.7 47.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.802 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 21.8 p -122.45 126.18 47.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.9 mt -130.47 162.19 29.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.21 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -73.64 156.6 88.43 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.333 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.14 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.655 2.237 . . . . 0.0 112.16 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.7 Cg_endo -56.06 -37.74 95.84 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.518 2.145 . . . . 0.0 112.546 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.01 -0.72 86.33 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.3 mmm -118.51 160.22 22.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.523 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.423 ' O ' ' SG ' ' A' ' 49' ' ' CYS . 16.6 m -130.37 -169.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.719 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -122.13 117.58 26.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.292 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -133.16 124.45 27.51 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 44.47 49.25 8.31 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.269 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' ASN . 29.1 t-20 66.89 5.22 3.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -123.31 151.08 42.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.8 m -103.02 131.69 49.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.337 0.589 . . . . 0.0 110.944 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.48 155.94 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.421 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -65.29 150.1 48.82 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.452 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 4.3 mm? -47.04 -50.65 19.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.862 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -66.89 -14.72 63.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 62' ' ' ALA . 22.1 mmt85 -95.86 -6.18 39.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 110.439 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m -56.38 150.5 33.01 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.34 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.36 157.6 37.04 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.52 2.147 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -109.47 148.25 31.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.739 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.83 127.61 50.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.971 0.415 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -145.44 134.4 22.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.099 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 53.01 33.82 15.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.119 -0.363 . . . . 0.0 111.935 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.25 -5.83 58.59 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.224 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.68 148.85 25.07 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -101.08 127.15 47.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 9.9 m-85 -118.17 178.71 4.34 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.152 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.68 173.58 2.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.5 137.02 53.12 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.184 1.923 . . . . 0.0 111.737 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.18 82.07 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -81.98 134.37 35.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.63 148.92 24.97 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.846 0.831 . . . . 0.0 112.366 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.434 ' O ' ' OG1' ' A' ' 87' ' ' THR . 15.1 m -141.0 149.83 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.759 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 44.1 tptt -106.39 132.2 52.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 86' ' ' ASN . 54.9 mt -130.98 86.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.228 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 51.41 85.95 0.02 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.488 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER 64.76 -37.42 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.771 0.32 . . . . 0.0 111.374 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 84' ' ' GLY . 36.2 t-20 -88.88 140.76 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.123 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 1.3 t -126.99 152.61 46.99 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.042 0.448 . . . . 0.0 110.221 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.19 156.73 46.89 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.007 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 p -128.9 138.33 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.98 112.81 6.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -141.66 123.32 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.029 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 62.03 51.46 3.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.33 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.517 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 77.2 mtp180 53.36 15.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.289 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.25 161.15 35.25 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -98.36 132.09 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.92 95.83 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 86.6 m -80.56 138.74 36.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.052 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.567 ' CG2' ' H ' ' A' ' 99' ' ' ASP . 3.0 t -60.28 -53.17 60.81 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.356 1.074 . . . . 0.0 110.867 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.567 ' H ' ' CG2' ' A' ' 98' ' ' THR . 57.3 t0 60.79 26.44 16.27 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 112.977 -1.92 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.525 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.65 171.39 7.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.11 149.73 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.0 m -77.45 97.42 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--O 1.219 -0.54 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.646 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.45 94.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.41 141.64 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.556 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.4 75.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.506 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 44.1 t -61.88 -43.82 98.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.684 0.278 . . . . 0.0 110.715 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 5' ' ' SER . 1.2 p 52.96 168.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' NH1' ' CZ ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -40.72 165.08 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.859 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 7' ' ' ARG . 96.6 Cg_exo -33.01 105.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.434 2.089 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.91 144.59 17.17 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.327 2.018 . . . . 0.0 112.928 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.1 mtm -127.05 -40.3 1.87 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.874 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.29 115.13 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -90.88 111.8 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 110.195 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.67 122.71 47.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.877 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.47 163.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.665 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.493 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 57.9 m -107.63 101.5 40.18 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -50.04 178.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.193 1.929 . . . . 0.0 112.801 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.72 77.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.6 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -94.95 3.41 54.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.906 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 59.6 66.47 1.0 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.55 18.9 15.7 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -149.96 55.8 0.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.313 . . . . 0.0 110.229 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.67 22.08 6.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.242 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' GLY . 98.7 mt-10 54.57 167.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 23' ' ' GLU . . . -47.01 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.18 134.14 47.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -89.47 -179.51 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' OG ' ' A' ' 40' ' ' SER . 5.5 t 59.01 -169.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.9 p -81.51 176.73 9.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.53 95.86 2.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.767 ' H ' HD22 ' A' ' 33' ' ' ASN . 27.7 p -133.06 154.3 50.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.775 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 m -60.27 7.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.715 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.585 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 pt20 -105.72 -43.11 4.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 111.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.767 HD22 ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -108.27 -6.52 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.391 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' N ' HD21 ' A' ' 33' ' ' ASN . 77.8 t80 -44.43 -54.81 5.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.809 0.337 . . . . 0.0 110.588 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.75 -4.87 24.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 33' ' ' ASN . 62.8 mt -114.37 169.75 8.81 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.111 0.481 . . . . 0.0 111.029 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -41.89 159.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.15 170.96 8.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.668 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -83.82 -7.25 59.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.489 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.498 ' OG ' ' SG ' ' A' ' 27' ' ' CYS . 33.8 p -159.68 160.37 34.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 ttt -101.14 -54.58 2.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.62 -178.72 42.36 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -80.62 158.38 25.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 45' ' ' SER . 7.6 p -157.77 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' VAL . 5.8 t 15.77 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.19 161.54 29.15 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.887 0.715 . . . . 0.0 111.536 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.64 99.8 7.2 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.2 -173.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.881 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 174.87 4.55 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.18 167.32 17.86 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.014 1.809 . . . . 0.0 112.936 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -54.23 147.47 45.11 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.237 1.958 . . . . 0.0 112.372 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.34 -17.85 40.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.29 148.55 32.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.27 140.27 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.559 ' CZ ' ' NH1' ' A' ' 7' ' ' ARG . 66.0 mtp180 -72.6 122.69 21.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.287 0.565 . . . . 0.0 110.583 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.84 117.91 19.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 70.7 mm-40 51.1 35.0 11.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.2 m-80 79.01 11.58 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.624 0.577 . . . . 0.0 110.985 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -122.91 148.91 44.91 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.36 129.98 44.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.676 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.63 154.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.125 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 153.22 41.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.23 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -49.78 -55.64 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.855 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -57.82 -17.4 15.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.47 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.66 -3.48 32.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.9 t -54.4 116.89 11.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.413 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -48.86 153.55 3.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.259 1.973 . . . . 0.0 112.429 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -103.18 163.95 11.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.412 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 21.1 m-85 -137.06 129.3 29.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.071 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -144.48 127.82 16.83 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 55.47 39.57 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.497 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 -5.91 37.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -100.54 144.43 29.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.39 127.18 43.14 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.997 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 31.7 m-85 -120.28 178.41 4.65 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.314 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.04 172.35 3.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.508 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.33 138.79 68.03 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.339 2.026 . . . . 0.0 111.566 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.63 -1.6 71.69 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -79.35 133.25 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.6 144.51 31.6 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.82 0.819 . . . . 0.0 111.993 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.95 152.89 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.53 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -99.18 129.93 45.46 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 59.9 mt -129.17 107.85 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.094 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.64 -115.15 7.62 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.74 1.18 31.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.738 0.304 . . . . 0.0 110.454 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 19.2 p30 -127.16 159.84 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.428 0.632 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.31 151.87 35.0 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.54 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.29 147.92 52.42 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.346 -178.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.33 138.85 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.564 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.22 107.76 3.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.416 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -137.45 121.62 17.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.422 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 94' ' ' LYS . 63.6 m-20 65.34 51.41 1.58 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.654 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 56.61 9.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.621 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 92' ' ' ASP . 68.2 mttm -133.48 163.29 29.7 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -96.96 133.49 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.908 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.436 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.7 m-80 -111.58 106.57 15.45 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.621 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 62.9 m -86.42 137.03 32.88 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 112.063 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.423 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 54.2 m -58.04 -48.8 78.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.116 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 98' ' ' THR . 2.2 m-20 80.02 11.49 1.15 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.286 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.3 OUTLIER -78.76 157.91 28.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -86.14 132.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.53 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 103' ' ' ASP . 10.5 p -67.47 -53.0 32.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.442 0.639 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 98.2 m-20 . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.28 86.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.59 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.2 ttp -147.69 116.28 6.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -94.91 -177.91 37.87 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.45 ' C ' ' SG ' ' A' ' 6' ' ' CYS . 88.3 p -54.91 117.77 3.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 19.2 m -151.48 101.96 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 9.9 mpt_? -89.4 -66.36 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.092 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 56.0 Cg_endo -69.5 169.45 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.133 1.888 . . . . 0.0 111.108 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.99 96.39 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 119.033 0.69 . . . . 0.0 111.629 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.602 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 40.6 mmm -91.92 2.38 56.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.018 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 10' ' ' MET . 0.2 OUTLIER 56.74 128.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.53 178.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -86.52 132.6 33.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.154 0.502 . . . . 0.0 110.05 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp -123.78 135.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.2 159.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 16' ' ' PRO . 35.8 m -70.02 114.36 24.68 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.633 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 15' ' ' CYS . 77.5 Cg_exo -46.17 178.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.743 1.629 . . . . 0.0 112.755 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.51 -46.36 90.32 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.807 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -98.2 5.0 48.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.634 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 57.81 66.43 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.72 14.44 17.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -149.11 51.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.08 0.467 . . . . 0.0 109.874 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.24 125.11 40.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.526 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -177.17 34.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.39 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.72 -4.11 90.22 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 26' ' ' GLU . 32.6 mt -64.55 135.03 55.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.821 0.343 . . . . 0.0 110.381 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' CYS . 95.2 mt-10 -42.84 166.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.454 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 1.1 t 82.74 10.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 p -49.55 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.106 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 11.9 ptmt -147.32 105.51 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.39 0.614 . . . . 0.0 109.347 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -143.12 159.59 41.99 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 67.5 m -40.91 -25.76 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.508 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' THR . 6.6 pt20 -76.62 -44.5 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 27' ' ' CYS . 2.7 p-10 -114.4 0.08 13.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.11 0.481 . . . . 0.0 110.834 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 30' ' ' THR . 64.2 t80 -47.5 -51.85 19.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.012 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -103.43 -2.28 27.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.027 0.441 . . . . 0.0 109.829 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 33' ' ' ASN . 1.7 tp -113.33 127.48 56.15 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.04 149.4 37.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.636 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -155.21 140.47 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.236 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 39' ' ' MET . 2.0 mpt? -79.88 138.79 37.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.793 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 p -174.53 85.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.23 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 96.1 mtp -134.9 137.52 43.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.347 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.12 148.74 4.81 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.39 101.57 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 0.0 110.343 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.8 t -142.04 107.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.702 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -73.67 140.88 46.38 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.341 0.401 . . . . 0.0 111.264 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 -171.96 45.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.07 39.67 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 10' ' ' MET . 4.3 pp -119.45 -173.34 2.5 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.421 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.4 t -110.78 128.18 25.73 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.29 171.76 7.41 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.257 1.304 . . . . 0.0 113.197 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 53' ' ' MET . 26.7 Cg_exo -61.21 152.23 73.45 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.392 2.061 . . . . 0.0 112.503 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.75 -21.06 4.87 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.548 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 85.7 mmm -111.86 150.03 30.98 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.44 141.5 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.117 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -72.92 120.14 18.13 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -133.87 120.29 20.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 52.27 37.47 22.21 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.268 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 76.37 10.88 2.88 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.879 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -123.4 153.01 40.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.602 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 18.6 m -103.04 124.7 49.03 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.102 0.477 . . . . 0.0 110.135 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.07 159.74 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.314 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 145.01 51.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.625 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 tp -51.49 -53.48 36.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.66 -20.0 4.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.977 0.417 . . . . 0.0 110.442 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -98.02 -4.25 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 110.27 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.439 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 6.3 t -53.86 126.54 50.69 Favored Pre-proline 0 C--N 1.32 -0.704 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.891 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.03 154.95 9.4 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.914 1.743 . . . . 0.0 112.419 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -99.16 165.63 11.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.133 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 22.1 m-85 -137.1 122.58 19.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -147.26 133.7 19.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.233 0.54 . . . . 0.0 110.426 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 54.11 35.44 22.34 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.708 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.02 -5.65 52.94 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.145 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.8 156.88 17.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -106.48 130.92 54.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.071 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 4.8 m-85 -120.84 177.52 5.06 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.89 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.65 175.46 1.94 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.198 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.66 135.07 43.59 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.235 1.957 . . . . 0.0 111.688 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.56 -2.76 84.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -77.85 136.68 38.11 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.71 152.05 23.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.08 0.466 . . . . 0.0 111.126 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.0 m -145.88 151.2 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.549 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -103.31 135.09 45.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.413 0.625 . . . . 0.0 110.254 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' ASN . 49.6 mt -134.42 84.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 49.97 85.01 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.89 -33.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 99' ' ' ASP . 2.0 t-20 -90.17 136.94 32.74 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.446 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -120.86 152.97 37.77 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.05 0.452 . . . . 0.0 110.973 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 4.0 m -140.57 154.77 46.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.346 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.88 139.68 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.393 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 24.1 t -71.78 109.64 5.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.288 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -140.07 122.78 16.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.67 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 62.55 51.37 3.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.286 0.565 . . . . 0.0 109.871 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 54.8 ttt-85 51.23 19.11 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.129 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -136.76 153.63 50.78 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 109.978 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -90.18 130.81 36.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.451 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -105.09 94.43 5.23 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.98 133.15 36.15 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.635 0.731 . . . . 0.0 111.79 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.431 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 65.4 m -63.89 -52.53 59.51 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.681 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 95.1 m-20 60.25 31.54 20.5 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.44 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -96.54 170.15 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.047 178.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.33 144.43 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.5 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 t -65.38 95.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.9 t0 . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.659 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' H3 ' ' H ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . . . -63.57 -39.06 93.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.2 mmm -65.37 -42.58 92.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.568 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.56 -171.95 39.86 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -60.89 -42.9 98.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 25.9 p -63.89 123.31 18.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 7.0 mtp180 -82.85 -65.4 0.23 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 29.2 Cg_endo -60.71 110.09 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.269 1.98 . . . . 0.0 111.367 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' C ' ' SD ' ' A' ' 10' ' ' MET . 92.0 Cg_endo -85.83 113.97 1.36 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 121.807 1.672 . . . . 0.0 113.208 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 10' ' ' MET . 4.4 mpp? -120.29 -58.33 1.86 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.05 122.58 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.625 ' HZ3' ' CG1' ' A' ' 14' ' ' VAL . 64.1 tttm -89.91 125.15 35.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.071 0.462 . . . . 0.0 111.013 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -123.55 122.61 38.63 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.602 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.625 ' CG1' ' HZ3' ' A' ' 12' ' ' LYS . 34.1 m -111.11 160.48 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.705 0.288 . . . . 0.0 110.273 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.596 ' SG ' ' ND2' ' A' ' 19' ' ' ASN . 10.0 t -73.26 114.7 33.78 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.52 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 77.9 Cg_exo -47.85 -179.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.078 1.852 . . . . 0.0 112.61 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.66 96.42 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -116.96 21.6 13.16 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.427 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.596 ' ND2' ' SG ' ' A' ' 15' ' ' CYS . 1.8 m120 58.78 57.16 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.119 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.52 ' H ' ' HB2' ' A' ' 16' ' ' PRO . 4.5 mm? -64.38 -42.09 96.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.805 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 65.6 ttp85 -139.17 57.31 1.66 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.814 0.34 . . . . 0.0 110.09 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.75 96.69 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.579 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -172.81 171.55 4.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' MET . . . 72.34 68.83 1.51 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 7.0 mp 54.67 163.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.6 pm0 -88.21 147.66 24.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.13 0.491 . . . . 0.0 111.704 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -160.04 -153.87 0.36 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.272 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 29' ' ' LYS . 10.2 t -154.62 -154.39 0.51 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.41 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.9 ttpm? -144.74 99.7 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -132.28 157.32 44.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.93 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.406 ' HB2' ' HE ' ' A' ' 93' ' ' ARG . 1.7 p -47.83 -13.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.54 ' C ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -85.49 -40.95 15.79 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.338 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.54 HD21 ' C ' ' A' ' 32' ' ' GLN . 2.0 m120 -108.9 -5.94 15.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 30' ' ' THR . 18.7 t80 -49.61 -49.71 45.76 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.108 -0.37 . . . . 0.0 110.243 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -99.93 -3.33 32.57 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 33' ' ' ASN . 3.2 tp -116.2 122.25 44.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.7 136.47 57.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.342 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 2.6 p -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.872 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 38' ' ' CYS . 72.9 mtm 30.17 35.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.901 0.381 . . . . 0.0 111.513 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 38' ' ' CYS . 11.0 m 39.21 -108.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 95.6 mtp -141.85 -23.7 0.7 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . 74.95 159.87 7.51 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 43.9 t -96.03 54.5 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.0 110.3 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.4 154.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.111 0.481 . . . . 0.0 110.803 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -69.06 138.54 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.634 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.04 164.99 33.06 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 12.7 p -122.19 111.81 17.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.126 0.489 . . . . 0.0 110.963 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.28 165.41 17.0 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.889 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.78 47.95 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.51 157.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.787 2.325 . . . . 0.0 112.171 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.87 -18.79 63.39 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.602 2.201 . . . . 0.0 111.887 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.92 -17.24 44.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 mtp -111.14 149.71 30.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.909 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.01 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.484 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -74.17 122.5 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.719 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -135.55 124.04 23.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 60.0 tt0 51.97 33.46 11.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.472 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.1 m120 79.51 14.24 1.02 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.019 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -124.77 148.04 48.34 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -103.95 113.81 27.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 0.0 111.176 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 m -123.81 161.02 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.001 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.4 144.6 53.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.46 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.96 -51.11 32.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.273 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -60.74 -17.41 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -102.5 -8.99 20.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.533 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.4 138.45 67.93 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.552 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.76 158.43 53.65 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.147 1.898 . . . . 0.0 112.418 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.03 165.63 11.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.454 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.22 128.39 35.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.932 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -141.3 118.56 11.39 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.416 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 60.55 45.57 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.03 -6.22 28.71 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.256 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -102.78 149.14 24.78 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.849 0.357 . . . . 0.0 110.276 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 74' ' ' GLU . 7.2 tm-20 -103.89 129.64 51.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.652 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 11.4 m-85 -118.53 178.33 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.461 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.66 165.55 13.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.443 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.18 134.56 56.66 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.617 2.212 . . . . 0.0 111.454 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.93 80.79 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -78.64 134.29 37.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.43 151.15 23.87 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.837 0.827 . . . . 0.0 111.645 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 151.79 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.592 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -99.81 131.86 45.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.807 0.337 . . . . 0.0 110.592 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' ASN . 76.8 mt -129.9 119.44 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.866 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.11 -110.53 1.18 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.16 4.09 20.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.047 0.451 . . . . 0.0 110.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ILE . 4.2 p30 -126.02 155.9 40.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.773 0.797 . . . . 0.0 110.306 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -114.95 152.24 32.7 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.235 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -133.57 157.03 46.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.222 -178.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.85 144.72 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.564 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.683 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 76.6 m -69.47 107.55 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.742 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.576 HH21 ' ND2' ' A' ' 96' ' ' ASN . 67.3 ttp85 -139.52 120.73 14.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 94' ' ' LYS . 98.3 m-20 61.94 51.71 3.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.469 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 31' ' ' CYS . 45.0 mtp180 55.68 9.83 0.46 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.008 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 92' ' ' ASP . 72.5 mmtt -133.1 156.49 47.33 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.683 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 96.2 m95 -88.06 132.96 34.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.576 ' ND2' HH21 ' A' ' 91' ' ' ARG . 5.3 t-20 -106.64 102.29 11.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 57.8 m -88.1 134.79 33.68 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.26 0.553 . . . . 0.0 111.61 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.546 ' CG2' ' H ' ' A' ' 99' ' ' ASP . 9.1 t -60.67 -52.47 64.99 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.501 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.546 ' H ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER 77.35 -0.51 2.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.07 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 1.4 p80 -42.6 170.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 103' ' ' ASP . 14.6 t -62.02 133.81 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.127 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.9 m -60.59 74.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . 68.3 t0 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.491 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.541 ' N ' ' SD ' ' A' ' 10' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.46 0.066 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.62 124.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.256 0.55 . . . . 0.0 110.81 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 51' ' ' PRO . 6.5 ttpt . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -137.12 156.65 48.1 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.6 t -46.46 -17.05 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.33 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 30' ' ' THR . 12.6 pt20 -84.97 -42.75 14.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.4 m-20 -109.31 -2.44 17.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.284 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.5 t80 -44.27 -53.0 7.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -105.74 -3.63 21.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASN . 31.4 mt . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.087 0.47 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 p . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.699 0.285 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.0 mt -123.73 -174.59 3.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 50' ' ' PRO . 69.1 m -92.48 149.76 38.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.301 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 99.6 Cg_exo -38.47 165.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.745 2.297 . . . . 0.0 112.62 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 53.2 Cg_exo -53.87 -48.17 23.2 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.052 1.835 . . . . 0.0 112.926 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.15 -6.24 82.61 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.516 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.9 mtp -112.83 154.38 26.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 111.023 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 61' ' ' VAL . 3.0 m -125.91 152.25 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -86.72 117.61 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.289 0.566 . . . . 0.0 110.887 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -138.55 126.45 22.44 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.349 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 46.83 45.56 15.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.261 0.553 . . . . 0.0 110.352 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 63.04 8.44 3.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.978 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -120.43 149.24 42.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -97.34 128.08 43.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.516 . . . . 0.0 110.385 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.3 m -135.59 155.17 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.582 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 148.33 47.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.588 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 93' ' ' ARG . 10.5 mp -52.01 -52.22 52.15 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.024 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.62 -15.58 29.69 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.533 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -104.25 -4.9 22.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.473 0.177 . . . . 0.0 111.45 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -53.79 151.78 11.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.438 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 92.4 Cg_endo -74.51 156.66 45.2 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 110.99 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -116.25 151.69 35.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.069 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 3.5 m-85 -120.94 130.85 54.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.087 0.47 . . . . 0.0 110.58 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.506 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.5 t60 -152.79 98.54 2.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.033 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 30.8 tt0 87.81 36.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.963 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.17 -5.59 48.78 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.0 148.45 26.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 110.522 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.88 125.39 41.28 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.988 0.423 . . . . 0.0 110.966 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 26.5 m-85 -114.53 177.06 4.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -117.8 173.58 3.15 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.695 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.437 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.8 Cg_exo -64.56 139.12 62.6 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.248 1.965 . . . . 0.0 111.472 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.7 0.16 67.36 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -81.73 129.22 34.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.35 145.07 30.77 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.112 0.958 . . . . 0.0 112.313 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.08 153.78 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.17 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.72 130.42 48.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.756 0.312 . . . . 0.0 110.159 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.14 98.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.3 -116.68 7.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 3.6 40.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.115 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -126.75 159.01 35.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -123.25 153.29 40.36 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.691 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -134.51 151.1 50.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.432 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.26 138.86 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.36 116.01 12.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.346 0.593 . . . . 0.0 111.124 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -144.0 118.78 9.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.325 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.29 51.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.426 ' CZ ' HD23 ' A' ' 63' ' ' LEU . 89.7 mtm180 54.23 12.24 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 157.54 44.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.68 133.48 36.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.0 m120 -112.86 109.36 18.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.609 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 65.2 m -89.21 134.6 33.97 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.384 0.612 . . . . 0.0 111.792 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.797 HG22 ' H ' ' A' ' 100' ' ' HIS . 0.8 OUTLIER -71.68 -37.04 70.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.913 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.52 32.65 19.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.797 ' H ' HG22 ' A' ' 98' ' ' THR . 15.0 p80 -61.04 171.26 1.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.576 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.305 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.439 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 44.5 mtm . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.549 0.214 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.06 115.36 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp . . . . . 0 C--N 1.319 -0.748 0 CA-C-O 121.181 0.515 . . . . 0.0 111.026 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 3.7 tttp . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -135.64 156.08 49.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.991 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.465 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 1.5 t -52.12 -4.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.7 pt20 -100.4 -42.36 6.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.302 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.2 m-20 -113.74 -2.8 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.027 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 30' ' ' THR . 15.1 t80 -51.88 -45.47 64.14 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -102.17 -3.8 26.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.636 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 33' ' ' ASN . 50.5 mt . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.944 0.402 . . . . 0.0 111.052 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.947 0.403 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.08 -172.96 2.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -103.28 173.39 3.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.12 157.11 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.544 2.163 . . . . 0.0 112.344 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 32.1 Cg_endo -62.15 -27.97 79.28 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.602 2.201 . . . . 0.0 112.198 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 -8.79 75.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.11 153.0 31.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.002 0.429 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.96 135.05 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.945 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -73.84 129.75 38.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 59' ' ' ARG . 3.5 t60 -139.11 130.33 26.78 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.052 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 22.1 tp10 45.72 26.64 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 40.9 t30 88.56 10.27 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.916 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 56' ' ' HIS . 2.1 ptm180 -126.92 151.94 47.78 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.8 m -99.42 131.56 45.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.301 0.572 . . . . 0.0 110.539 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.03 157.17 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.574 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.04 148.8 48.37 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.456 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.8 mm? -52.17 -46.21 65.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.176 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.75 -13.42 62.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.441 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -102.07 -6.9 22.79 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 110.987 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.15 148.9 49.44 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.34 162.26 40.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.624 2.216 . . . . 0.0 111.83 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.6 m -103.41 166.19 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 17.8 m-85 -132.23 123.12 26.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.948 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 83' ' ' ILE . 13.4 t60 -142.67 126.92 17.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 110.049 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.6 42.15 29.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.62 -3.38 49.47 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.353 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -104.31 151.33 23.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.975 0.417 . . . . 0.0 110.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -104.63 129.14 52.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.654 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 10.4 m-85 -117.53 176.51 5.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.486 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.74 162.55 24.73 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.765 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 20.4 Cg_endo -59.6 136.06 68.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.411 2.074 . . . . 0.0 111.522 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.42 -2.62 86.9 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' C ' ' OE1' ' A' ' 79' ' ' GLU . 9.5 tm-20 -82.78 137.46 34.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -104.9 149.69 25.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.789 0.804 . . . . 0.0 111.966 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.16 146.07 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.399 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 84' ' ' GLY . 6.0 tmtt? -101.82 129.43 48.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 70' ' ' HIS . 81.4 mt -129.52 117.31 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . . . 56.41 -117.83 10.12 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.438 ' C ' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -102.19 1.98 36.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.328 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 6.7 p30 -125.81 162.38 25.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.397 0.617 . . . . 0.0 111.044 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -127.88 157.57 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.909 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.38 163.01 33.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.29 142.41 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.19 105.55 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.426 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -137.7 122.42 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.593 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 60.14 51.94 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.37 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 62.7 mtp180 54.47 12.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.157 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -132.91 158.07 43.52 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -92.86 133.73 35.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -105.53 94.21 5.08 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.7 m -82.0 135.03 35.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.187 0.518 . . . . 0.0 111.226 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.0 t -63.46 -52.57 60.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.281 1.039 . . . . 0.0 110.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.697 ' N ' HG23 ' A' ' 98' ' ' THR . 27.7 t0 68.74 18.76 8.64 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.929 -1.941 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 3.6 p80 -59.6 171.27 0.88 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 62.0 t . . . . . 0 CA--C 1.52 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.248 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.555 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.52 107.58 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 121.285 0.564 . . . . 0.0 111.241 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.72 ' HZ3' ' HA ' ' A' ' 51' ' ' PRO . 35.0 mtpt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 55' ' ' ARG . 36.4 p -131.25 152.57 50.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.832 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -50.42 -4.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.742 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.566 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.6 pt20 -104.31 -54.43 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.655 0.264 . . . . 0.0 111.618 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.49 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 27.7 p30 -93.3 -7.11 45.85 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.687 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.47 ' CD1' HD11 ' A' ' 63' ' ' LEU . 67.8 t80 -44.29 -47.5 9.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.248 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 17.1 p-10 -102.02 -0.63 33.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 32' ' ' GLN . 4.5 mt . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.29 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.726 0.298 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' O ' ' SD ' ' A' ' 10' ' ' MET . 95.6 mt -136.68 -173.41 3.42 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.172 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 50' ' ' PRO . 93.2 m -96.35 150.6 37.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.944 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 49' ' ' CYS . 84.4 Cg_exo -34.2 158.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.72 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 19.3 Cg_endo -58.14 -26.68 77.02 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.791 2.327 . . . . 0.0 112.179 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.5 -1.32 60.59 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtp -122.95 164.34 18.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.31 -0.445 . . . . 0.0 111.23 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.11 148.79 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.609 ' O ' HG22 ' A' ' 30' ' ' THR . 78.9 ttt-85 -76.26 123.05 25.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.153 0.501 . . . . 0.0 110.712 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -139.95 127.95 22.19 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 55.2 tt0 47.42 35.07 3.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.6 m-20 76.31 9.39 3.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.745 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -127.1 152.1 47.76 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.66 126.95 40.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 0.0 109.992 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.42 156.98 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.942 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.97 41.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.464 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 63' ' ' LEU . 4.3 mm? -48.05 -50.24 28.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.111 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -59.67 -14.34 13.48 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.188 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -99.95 -6.58 26.38 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.471 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.9 m -55.11 138.87 65.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.197 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.79 159.99 47.2 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.593 2.195 . . . . 0.0 112.138 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.76 167.07 10.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.812 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.98 129.71 32.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -142.72 122.73 13.62 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 58.86 42.8 19.17 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.617 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.09 -3.98 34.65 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.119 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -101.79 142.02 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -96.23 129.08 43.63 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.194 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 39.0 m-85 -118.95 176.91 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.003 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.89 164.51 16.44 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 19.2 Cg_endo -59.34 133.96 55.76 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.519 2.146 . . . . 0.0 111.529 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.92 86.51 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 80' ' ' THR . 11.1 tm-20 -80.74 138.67 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.423 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -110.66 154.9 23.17 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.622 0.725 . . . . 0.0 111.696 -177.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.9 150.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.61 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -99.71 131.55 45.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASN . 55.6 mt -135.26 99.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.687 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 41.34 78.23 0.07 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 63.35 -29.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.667 0.27 . . . . 0.0 110.918 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 84' ' ' GLY . 23.4 t-20 -89.92 128.62 36.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.229 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.28 148.02 33.8 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.804 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.61 153.55 51.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.168 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.93 146.27 29.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.515 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.649 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 77.1 m -71.31 108.66 4.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -139.84 114.63 9.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.363 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 68.92 50.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.407 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 55.99 11.93 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.53 161.02 34.84 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.649 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 95.3 m95 -93.34 130.41 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.115 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.0 t-20 -105.88 105.41 15.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.728 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 53.3 m -87.92 132.62 34.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.627 0.727 . . . . 0.0 112.808 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.456 HG21 ' ND1' ' A' ' 100' ' ' HIS . 52.5 m -61.58 -47.9 83.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.359 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' THR . 14.6 t0 79.04 11.06 1.51 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.952 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.592 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.91 151.38 45.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.032 0.444 . . . . 0.0 110.486 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.578 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 58.9 mtm . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.63 120.29 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.551 -179.466 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.738 ' NZ ' ' H ' ' A' ' 52' ' ' GLY . 77.6 tttt . . . . . 0 CA--C 1.515 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' TYR . 6.4 m -136.78 155.84 49.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.872 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 3.7 t -59.15 1.37 0.07 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.017 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.0 pt20 -104.06 -44.0 5.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.622 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' LEU . 96.5 m-20 -111.81 -7.14 14.21 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.9 t80 -48.52 -47.13 39.24 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.935 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 48.8 t0 -101.45 -5.2 25.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 110.463 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 33' ' ' ASN . 45.0 mt . . . . . 0 N--CA 1.468 0.443 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.603 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -120.23 -172.66 2.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -90.44 171.75 7.97 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.617 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' CD ' ' SG ' ' A' ' 49' ' ' CYS . 25.6 Cg_exo -61.55 -179.84 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.298 1.999 . . . . 0.0 112.673 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.53 151.43 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.791 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.738 ' H ' ' NZ ' ' A' ' 29' ' ' LYS . . . 79.76 -9.57 43.58 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mtp -116.68 152.23 34.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.214 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.8 139.6 50.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.257 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -73.55 126.35 30.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.385 0.612 . . . . 0.0 110.516 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -133.88 122.83 23.73 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.905 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 80.9 mt-10 46.99 31.68 1.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.788 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.4 m120 83.71 11.43 0.43 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.553 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -125.79 149.02 48.92 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.0 m -97.5 133.44 42.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.899 -0.5 . . . . 0.0 110.589 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.62 157.73 24.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.288 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.31 150.45 45.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.297 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.9 mm? -49.16 -46.61 45.54 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.52 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.99 -14.38 61.52 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.868 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -101.39 -8.98 21.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.801 0.334 . . . . 0.0 110.952 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 147.02 30.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.615 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.55 163.73 37.7 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.692 2.262 . . . . 0.0 111.582 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.41 158.48 22.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.921 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -127.89 128.11 44.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.398 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 83' ' ' ILE . 84.4 t60 -144.82 126.18 14.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 59.24 37.88 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.502 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.95 -5.2 50.2 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.096 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -102.2 145.7 29.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 0.0 109.875 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -100.73 129.31 46.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 29.0 m-85 -118.96 177.31 4.91 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.316 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.79 175.11 2.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.736 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.519 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.5 Cg_exo -63.37 138.75 67.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.429 2.086 . . . . 0.0 111.605 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.97 -0.86 61.19 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.29 134.0 36.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.85 151.6 24.32 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.029 0.443 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.72 148.52 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.656 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -96.52 129.14 43.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 86' ' ' ASN . 97.9 mt -136.78 127.06 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.961 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 86' ' ' ASN . . . 32.52 83.97 0.01 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 1.6 p 41.48 13.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.627 0.251 . . . . 0.0 111.441 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 84' ' ' GLY . 8.8 m120 -128.04 161.1 29.97 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.97 149.68 52.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.165 0.507 . . . . 0.0 111.006 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 m -137.33 157.65 46.13 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.707 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.86 144.09 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.658 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 71.2 m -67.01 107.11 2.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -137.71 118.61 14.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 63.48 50.73 2.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.584 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 58.1 mtp180 55.92 11.95 0.8 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.3 160.86 35.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 110.054 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.658 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 93.5 m95 -93.1 131.94 37.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.101 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -106.26 94.29 5.07 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 95.2 m -78.26 135.24 37.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.605 0.717 . . . . 0.0 111.576 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.557 HG21 ' CD2' ' A' ' 100' ' ' HIS . 68.7 m -59.62 -45.48 91.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 59.47 28.0 17.28 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.559 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.557 ' CD2' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -76.78 170.53 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.827 177.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.647 -179.416 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' ' SG ' ' A' ' 49' ' ' CYS . 64.7 mtm . . . . . 0 C--O 1.234 0.246 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.44 118.98 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 pttm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.504 179.363 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' TYR . 10.6 m -128.27 165.28 20.82 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.831 ' SG ' HG21 ' A' ' 54' ' ' VAL . 80.9 m -55.08 -13.11 1.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.154 -0.341 . . . . 0.0 110.663 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -96.87 -38.01 10.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.492 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.9 m-20 -106.0 -4.96 19.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.918 ' CD2' HD11 ' A' ' 63' ' ' LEU . 22.2 t80 -44.36 -53.88 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.228 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -102.8 -0.2 31.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.421 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' ASN . 55.4 mt . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.694 0.283 . . . . 0.0 110.681 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 121.0 0.429 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -118.68 -174.58 2.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.73 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' SG ' ' CE ' ' A' ' 10' ' ' MET . 0.4 OUTLIER -86.98 161.41 47.04 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.064 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.42 168.11 23.37 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.651 2.234 . . . . 0.0 112.622 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.39 145.99 53.86 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.035 1.824 . . . . 0.0 112.163 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.54 -23.02 24.51 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 96.2 mmm -116.43 155.71 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 109.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.831 HG21 ' SG ' ' A' ' 31' ' ' CYS . 34.3 m -131.21 -167.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.85 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -120.7 118.07 29.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.54 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -135.97 126.53 27.0 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 44.74 45.07 8.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.213 0.53 . . . . 0.0 110.102 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.9 m120 68.21 10.41 7.82 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -126.46 152.95 45.75 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -100.26 134.04 43.77 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.704 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 54' ' ' VAL . 11.5 m -137.84 155.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.18 153.11 44.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.473 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 34' ' ' TYR . 3.8 mm? -52.46 -50.81 61.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.41 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -56.62 -15.57 4.66 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.88 -1.52 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.091 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -55.22 115.61 9.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.45 159.47 2.07 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.737 1.625 . . . . 0.0 112.406 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.01 166.62 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -136.39 130.75 33.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.416 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.4 t60 -150.94 104.21 3.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.247 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 32.0 tt0 83.1 37.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.34 48.67 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -104.07 145.45 30.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -97.83 127.22 43.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 37.9 m-85 -115.11 177.24 4.73 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.127 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.73 170.12 6.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.37 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.34 138.28 65.19 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.969 1.779 . . . . 0.0 111.306 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.25 -1.23 76.8 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.51 128.47 34.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.48 145.74 29.85 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.688 0.756 . . . . 0.0 111.886 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.22 154.37 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -101.08 130.24 47.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 77.2 mt -128.45 106.61 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.87 -116.78 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' NE2' ' A' ' 100' ' ' HIS . 7.6 p -103.99 3.94 33.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.03 0.443 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 17.3 p30 -126.27 164.72 20.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.393 0.615 . . . . 0.0 110.61 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.32 152.07 41.81 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.879 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.76 150.62 52.14 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.2 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.55 140.85 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.52 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 t -71.11 110.26 5.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.74 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -140.9 118.93 11.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.794 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.5 t0 63.96 50.52 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.317 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 55.59 9.27 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.296 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -129.71 155.91 45.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -94.63 134.42 37.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.437 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 98.5 m-20 -111.67 104.44 12.8 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.632 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 78.4 m -86.94 137.92 31.96 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.913 0.863 . . . . 0.0 112.175 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 100' ' ' HIS . 2.8 m -61.03 -44.78 96.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t0 55.0 29.61 12.63 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.074 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.646 ' H ' HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -70.6 172.21 8.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.705 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.39 117.01 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.029 0.443 . . . . 0.0 110.843 179.884 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -140.82 162.56 35.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.105 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.0 t -59.26 6.45 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.081 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.9 pt20 -105.13 -46.14 4.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.057 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.449 ' N ' ' CG ' ' A' ' 32' ' ' GLN . 99.2 m-20 -115.83 -3.16 12.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.014 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -50.46 -46.59 56.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.926 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 58.2 t0 -106.82 -8.51 16.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ASN . 52.8 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.538 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 20.0 p . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 62.3 mt -123.75 -177.17 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.972 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -98.07 159.09 31.61 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' CYS . 87.5 Cg_exo -42.11 173.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.754 2.303 . . . . 0.0 112.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.03 154.72 57.72 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.507 2.138 . . . . 0.0 111.974 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 -4.37 58.71 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.1 mtp -110.54 150.22 29.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.061 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.59 137.3 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -72.31 118.59 15.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.262 0.553 . . . . 0.0 110.442 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.24 117.88 20.52 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 56.4 mm-40 53.19 35.1 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 3.5 m120 77.94 10.79 2.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.745 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -123.01 151.89 41.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.7 m -98.98 128.25 45.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 0.0 110.644 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.699 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.09 143.83 57.58 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.398 0.618 . . . . 0.0 109.86 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 93' ' ' ARG . 57.2 tp -51.27 -52.34 45.9 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.43 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.16 -12.92 31.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.01 0.434 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -103.29 -3.72 25.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.403 0.621 . . . . 0.0 110.464 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -54.2 149.02 20.45 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.143 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 67.4 Cg_endo -71.41 159.38 51.7 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.452 2.101 . . . . 0.0 111.132 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.06 148.98 29.97 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.188 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 7.3 m-85 -114.48 122.87 47.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.25 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' NE2' HD11 ' A' ' 83' ' ' ILE . 6.1 t-80 -137.07 121.08 17.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 58.84 43.02 18.88 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.798 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.63 -4.79 33.76 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.699 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.12 150.52 24.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.2 mp0 -103.2 129.72 50.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.794 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 12.8 m-85 -118.16 175.53 5.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.096 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.11 167.77 9.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.201 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 29.4 Cg_endo -62.19 128.29 23.52 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.561 2.174 . . . . 0.0 111.869 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.28 83.89 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -78.14 132.81 37.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.58 152.37 21.81 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.444 0.64 . . . . 0.0 110.931 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.44 150.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.179 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 14.9 tptp -98.72 131.48 44.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 86' ' ' ASN . 56.6 mt -135.01 114.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 34.68 66.09 0.34 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.56 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 70.78 -29.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.958 0.409 . . . . 0.0 110.909 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 83' ' ' ILE . 59.8 t-20 -87.58 133.82 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.358 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.78 148.92 29.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.63 151.76 50.56 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.53 144.29 35.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.4 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.628 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 87.2 m -70.37 111.48 5.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -142.15 121.35 13.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.348 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 61.74 50.62 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.263 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.526 HH11 HD11 ' A' ' 63' ' ' LEU . 32.1 ttp180 57.63 10.14 0.97 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.285 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -133.89 152.78 51.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.326 0.584 . . . . 0.0 110.055 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.628 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 94.9 m95 -83.39 133.5 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.108 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.442 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.2 t-20 -108.58 104.53 13.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.781 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 55.8 m -86.97 132.88 33.66 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.014 0.911 . . . . 0.0 112.235 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.451 HG21 ' ND1' ' A' ' 100' ' ' HIS . 54.1 m -58.07 -45.63 86.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.068 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.86 13.55 3.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.047 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.611 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.03 141.93 58.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.374 178.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.639 179.74 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 10' ' ' MET . 5.1 mpp? . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.54 120.31 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 0.0 110.904 179.562 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 11.6 ttpt . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -132.14 152.05 51.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.648 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -49.45 -13.22 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.263 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 30' ' ' THR . 11.7 pt20 -82.33 -38.63 23.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.265 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' LEU . 99.3 m-20 -113.17 -4.39 13.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.581 0.353 . . . . 0.0 111.016 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' THR . 11.9 t80 -48.56 -48.25 38.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -105.18 -7.27 19.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.021 0.438 . . . . 0.0 110.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.04 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 21.8 p . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 120.577 0.227 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.9 mt -130.47 162.19 29.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.21 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -73.64 156.6 88.43 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.333 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.14 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.655 2.237 . . . . 0.0 112.16 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.7 Cg_endo -56.06 -37.74 95.84 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.518 2.145 . . . . 0.0 112.546 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.01 -0.72 86.33 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.3 mmm -118.51 160.22 22.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.523 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 61' ' ' VAL . 16.6 m -130.37 -169.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.719 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 30' ' ' THR . 22.3 mtp-105 -122.13 117.58 26.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.292 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -133.16 124.45 27.51 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 44.47 49.25 8.31 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.269 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' ASN . 29.1 t-20 66.89 5.22 3.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -123.31 151.08 42.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.8 m -103.02 131.69 49.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.337 0.589 . . . . 0.0 110.944 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.4 m -135.48 155.94 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.421 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.29 150.1 48.82 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.452 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' SG ' ' A' ' 31' ' ' CYS . 4.3 mm? -47.04 -50.65 19.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.862 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -66.89 -14.72 63.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -95.86 -6.18 39.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 110.439 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' HG21 ' A' ' 54' ' ' VAL . 57.9 m -56.38 150.5 33.01 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.34 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.36 157.6 37.04 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.52 2.147 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -109.47 148.25 31.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.739 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.83 127.61 50.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.971 0.415 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.451 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.0 t-80 -145.44 134.4 22.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.099 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 53.01 33.82 15.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.119 -0.363 . . . . 0.0 111.935 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.25 -5.83 58.59 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.224 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.68 148.85 25.07 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -101.08 127.15 47.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 9.9 m-85 -118.17 178.71 4.34 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.152 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.68 173.58 2.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 22.9 Cg_exo -64.5 137.02 53.12 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.184 1.923 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.18 82.07 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -81.98 134.37 35.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.63 148.92 24.97 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.846 0.831 . . . . 0.0 112.366 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -141.0 149.83 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.759 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -106.39 132.2 52.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.451 HD11 ' NE2' ' A' ' 70' ' ' HIS . 54.9 mt -130.98 86.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.228 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 51.41 85.95 0.02 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.76 -37.42 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.771 0.32 . . . . 0.0 111.374 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 84' ' ' GLY . 36.2 t-20 -88.88 140.76 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.123 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.566 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -126.99 152.61 46.99 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.042 0.448 . . . . 0.0 110.221 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.19 156.73 46.89 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.007 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 p -128.9 138.33 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.98 112.81 6.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -141.66 123.32 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.029 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 62.03 51.46 3.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.33 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.517 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 77.2 mtp180 53.36 15.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.289 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.25 161.15 35.25 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -98.36 132.09 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.92 95.83 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.425 ' HB3' HD21 ' A' ' 86' ' ' ASN . 86.6 m -80.56 138.74 36.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.052 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 99' ' ' ASP . 3.0 t -60.28 -53.17 60.81 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.356 1.074 . . . . 0.0 110.867 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.654 ' H ' HG23 ' A' ' 98' ' ' THR . 57.3 t0 60.79 26.44 16.27 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 112.977 -1.92 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.617 ' CG ' ' HG1' ' A' ' 98' ' ' THR . 0.0 OUTLIER -104.65 171.39 7.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.53 0.181 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.1 mtm . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.29 115.13 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.1 tttp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 110.195 179.605 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.554 ' C ' ' H ' ' A' ' 32' ' ' GLN . 27.7 p -133.06 154.3 50.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.775 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 m -60.27 7.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.715 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 pt20 -105.72 -43.11 4.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 111.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 36' ' ' LEU . 22.8 p30 -108.27 -6.52 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.391 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 63' ' ' LEU . 77.8 t80 -44.43 -54.81 5.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.809 0.337 . . . . 0.0 110.588 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.75 -4.87 24.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 33' ' ' ASN . 62.8 mt . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 121.111 0.481 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.2 -173.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.881 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 174.87 4.55 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.18 167.32 17.86 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.014 1.809 . . . . 0.0 112.936 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -54.23 147.47 45.11 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.237 1.958 . . . . 0.0 112.372 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.34 -17.85 40.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.29 148.55 32.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.27 140.27 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.6 122.69 21.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.287 0.565 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.84 117.91 19.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 70.7 mm-40 51.1 35.0 11.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.9 m120 79.01 11.58 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.624 0.577 . . . . 0.0 110.985 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -122.91 148.91 44.91 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.36 129.98 44.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.676 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.63 154.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.125 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 153.22 41.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.23 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 34' ' ' TYR . 2.9 mm? -49.78 -55.64 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.855 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -57.82 -17.4 15.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.47 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.66 -3.48 32.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.9 t -54.4 116.89 11.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.413 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -48.86 153.55 3.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.259 1.973 . . . . 0.0 112.429 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -103.18 163.95 11.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.412 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 21.1 m-85 -137.06 129.3 29.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.071 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.542 ' NE2' HD11 ' A' ' 83' ' ' ILE . 9.4 t-80 -144.48 127.82 16.83 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 55.47 39.57 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.497 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 -5.91 37.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -100.54 144.43 29.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.39 127.18 43.14 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.997 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 31.7 m-85 -120.28 178.41 4.65 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.314 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.04 172.35 3.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.508 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.443 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.6 Cg_exo -63.33 138.79 68.03 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.339 2.026 . . . . 0.0 111.566 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.63 -1.6 71.69 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -79.35 133.25 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.6 144.51 31.6 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.82 0.819 . . . . 0.0 111.993 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.95 152.89 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.53 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -99.18 129.93 45.46 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.542 HD11 ' NE2' ' A' ' 70' ' ' HIS . 59.9 mt -129.17 107.85 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.094 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.64 -115.15 7.62 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.74 1.18 31.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.738 0.304 . . . . 0.0 110.454 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.504 ' HA ' ' CE1' ' A' ' 100' ' ' HIS . 19.2 p30 -127.16 159.84 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.428 0.632 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.31 151.87 35.0 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.54 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.29 147.92 52.42 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.346 -178.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.33 138.85 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.564 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.22 107.76 3.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.416 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -137.45 121.62 17.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.422 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 65.34 51.41 1.58 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.654 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.785 HH11 HD12 ' A' ' 63' ' ' LEU . 35.5 mtm180 56.61 9.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.621 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -133.48 163.29 29.7 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -96.96 133.49 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.908 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.436 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 5.5 m120 -111.58 106.57 15.45 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.621 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 62.9 m -86.42 137.03 32.88 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 112.063 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.579 HG21 ' CD2' ' A' ' 100' ' ' HIS . 54.2 m -58.04 -48.8 78.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.116 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 98' ' ' THR . 2.2 m-20 80.02 11.49 1.15 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.286 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.579 ' CD2' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -78.76 157.91 28.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.53 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.602 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 40.6 mmm . . . . . 0 CA--C 1.517 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 10' ' ' MET . 0.2 OUTLIER 56.74 128.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.53 178.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.154 0.502 . . . . 0.0 110.05 179.071 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 11.9 ptmt . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -143.12 159.59 41.99 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 67.5 m -40.91 -25.76 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.508 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' THR . 6.6 pt20 -76.62 -44.5 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 36' ' ' LEU . 2.7 p-10 -114.4 0.08 13.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.11 0.481 . . . . 0.0 110.834 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 30' ' ' THR . 64.2 t80 -47.5 -51.85 19.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.012 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -103.43 -2.28 27.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.027 0.441 . . . . 0.0 109.829 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 33' ' ' ASN . 1.7 tp . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 49' ' ' CYS . 4.3 pp -119.45 -173.34 2.5 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.688 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.4 t -110.78 128.18 25.73 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.29 171.76 7.41 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.257 1.304 . . . . 0.0 113.197 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.21 152.23 73.45 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.392 2.061 . . . . 0.0 112.503 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.75 -21.06 4.87 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.538 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 85.7 mmm -111.86 150.03 30.98 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.44 141.5 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.117 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 30' ' ' THR . 69.8 ttt180 -72.92 120.14 18.13 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -133.87 120.29 20.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 52.27 37.47 22.21 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.268 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 76.37 10.88 2.88 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.879 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -123.4 153.01 40.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.602 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 18.6 m -103.04 124.7 49.03 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.102 0.477 . . . . 0.0 110.135 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.07 159.74 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.314 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 145.01 51.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.625 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 tp -51.49 -53.48 36.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.66 -20.0 4.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.977 0.417 . . . . 0.0 110.442 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -98.02 -4.25 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 110.27 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.439 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 6.3 t -53.86 126.54 50.69 Favored Pre-proline 0 C--N 1.32 -0.704 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.891 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.03 154.95 9.4 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.914 1.743 . . . . 0.0 112.419 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -99.16 165.63 11.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.133 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 22.1 m-85 -137.1 122.58 19.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.534 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.8 t-80 -147.26 133.7 19.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.233 0.54 . . . . 0.0 110.426 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 54.11 35.44 22.34 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.708 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.02 -5.65 52.94 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.145 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.8 156.88 17.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -106.48 130.92 54.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.071 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 4.8 m-85 -120.84 177.52 5.06 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.89 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.65 175.46 1.94 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.198 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.528 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.1 Cg_exo -64.66 135.07 43.59 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.235 1.957 . . . . 0.0 111.688 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.56 -2.76 84.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -77.85 136.68 38.11 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.71 152.05 23.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.08 0.466 . . . . 0.0 111.126 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.0 m -145.88 151.2 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.549 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -103.31 135.09 45.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.413 0.625 . . . . 0.0 110.254 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.534 HD11 ' NE2' ' A' ' 70' ' ' HIS . 49.6 mt -134.42 84.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 49.97 85.01 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.89 -33.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.753 HD22 ' HB3' ' A' ' 97' ' ' CYS . 15.2 t30 -90.17 136.94 32.74 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.86 152.97 37.77 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.05 0.452 . . . . 0.0 110.973 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 83' ' ' ILE . 4.0 m -140.57 154.77 46.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.346 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.88 139.68 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.393 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 24.1 t -71.78 109.64 5.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.288 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -140.07 122.78 16.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.67 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 62.55 51.37 3.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.286 0.565 . . . . 0.0 109.871 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 54.8 ttt-85 51.23 19.11 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.129 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -136.76 153.63 50.78 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 109.978 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -90.18 130.81 36.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.451 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -105.09 94.43 5.23 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.753 ' HB3' HD22 ' A' ' 86' ' ' ASN . 85.1 m -79.98 133.15 36.15 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.635 0.731 . . . . 0.0 111.79 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.431 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 65.4 m -63.89 -52.53 59.51 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 60.25 31.54 20.5 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.44 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER -96.54 170.15 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.047 178.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.5 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 10' ' ' MET . 4.4 mpp? . . . . . 0 CA--C 1.524 -0.037 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' CYS . 2.4 t -122.05 122.58 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.071 0.462 . . . . 0.0 111.013 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.487 ' C ' ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -132.28 157.32 44.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.93 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' HB2' ' HE ' ' A' ' 93' ' ' ARG . 1.7 p -47.83 -13.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.487 ' N ' ' C ' ' A' ' 30' ' ' THR . 1.6 pt20 -85.49 -40.95 15.79 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.53 ' O ' ' O ' ' A' ' 36' ' ' LEU . 18.9 m-20 -108.9 -5.94 15.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' HD21 ' A' ' 63' ' ' LEU . 18.7 t80 -49.61 -49.71 45.76 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.108 -0.37 . . . . 0.0 110.243 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -99.93 -3.33 32.57 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 33' ' ' ASN . 3.2 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.779 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.566 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 12.7 p . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.28 165.41 17.0 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.889 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.78 47.95 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.51 157.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.787 2.325 . . . . 0.0 112.171 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.87 -18.79 63.39 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.602 2.201 . . . . 0.0 111.887 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.92 -17.24 44.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 mtp -111.14 149.71 30.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.909 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.01 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.484 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 55' ' ' ARG . 7.5 ptm180 -74.17 122.5 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.719 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -135.55 124.04 23.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 60.0 tt0 51.97 33.46 11.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.472 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.1 m120 79.51 14.24 1.02 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.019 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -124.77 148.04 48.34 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -103.95 113.81 27.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 0.0 111.176 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 m -123.81 161.02 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.001 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.4 144.6 53.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.46 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 34' ' ' TYR . 14.4 mt -48.96 -51.11 32.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.273 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -60.74 -17.41 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -102.5 -8.99 20.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.533 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.4 138.45 67.93 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.552 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.76 158.43 53.65 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.147 1.898 . . . . 0.0 112.418 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.03 165.63 11.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.454 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.22 128.39 35.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.932 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 83' ' ' ILE . 7.2 t60 -141.3 118.56 11.39 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 60.55 45.57 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.03 -6.22 28.71 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.256 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -102.78 149.14 24.78 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.849 0.357 . . . . 0.0 110.276 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 74' ' ' GLU . 7.2 tm-20 -103.89 129.64 51.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.652 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 11.4 m-85 -118.53 178.33 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.461 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.66 165.55 13.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.443 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 21.0 Cg_endo -60.18 134.56 56.66 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.617 2.212 . . . . 0.0 111.454 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.93 80.79 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -78.64 134.29 37.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.43 151.15 23.87 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.837 0.827 . . . . 0.0 111.645 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 151.79 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.592 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -99.81 131.86 45.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.807 0.337 . . . . 0.0 110.592 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 70' ' ' HIS . 76.8 mt -129.9 119.44 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.866 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.11 -110.53 1.18 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.16 4.09 20.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.047 0.451 . . . . 0.0 110.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ILE . 4.2 p30 -126.02 155.9 40.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.773 0.797 . . . . 0.0 110.306 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -114.95 152.24 32.7 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.235 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -133.57 157.03 46.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.222 -178.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.85 144.72 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.564 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.683 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 76.6 m -69.47 107.55 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.742 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -139.52 120.73 14.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.94 51.71 3.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.469 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HE ' ' HB2' ' A' ' 31' ' ' CYS . 45.0 mtp180 55.68 9.83 0.46 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.008 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -133.1 156.49 47.33 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.683 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 96.2 m95 -88.06 132.96 34.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.438 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 1.8 t30 -106.64 102.29 11.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 57.8 m -88.1 134.79 33.68 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.26 0.553 . . . . 0.0 111.61 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.1 t -60.67 -52.47 64.99 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.501 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.685 ' N ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER 77.35 -0.51 2.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.07 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 1.4 p80 -42.6 170.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 14.6 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.127 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.42 38.62 18.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.748 0.308 . . . . 0.0 110.661 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.1 ttp -94.36 116.73 29.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 6' ' ' CYS . . . -63.75 -42.34 98.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t 53.12 8.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 4' ' ' GLY . 7.7 p -84.25 64.37 8.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.692 ' HE ' ' NH2' ' A' ' 55' ' ' ARG . 2.1 mtt-85 49.42 178.05 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.314 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.89 105.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.977 1.785 . . . . 0.0 110.64 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' C ' ' SD ' ' A' ' 10' ' ' MET . 88.3 Cg_endo -83.61 145.72 11.77 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.839 1.693 . . . . 0.0 113.226 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.541 ' N ' ' SD ' ' A' ' 10' ' ' MET . 2.9 mpp? -114.25 -55.78 2.46 Favored 'General case' 0 N--CA 1.46 0.066 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.62 124.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.552 ' NZ ' ' CG1' ' A' ' 14' ' ' VAL . 64.3 tttm -86.8 132.76 33.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.256 0.55 . . . . 0.0 110.81 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 pp -132.42 124.45 28.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' CG1' ' NZ ' ' A' ' 12' ' ' LYS . 33.3 m -113.87 159.37 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 1.3 m -107.95 105.29 56.0 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.208 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 15' ' ' CYS . 82.4 Cg_exo -46.0 -179.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.957 1.771 . . . . 0.0 112.475 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.76 78.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -98.55 4.41 48.17 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' GLU . 1.9 m120 64.87 52.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.024 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.612 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.2 mm? -69.83 -40.3 75.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.528 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 63.3 ttm-85 -64.32 -43.3 95.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.531 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -95.63 -1.64 49.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.998 0.428 . . . . 0.0 110.709 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 19' ' ' ASN . 98.9 mt-10 51.17 11.8 0.11 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.439 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.83 -48.08 1.6 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.96 -43.54 98.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.958 0.409 . . . . 0.0 110.616 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -79.2 145.77 33.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.159 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.16 -48.56 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.606 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.472 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 71.5 p -134.14 159.95 39.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.383 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 51' ' ' PRO . 6.5 ttpt -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.685 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -137.12 156.65 48.1 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.6 t -46.46 -17.05 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.33 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 30' ' ' THR . 12.6 pt20 -84.97 -42.75 14.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.4 m-20 -109.31 -2.44 17.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.284 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.5 t80 -44.27 -53.0 7.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -105.74 -3.63 21.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASN . 31.4 mt -114.33 173.83 6.26 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.087 0.47 . . . . 0.0 110.695 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -48.7 152.94 0.89 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.308 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 39' ' ' MET . 8.0 t -103.91 159.35 15.72 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.956 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.558 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 97.1 mmm -78.78 146.66 33.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.185 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -60.4 -43.01 97.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttp -87.75 129.27 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.474 ' O ' HD11 ' A' ' 13' ' ' LEU . . . 150.23 -36.13 0.96 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -65.51 -39.94 92.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.08 0.467 . . . . 0.0 110.238 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 45' ' ' SER . 26.6 m -84.39 128.46 38.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.664 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 44' ' ' VAL . 5.8 t 20.32 92.57 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.649 1.218 . . . . 0.0 110.949 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.88 160.54 28.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 29.6 p -122.08 119.05 30.23 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.699 0.285 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.0 mt -123.73 -174.59 3.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 50' ' ' PRO . 69.1 m -92.48 149.76 38.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.301 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 99.6 Cg_exo -38.47 165.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.745 2.297 . . . . 0.0 112.62 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 53.2 Cg_exo -53.87 -48.17 23.2 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.052 1.835 . . . . 0.0 112.926 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.15 -6.24 82.61 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.516 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.9 mtp -112.83 154.38 26.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 111.023 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 61' ' ' VAL . 3.0 m -125.91 152.25 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.692 ' NH2' ' HE ' ' A' ' 7' ' ' ARG . 80.1 ttt-85 -86.72 117.61 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.289 0.566 . . . . 0.0 110.887 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -138.55 126.45 22.44 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.349 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 46.83 45.56 15.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.261 0.553 . . . . 0.0 110.352 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.513 HD22 ' HB3' ' A' ' 7' ' ' ARG . 37.1 t-20 63.04 8.44 3.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -120.43 149.24 42.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -97.34 128.08 43.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.516 . . . . 0.0 110.385 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.3 m -135.59 155.17 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.582 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 148.33 47.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.588 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 93' ' ' ARG . 10.5 mp -52.01 -52.22 52.15 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.024 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.62 -15.58 29.69 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.533 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -104.25 -4.9 22.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.473 0.177 . . . . 0.0 111.45 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -53.79 151.78 11.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.438 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 92.4 Cg_endo -74.51 156.66 45.2 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 110.99 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -116.25 151.69 35.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.069 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 3.5 m-85 -120.94 130.85 54.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.087 0.47 . . . . 0.0 110.58 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.506 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.5 t60 -152.79 98.54 2.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.033 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 30.8 tt0 87.81 36.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.963 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.17 -5.59 48.78 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.0 148.45 26.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 110.522 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.88 125.39 41.28 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.988 0.423 . . . . 0.0 110.966 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 26.5 m-85 -114.53 177.06 4.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -117.8 173.58 3.15 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.695 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.437 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.8 Cg_exo -64.56 139.12 62.6 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.248 1.965 . . . . 0.0 111.472 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.7 0.16 67.36 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -81.73 129.22 34.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.35 145.07 30.77 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.112 0.958 . . . . 0.0 112.313 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.08 153.78 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.17 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.72 130.42 48.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.756 0.312 . . . . 0.0 110.159 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.14 98.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.3 -116.68 7.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 3.6 40.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.115 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -126.75 159.01 35.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -123.25 153.29 40.36 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.691 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -134.51 151.1 50.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.432 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.26 138.86 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.36 116.01 12.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.346 0.593 . . . . 0.0 111.124 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -144.0 118.78 9.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.325 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.29 51.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.426 ' CZ ' HD23 ' A' ' 63' ' ' LEU . 89.7 mtm180 54.23 12.24 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 157.54 44.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.68 133.48 36.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.0 m120 -112.86 109.36 18.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.609 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 65.2 m -89.21 134.6 33.97 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.384 0.612 . . . . 0.0 111.792 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.797 HG22 ' H ' ' A' ' 100' ' ' HIS . 0.8 OUTLIER -71.68 -37.04 70.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.913 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.52 32.65 19.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.797 ' H ' HG22 ' A' ' 98' ' ' THR . 15.0 p80 -61.04 171.26 1.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.576 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 103' ' ' ASP . 62.7 t -55.05 135.44 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.305 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 34.8 t -66.82 69.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.665 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 101' ' ' VAL . 68.5 t0 . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.762 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.65 140.54 55.49 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 ttp -123.51 128.98 50.54 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.76 -178.28 39.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 7' ' ' ARG . 63.2 m -79.65 -12.22 59.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.365 . . . . 0.0 110.577 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.541 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 8.3 t -60.24 81.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.241 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.582 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.4 ttm-85 -66.83 -43.96 50.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 7' ' ' ARG . 58.1 Cg_endo -90.86 108.37 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.014 2.476 . . . . 0.0 110.793 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.01 116.79 2.49 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.568 1.512 . . . . 0.0 111.946 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.439 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 44.5 mtm -122.32 -58.79 1.68 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.264 -0.273 . . . . 0.0 110.589 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.06 115.36 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.2 137.05 34.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.181 0.515 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -137.4 128.57 27.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.771 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.77 122.6 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.431 0.634 . . . . 0.0 110.144 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OD1' ' A' ' 19' ' ' ASN . 2.3 t -100.21 105.17 34.28 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' CYS . 86.7 Cg_exo -46.32 179.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.105 1.87 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -47.69 84.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.671 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -95.9 5.41 51.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.42 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.521 ' OD1' ' SG ' ' A' ' 15' ' ' CYS . 52.0 m-20 59.45 57.04 3.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -106.48 20.0 19.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.77 52.29 0.93 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.045 0.45 . . . . 0.0 110.112 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.88 158.67 23.91 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.08 0.466 . . . . 0.0 110.283 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' OE2' HD12 ' A' ' 25' ' ' LEU . 15.3 pt-20 -64.86 -35.74 82.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.29 -12.85 0.6 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD12 ' OE2' ' A' ' 23' ' ' GLU . 87.6 mt -92.34 135.1 34.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.837 0.351 . . . . 0.0 110.324 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.74 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 p -154.61 -124.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.38 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.467 ' OG1' ' SG ' ' A' ' 38' ' ' CYS . 66.6 p -84.84 168.27 15.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.481 0.182 . . . . 0.0 110.66 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 3.7 tttp -147.05 89.94 1.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -135.64 156.08 49.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.991 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.465 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 1.5 t -52.12 -4.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 30' ' ' THR . 14.7 pt20 -100.4 -42.36 6.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.302 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.2 m-20 -113.74 -2.8 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.027 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 30' ' ' THR . 15.1 t80 -51.88 -45.47 64.14 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -102.17 -3.8 26.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.636 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 33' ' ' ASN . 50.5 mt -120.38 174.88 6.26 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.944 0.402 . . . . 0.0 111.052 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.07 149.16 45.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.012 0.434 . . . . 0.0 110.994 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.467 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 90.5 m -82.98 145.86 29.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 41' ' ' MET . 4.7 ptp -66.06 -178.88 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.198 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 m -47.31 88.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.53 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 39' ' ' MET . 7.5 tpp -149.23 124.72 10.32 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.92 37.51 3.78 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t 52.99 100.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.844 0.354 . . . . 0.0 110.143 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.85 159.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.3 t -55.95 134.16 52.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 110.76 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.92 -175.19 45.76 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.541 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 1.6 p -123.16 129.63 51.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.947 0.403 . . . . 0.0 111.134 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.08 -172.96 2.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -103.28 173.39 3.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.12 157.11 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.544 2.163 . . . . 0.0 112.344 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 32.1 Cg_endo -62.15 -27.97 79.28 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.602 2.201 . . . . 0.0 112.198 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 -8.79 75.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.11 153.0 31.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.002 0.429 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.96 135.05 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.945 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -73.84 129.75 38.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 59' ' ' ARG . 3.5 t60 -139.11 130.33 26.78 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.052 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 22.1 tp10 45.72 26.64 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 40.9 t30 88.56 10.27 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.916 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 56' ' ' HIS . 2.1 ptm180 -126.92 151.94 47.78 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.8 m -99.42 131.56 45.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.301 0.572 . . . . 0.0 110.539 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.03 157.17 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.574 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.04 148.8 48.37 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.456 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.8 mm? -52.17 -46.21 65.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.176 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.75 -13.42 62.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.441 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -102.07 -6.9 22.79 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 110.987 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.15 148.9 49.44 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.34 162.26 40.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.624 2.216 . . . . 0.0 111.83 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.6 m -103.41 166.19 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 17.8 m-85 -132.23 123.12 26.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.948 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 83' ' ' ILE . 13.4 t60 -142.67 126.92 17.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 110.049 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.6 42.15 29.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.62 -3.38 49.47 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.353 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -104.31 151.33 23.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.975 0.417 . . . . 0.0 110.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -104.63 129.14 52.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.654 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 10.4 m-85 -117.53 176.51 5.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.486 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.74 162.55 24.73 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.765 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 20.4 Cg_endo -59.6 136.06 68.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.411 2.074 . . . . 0.0 111.522 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.42 -2.62 86.9 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' C ' ' OE1' ' A' ' 79' ' ' GLU . 9.5 tm-20 -82.78 137.46 34.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -104.9 149.69 25.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.789 0.804 . . . . 0.0 111.966 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.16 146.07 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.399 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 84' ' ' GLY . 6.0 tmtt? -101.82 129.43 48.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 70' ' ' HIS . 81.4 mt -129.52 117.31 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . . . 56.41 -117.83 10.12 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.438 ' C ' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -102.19 1.98 36.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.328 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 6.7 p30 -125.81 162.38 25.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.397 0.617 . . . . 0.0 111.044 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -127.88 157.57 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.909 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.38 163.01 33.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.29 142.41 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.19 105.55 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.426 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -137.7 122.42 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.593 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 60.14 51.94 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.37 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 62.7 mtp180 54.47 12.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.157 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -132.91 158.07 43.52 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -92.86 133.73 35.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -105.53 94.21 5.08 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.7 m -82.0 135.03 35.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.187 0.518 . . . . 0.0 111.226 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.0 t -63.46 -52.57 60.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.281 1.039 . . . . 0.0 110.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.697 ' N ' HG23 ' A' ' 98' ' ' THR . 27.7 t0 68.74 18.76 8.64 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.929 -1.941 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 3.6 p80 -59.6 171.27 0.88 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 62.0 t -55.33 134.94 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 102' ' ' CYS . 28.6 t -63.09 70.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . 67.6 t0 . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.534 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.01 140.53 57.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 110.577 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 ttp -102.2 121.77 42.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.565 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.95 -171.58 42.4 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 m -56.26 -173.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.71 0.29 . . . . 0.0 110.256 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 7.9 t 56.72 96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.676 ' NH2' HH22 ' A' ' 55' ' ' ARG . 2.3 mpp_? -72.41 -64.9 0.86 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.585 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' O ' ' SD ' ' A' ' 10' ' ' MET . 31.7 Cg_endo -62.06 110.73 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.312 2.008 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -83.07 118.86 2.73 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.942 1.761 . . . . 0.0 112.588 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.555 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -128.96 -59.45 1.12 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.52 107.58 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -81.35 141.89 33.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.285 0.564 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.0 pp -140.34 122.54 15.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.671 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.98 160.9 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.13 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 26.9 m -108.04 115.06 59.15 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -46.31 177.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.93 1.753 . . . . 0.0 112.845 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.86 90.19 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.526 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 94.8 m-20 -104.08 21.46 16.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.003 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.575 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.8 OUTLIER 44.0 62.18 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.235 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.01 21.1 15.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.26 55.52 1.45 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.996 0.427 . . . . 0.0 110.153 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.62 157.25 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.574 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -142.36 173.57 11.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.61 94.09 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.8 mm? -64.51 -39.7 94.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.769 0.319 . . . . 0.0 110.503 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -61.79 -34.42 75.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.9 t -40.32 -76.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.544 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 29' ' ' LYS . 13.6 m -149.77 160.39 43.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.406 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.72 ' HZ3' ' HA ' ' A' ' 51' ' ' PRO . 35.0 mtpt -147.72 91.39 1.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 55' ' ' ARG . 36.4 p -131.25 152.57 50.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.832 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -50.42 -4.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.742 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.566 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.6 pt20 -104.31 -54.43 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.655 0.264 . . . . 0.0 111.618 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.49 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 27.7 p30 -93.3 -7.11 45.85 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.687 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' CD1' HD11 ' A' ' 63' ' ' LEU . 67.8 t80 -44.29 -47.5 9.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.248 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 17.1 p-10 -102.02 -0.63 33.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 32' ' ' GLN . 4.5 mt -117.82 174.66 6.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.29 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -77.86 142.64 38.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.748 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.6 p -83.12 165.22 19.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 41' ' ' MET . 98.6 mtp -60.27 166.01 3.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.313 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -68.3 61.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.806 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 39' ' ' MET . 93.2 mmm -63.75 -41.6 97.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 21.39 74.67 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 6.9 t 65.47 96.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.559 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.45 156.88 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.496 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -61.36 132.33 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.375 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.32 175.57 46.69 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.533 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.8 p -117.25 146.48 43.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 110.511 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' O ' ' SD ' ' A' ' 10' ' ' MET . 95.6 mt -136.68 -173.41 3.42 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.172 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 50' ' ' PRO . 93.2 m -96.35 150.6 37.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.944 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 49' ' ' CYS . 84.4 Cg_exo -34.2 158.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.72 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 19.3 Cg_endo -58.14 -26.68 77.02 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.791 2.327 . . . . 0.0 112.179 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.5 -1.32 60.59 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtp -122.95 164.34 18.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.31 -0.445 . . . . 0.0 111.23 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.11 148.79 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.676 HH22 ' NH2' ' A' ' 7' ' ' ARG . 78.9 ttt-85 -76.26 123.05 25.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.153 0.501 . . . . 0.0 110.712 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -139.95 127.95 22.19 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 55.2 tt0 47.42 35.07 3.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.6 m-20 76.31 9.39 3.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.745 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -127.1 152.1 47.76 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.66 126.95 40.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 0.0 109.992 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.42 156.98 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.942 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.97 41.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.464 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 63' ' ' LEU . 4.3 mm? -48.05 -50.24 28.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.111 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -59.67 -14.34 13.48 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.188 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -99.95 -6.58 26.38 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.471 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.9 m -55.11 138.87 65.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.197 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.79 159.99 47.2 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.593 2.195 . . . . 0.0 112.138 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.76 167.07 10.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.812 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.98 129.71 32.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -142.72 122.73 13.62 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 58.86 42.8 19.17 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.617 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.09 -3.98 34.65 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.119 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -101.79 142.02 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -96.23 129.08 43.63 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.194 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 39.0 m-85 -118.95 176.91 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.003 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.89 164.51 16.44 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 19.2 Cg_endo -59.34 133.96 55.76 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.519 2.146 . . . . 0.0 111.529 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.92 86.51 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 80' ' ' THR . 11.1 tm-20 -80.74 138.67 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.423 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -110.66 154.9 23.17 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.622 0.725 . . . . 0.0 111.696 -177.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.9 150.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.61 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -99.71 131.55 45.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASN . 55.6 mt -135.26 99.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.687 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 41.34 78.23 0.07 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER 63.35 -29.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.667 0.27 . . . . 0.0 110.918 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 84' ' ' GLY . 23.4 t-20 -89.92 128.62 36.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.229 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.28 148.02 33.8 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.804 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.61 153.55 51.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.168 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.93 146.27 29.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.515 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.649 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 77.1 m -71.31 108.66 4.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -139.84 114.63 9.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.363 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 68.92 50.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.407 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 55.99 11.93 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.53 161.02 34.84 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.649 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 95.3 m95 -93.34 130.41 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.115 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.0 t-20 -105.88 105.41 15.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.728 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 53.3 m -87.92 132.62 34.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.627 0.727 . . . . 0.0 112.808 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.456 HG21 ' ND1' ' A' ' 100' ' ' HIS . 52.5 m -61.58 -47.9 83.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.359 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' THR . 14.6 t0 79.04 11.06 1.51 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.952 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.592 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.91 151.38 45.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.98 130.42 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.032 0.444 . . . . 0.0 110.486 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -149.49 5.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.444 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' GLY . . . -71.09 145.3 49.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 110.429 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.0 mtt 46.18 21.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.79 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 2' ' ' ALA . . . -72.45 171.18 49.73 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 m -71.38 144.9 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 110.487 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 7' ' ' ARG . 26.4 p -159.95 148.88 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.586 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.633 ' CD ' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -38.83 162.3 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.163 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' C ' ' O ' ' A' ' 7' ' ' ARG . 84.2 Cg_exo -31.51 104.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.769 2.313 . . . . 0.0 111.438 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -55.3 110.97 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.994 1.796 . . . . 0.0 113.68 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.578 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 58.9 mtm -124.06 -46.59 1.94 Allowed 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.63 120.29 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.68 111.23 22.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.551 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pp -110.64 129.62 55.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.604 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' CG2' ' NH2' ' A' ' 21' ' ' ARG . 3.6 m -124.39 164.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' CG ' ' A' ' 19' ' ' ASN . 41.4 t -103.16 104.49 40.78 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.792 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -47.27 178.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.009 1.806 . . . . 0.0 112.692 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.39 94.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.986 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.16 1.4 44.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.17 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 65.42 61.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.978 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.61 21.75 13.71 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' NH2' ' CG2' ' A' ' 14' ' ' VAL . 63.0 ttp85 -150.38 56.07 0.93 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.384 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' GLY . . . -75.16 -13.25 60.45 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 38.4 29.47 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.334 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -170.38 172.48 44.05 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' CYS . 67.9 mt -76.58 80.76 3.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.368 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 57.16 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.598 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LEU . 3.7 m -78.43 -144.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.366 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.5 p -86.69 -157.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.259 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.738 ' NZ ' ' H ' ' A' ' 52' ' ' GLY . 77.6 tttt -147.69 94.45 2.36 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 110.448 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' TYR . 6.4 m -136.78 155.84 49.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.872 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 3.7 t -59.15 1.37 0.07 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.017 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.0 pt20 -104.06 -44.0 5.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.622 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' LEU . 96.5 m-20 -111.81 -7.14 14.21 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.9 t80 -48.52 -47.13 39.24 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.935 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 48.8 t0 -101.45 -5.2 25.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 110.463 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 33' ' ' ASN . 45.0 mt -120.67 130.09 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.603 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 56.1 mp0 -54.05 138.02 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 40' ' ' SER . 26.7 p -67.77 161.42 26.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.614 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.1 ttm -61.31 -40.22 93.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.098 0.475 . . . . 0.0 110.581 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 32.3 t -115.5 104.62 11.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.361 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 27' ' ' CYS . 82.8 mmm -77.84 143.74 37.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.463 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.61 156.71 7.14 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 22.1 p -76.54 112.51 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.085 0.469 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.55 127.17 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.23 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.2 t -62.1 145.55 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.49 172.34 44.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 102.05 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -120.23 -172.66 2.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -90.44 171.75 7.97 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.617 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' CD ' ' SG ' ' A' ' 49' ' ' CYS . 25.6 Cg_exo -61.55 -179.84 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.298 1.999 . . . . 0.0 112.673 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.53 151.43 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.791 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.738 ' H ' ' NZ ' ' A' ' 29' ' ' LYS . . . 79.76 -9.57 43.58 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mtp -116.68 152.23 34.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.214 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.8 139.6 50.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.257 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.474 ' NH1' ' CZ ' ' A' ' 7' ' ' ARG . 36.5 ptt180 -73.55 126.35 30.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.385 0.612 . . . . 0.0 110.516 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -133.88 122.83 23.73 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.905 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 80.9 mt-10 46.99 31.68 1.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.788 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.4 m120 83.71 11.43 0.43 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.553 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -125.79 149.02 48.92 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.0 m -97.5 133.44 42.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.899 -0.5 . . . . 0.0 110.589 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.62 157.73 24.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.288 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.31 150.45 45.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.297 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.9 mm? -49.16 -46.61 45.54 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.52 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.99 -14.38 61.52 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.868 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -101.39 -8.98 21.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.801 0.334 . . . . 0.0 110.952 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 147.02 30.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.615 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.55 163.73 37.7 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.692 2.262 . . . . 0.0 111.582 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.41 158.48 22.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.921 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -127.89 128.11 44.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.398 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 83' ' ' ILE . 84.4 t60 -144.82 126.18 14.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 59.24 37.88 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.502 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.95 -5.2 50.2 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.096 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -102.2 145.7 29.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 0.0 109.875 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -100.73 129.31 46.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 29.0 m-85 -118.96 177.31 4.91 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.316 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.79 175.11 2.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.736 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.519 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.5 Cg_exo -63.37 138.75 67.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.429 2.086 . . . . 0.0 111.605 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.97 -0.86 61.19 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.29 134.0 36.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.85 151.6 24.32 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.029 0.443 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.72 148.52 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.656 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -96.52 129.14 43.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 86' ' ' ASN . 97.9 mt -136.78 127.06 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.961 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 86' ' ' ASN . . . 32.52 83.97 0.01 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 1.6 p 41.48 13.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.627 0.251 . . . . 0.0 111.441 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 84' ' ' GLY . 8.8 m120 -128.04 161.1 29.97 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.97 149.68 52.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.165 0.507 . . . . 0.0 111.006 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 m -137.33 157.65 46.13 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.707 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.86 144.09 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.658 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 71.2 m -67.01 107.11 2.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -137.71 118.61 14.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 63.48 50.73 2.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.584 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 58.1 mtp180 55.92 11.95 0.8 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.3 160.86 35.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 110.054 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.658 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 93.5 m95 -93.1 131.94 37.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.101 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -106.26 94.29 5.07 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 95.2 m -78.26 135.24 37.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.605 0.717 . . . . 0.0 111.576 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.557 HG21 ' CD2' ' A' ' 100' ' ' HIS . 68.7 m -59.62 -45.48 91.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 59.47 28.0 17.28 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.559 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.557 ' CD2' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -76.78 170.53 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.827 177.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -40.74 122.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.647 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 102' ' ' CYS . 7.3 t -79.93 74.34 6.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.072 0.463 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.7 t0 . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.519 179.753 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.31 93.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.569 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.6 mtp -95.02 137.34 34.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.0 165.63 38.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 m -83.35 -5.47 59.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 7' ' ' ARG . 19.3 p -40.73 153.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.655 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.584 ' CZ ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -40.04 163.97 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.093 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' A' ' 7' ' ' ARG . 93.2 Cg_exo -31.02 107.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 122.938 2.425 . . . . 0.0 111.464 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.62 121.76 4.77 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.642 1.561 . . . . 0.0 113.325 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' ' SG ' ' A' ' 49' ' ' CYS . 64.7 mtm -128.43 -41.85 1.52 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.44 118.98 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -86.8 133.87 33.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.504 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.1 pp -133.52 118.59 18.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.669 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 14' ' ' VAL . 5.7 m -101.57 116.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.909 0.385 . . . . 0.0 110.476 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.497 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -49.8 123.83 15.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 -179.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 73.5 Cg_exo -45.26 -179.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.845 1.697 . . . . 0.0 112.922 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.15 91.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.383 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -108.59 15.03 24.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.28 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' ALA . 21.9 m-20 62.56 58.08 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.785 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' H ' ' HB2' ' A' ' 16' ' ' PRO . 4.4 mm? -65.81 -41.5 91.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.438 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 70.2 ttt180 -66.84 -43.24 84.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.422 . . . . 0.0 110.799 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -95.67 168.38 10.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.804 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 54.3 26.2 6.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -159.48 -85.24 0.05 OUTLIER Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.5 tp -71.58 -88.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -147.88 98.66 2.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.3 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 p -60.44 -25.33 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.438 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' NH2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -138.88 170.26 16.32 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -149.67 90.27 1.69 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' TYR . 10.6 m -128.27 165.28 20.82 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.831 ' SG ' HG21 ' A' ' 54' ' ' VAL . 80.9 m -55.08 -13.11 1.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.154 -0.341 . . . . 0.0 110.663 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -96.87 -38.01 10.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.492 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 36' ' ' LEU . 72.9 m-20 -106.0 -4.96 19.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.918 ' CD2' HD11 ' A' ' 63' ' ' LEU . 22.2 t80 -44.36 -53.88 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.228 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -102.8 -0.2 31.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.421 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' ASN . 55.4 mt -120.06 165.89 14.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.694 0.283 . . . . 0.0 110.681 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.97 139.13 52.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.773 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 p -88.31 135.25 33.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 41' ' ' MET . 66.9 mtt -79.91 146.81 31.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.197 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -61.82 71.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' MET . 89.9 mmm -65.06 -39.99 94.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.64 92.65 0.09 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 38.7 t -73.59 49.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.082 0.468 . . . . 0.0 110.323 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 45' ' ' SER . 10.3 p -159.39 138.48 3.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 44' ' ' VAL . 29.0 p 20.34 98.82 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.594 1.184 . . . . 0.0 111.228 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.27 145.62 16.18 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 95.51 5.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.917 -0.642 . . . . 0.0 110.142 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -118.68 -174.58 2.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.73 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' SG ' ' CE ' ' A' ' 10' ' ' MET . 0.4 OUTLIER -86.98 161.41 47.04 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.064 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.42 168.11 23.37 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.651 2.234 . . . . 0.0 112.622 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.39 145.99 53.86 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.035 1.824 . . . . 0.0 112.163 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.54 -23.02 24.51 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 96.2 mmm -116.43 155.71 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 109.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.831 HG21 ' SG ' ' A' ' 31' ' ' CYS . 34.3 m -131.21 -167.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.85 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 7' ' ' ARG . 68.7 mtm180 -120.7 118.07 29.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.54 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -135.97 126.53 27.0 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 44.74 45.07 8.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.213 0.53 . . . . 0.0 110.102 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.9 m120 68.21 10.41 7.82 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -126.46 152.95 45.75 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -100.26 134.04 43.77 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.704 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 54' ' ' VAL . 11.5 m -137.84 155.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.18 153.11 44.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.473 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 34' ' ' TYR . 3.8 mm? -52.46 -50.81 61.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.41 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -56.62 -15.57 4.66 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.88 -1.52 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.091 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -55.22 115.61 9.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.45 159.47 2.07 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.737 1.625 . . . . 0.0 112.406 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.01 166.62 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -136.39 130.75 33.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.416 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.4 t60 -150.94 104.21 3.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.247 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 32.0 tt0 83.1 37.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.34 48.67 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -104.07 145.45 30.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -97.83 127.22 43.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 37.9 m-85 -115.11 177.24 4.73 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.127 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.73 170.12 6.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.37 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.34 138.28 65.19 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.969 1.779 . . . . 0.0 111.306 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.25 -1.23 76.8 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.51 128.47 34.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.48 145.74 29.85 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.688 0.756 . . . . 0.0 111.886 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.22 154.37 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -101.08 130.24 47.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 77.2 mt -128.45 106.61 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.87 -116.78 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' NE2' ' A' ' 100' ' ' HIS . 7.6 p -103.99 3.94 33.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.03 0.443 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 17.3 p30 -126.27 164.72 20.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.393 0.615 . . . . 0.0 110.61 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.32 152.07 41.81 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.879 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.76 150.62 52.14 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.2 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.55 140.85 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.52 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 t -71.11 110.26 5.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.74 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -140.9 118.93 11.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.794 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.5 t0 63.96 50.52 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.317 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 55.59 9.27 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.296 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -129.71 155.91 45.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -94.63 134.42 37.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.437 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 98.5 m-20 -111.67 104.44 12.8 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.632 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 78.4 m -86.94 137.92 31.96 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.913 0.863 . . . . 0.0 112.175 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 100' ' ' HIS . 2.8 m -61.03 -44.78 96.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t0 55.0 29.61 12.63 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.074 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.646 ' H ' HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -70.6 172.21 8.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -38.24 126.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.705 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 7.2 t -80.95 72.41 7.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.698 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.429 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.34 140.45 54.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.476 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -139.15 145.18 39.08 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.67 84.22 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 p 44.2 89.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.705 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 30.3 p -82.87 40.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.623 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 56.26 159.93 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CE ' ' A' ' 10' ' ' MET . 80.1 Cg_exo -31.17 105.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.696 2.264 . . . . 0.0 111.308 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.28 141.47 20.47 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.907 1.738 . . . . 0.0 112.701 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -124.42 -42.91 2.07 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.39 117.01 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.1 131.12 34.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.029 0.443 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 pp -130.94 122.92 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.776 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.37 162.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.838 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 85.4 m -106.52 102.15 39.69 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.484 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 15' ' ' CYS . 61.7 Cg_exo -46.17 179.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.037 1.825 . . . . 0.0 112.601 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.52 82.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.756 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.42 5.15 48.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.998 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 58.65 63.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.883 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.73 21.58 14.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -100.25 -41.84 6.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.883 0.373 . . . . 0.0 110.012 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.72 138.76 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.732 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 25' ' ' LEU . 22.2 pt-20 -167.86 135.08 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.643 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.43 -30.16 0.58 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 23' ' ' GLU . 91.4 mt -125.13 145.06 50.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 110.282 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 95.6 mt-10 -138.83 153.52 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 28' ' ' THR . 17.1 p 40.0 -138.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.597 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 63.3 p -86.02 167.16 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.95 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -147.24 99.74 3.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -140.82 162.56 35.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.105 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.0 t -59.26 6.45 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.081 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.9 pt20 -105.13 -46.14 4.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.057 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' N ' ' CG ' ' A' ' 32' ' ' GLN . 99.2 m-20 -115.83 -3.16 12.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.014 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -50.46 -46.59 56.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.926 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 35' ' ' ASP . 58.2 t0 -106.82 -8.51 16.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ASN . 52.8 mt -111.56 172.32 6.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.538 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -41.63 153.41 0.05 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.046 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 t -121.57 168.55 11.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.822 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 78.2 mtm -75.29 144.42 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.554 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.8 m -68.7 62.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 44.7 ttm -64.9 -40.27 94.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.31 31.62 77.61 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.6 t 66.16 92.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.688 0.28 . . . . 0.0 110.475 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.6 154.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -62.16 129.76 42.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.56 168.38 37.45 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 20.0 p -119.38 125.62 49.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 62.3 mt -123.75 -177.17 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.972 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -98.07 159.09 31.61 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' CYS . 87.5 Cg_exo -42.11 173.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.754 2.303 . . . . 0.0 112.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.03 154.72 57.72 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.507 2.138 . . . . 0.0 111.974 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 -4.37 58.71 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.1 mtp -110.54 150.22 29.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.061 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.59 137.3 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -72.31 118.59 15.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.262 0.553 . . . . 0.0 110.442 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.24 117.88 20.52 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 56.4 mm-40 53.19 35.1 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.0 m-80 77.94 10.79 2.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.745 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -123.01 151.89 41.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.7 m -98.98 128.25 45.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 0.0 110.644 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.699 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.09 143.83 57.58 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.398 0.618 . . . . 0.0 109.86 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 93' ' ' ARG . 57.2 tp -51.27 -52.34 45.9 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.43 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.16 -12.92 31.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.01 0.434 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -103.29 -3.72 25.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.403 0.621 . . . . 0.0 110.464 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -54.2 149.02 20.45 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.143 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 67.4 Cg_endo -71.41 159.38 51.7 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.452 2.101 . . . . 0.0 111.132 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.06 148.98 29.97 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.188 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 7.3 m-85 -114.48 122.87 47.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.25 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' NE2' HD11 ' A' ' 83' ' ' ILE . 6.1 t-80 -137.07 121.08 17.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 58.84 43.02 18.88 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.798 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.63 -4.79 33.76 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.699 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.12 150.52 24.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.2 mp0 -103.2 129.72 50.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.794 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 12.8 m-85 -118.16 175.53 5.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.096 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.11 167.77 9.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.201 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 29.4 Cg_endo -62.19 128.29 23.52 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.561 2.174 . . . . 0.0 111.869 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.28 83.89 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -78.14 132.81 37.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.58 152.37 21.81 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.444 0.64 . . . . 0.0 110.931 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.44 150.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.179 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 14.9 tptp -98.72 131.48 44.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 86' ' ' ASN . 56.6 mt -135.01 114.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 34.68 66.09 0.34 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.56 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 70.78 -29.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.958 0.409 . . . . 0.0 110.909 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 83' ' ' ILE . 59.8 t-20 -87.58 133.82 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.358 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.78 148.92 29.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.63 151.76 50.56 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.53 144.29 35.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.4 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 87.2 m -70.37 111.48 5.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -142.15 121.35 13.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.348 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 61.74 50.62 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.263 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.526 HH11 HD11 ' A' ' 63' ' ' LEU . 32.1 ttp180 57.63 10.14 0.97 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.285 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -133.89 152.78 51.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.326 0.584 . . . . 0.0 110.055 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.628 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 94.9 m95 -83.39 133.5 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.108 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.442 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.2 t-20 -108.58 104.53 13.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.781 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 55.8 m -86.97 132.88 33.66 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.014 0.911 . . . . 0.0 112.235 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.451 HG21 ' ND1' ' A' ' 100' ' ' HIS . 54.1 m -58.07 -45.63 86.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.068 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.86 13.55 3.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.047 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.611 ' H ' ' CD2' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.03 141.93 58.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.374 178.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -52.2 146.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.639 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.8 m -74.76 92.47 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.506 179.744 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 143.09 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.51 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.7 tpp -97.01 122.54 40.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.391 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.43 175.94 34.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 t -72.79 145.77 46.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 110.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 21.2 p -140.93 37.58 1.78 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' PRO . 30.9 mtm-85 57.96 159.25 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' O ' ' SD ' ' A' ' 10' ' ' MET . 87.4 Cg_exo -30.05 104.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 122.764 2.309 . . . . 0.0 111.174 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.42 134.09 5.62 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.063 1.842 . . . . 0.0 113.1 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 8' ' ' PRO . 5.1 mpp? -116.64 -45.69 2.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.54 120.31 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -84.84 135.32 34.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 0.0 110.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD11 ' SD ' ' A' ' 41' ' ' MET . 1.9 pp -131.67 132.7 44.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.351 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.49 160.92 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' SG ' ' OD1' ' A' ' 19' ' ' ASN . 36.8 t -92.77 111.98 53.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.391 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 85.2 Cg_exo -46.42 179.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -46.58 86.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.806 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.452 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.5 t0 -99.74 6.83 45.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.851 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' OD1' ' SG ' ' A' ' 15' ' ' CYS . 62.4 t30 61.08 66.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.025 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 20' ' ' LEU . 1.1 mm? -95.71 -15.72 22.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.246 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 63.4 ttm-85 -70.12 -43.0 71.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.81 161.43 19.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.949 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -145.12 -35.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.384 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.85 -162.04 36.62 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -79.42 -159.55 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.533 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -69.03 -3.64 13.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' N ' ' OE2' ' A' ' 26' ' ' GLU . 54.4 m -71.7 146.68 48.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.619 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 29' ' ' LYS . 33.5 p -98.72 -122.9 0.14 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 11.6 ttpt -147.63 97.92 2.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -132.14 152.05 51.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.648 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -49.45 -13.22 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.263 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 30' ' ' THR . 11.7 pt20 -82.33 -38.63 23.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.265 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' LEU . 99.3 m-20 -113.17 -4.39 13.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.581 0.353 . . . . 0.0 111.016 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' THR . 11.9 t80 -48.56 -48.25 38.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -105.18 -7.27 19.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.021 0.438 . . . . 0.0 110.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -101.19 139.46 36.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.04 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.999 ' N ' HD12 ' A' ' 36' ' ' LEU . 97.4 mt-10 -42.49 164.28 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.806 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 1.8 t 78.48 103.05 0.07 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.091 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.3 ptt? -161.35 -167.73 1.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.552 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 39' ' ' MET . 5.5 t 49.77 97.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.915 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 42' ' ' GLY . 5.6 ttt -43.95 125.74 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 41' ' ' MET . . . -55.4 -160.91 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 53.7 t -71.3 44.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.528 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 42' ' ' GLY . 72.3 t -122.87 127.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.077 0.465 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.5 p -75.34 153.82 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.699 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 -175.7 47.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.802 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 21.8 p -122.45 126.18 47.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.9 mt -130.47 162.19 29.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.21 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -73.64 156.6 88.43 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.333 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.14 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.655 2.237 . . . . 0.0 112.16 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.7 Cg_endo -56.06 -37.74 95.84 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.518 2.145 . . . . 0.0 112.546 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.01 -0.72 86.33 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.3 mmm -118.51 160.22 22.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.523 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 61' ' ' VAL . 16.6 m -130.37 -169.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.719 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 30' ' ' THR . 22.3 mtp-105 -122.13 117.58 26.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.292 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -133.16 124.45 27.51 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 44.47 49.25 8.31 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.269 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' ASN . 29.1 t-20 66.89 5.22 3.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -123.31 151.08 42.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.8 m -103.02 131.69 49.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.337 0.589 . . . . 0.0 110.944 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.4 m -135.48 155.94 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.421 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.29 150.1 48.82 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.452 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' SG ' ' A' ' 31' ' ' CYS . 4.3 mm? -47.04 -50.65 19.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.862 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -66.89 -14.72 63.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -95.86 -6.18 39.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 110.439 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' HG21 ' A' ' 54' ' ' VAL . 57.9 m -56.38 150.5 33.01 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.34 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.36 157.6 37.04 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.52 2.147 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -109.47 148.25 31.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.739 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.83 127.61 50.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.971 0.415 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.451 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.0 t-80 -145.44 134.4 22.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.099 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 53.01 33.82 15.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.119 -0.363 . . . . 0.0 111.935 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.25 -5.83 58.59 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.224 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.68 148.85 25.07 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -101.08 127.15 47.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 9.9 m-85 -118.17 178.71 4.34 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.152 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.68 173.58 2.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 22.9 Cg_exo -64.5 137.02 53.12 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.184 1.923 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.18 82.07 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -81.98 134.37 35.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.63 148.92 24.97 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.846 0.831 . . . . 0.0 112.366 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -141.0 149.83 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.759 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -106.39 132.2 52.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.451 HD11 ' NE2' ' A' ' 70' ' ' HIS . 54.9 mt -130.98 86.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.228 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 51.41 85.95 0.02 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.76 -37.42 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.771 0.32 . . . . 0.0 111.374 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 84' ' ' GLY . 36.2 t-20 -88.88 140.76 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.123 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.566 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -126.99 152.61 46.99 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.042 0.448 . . . . 0.0 110.221 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.19 156.73 46.89 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.007 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 p -128.9 138.33 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.98 112.81 6.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -141.66 123.32 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.029 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 62.03 51.46 3.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.33 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.517 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 77.2 mtp180 53.36 15.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.289 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.25 161.15 35.25 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -98.36 132.09 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -109.92 95.83 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.425 ' HB3' HD21 ' A' ' 86' ' ' ASN . 86.6 m -80.56 138.74 36.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.052 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 99' ' ' ASP . 3.0 t -60.28 -53.17 60.81 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.356 1.074 . . . . 0.0 110.867 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.654 ' H ' HG23 ' A' ' 98' ' ' THR . 57.3 t0 60.79 26.44 16.27 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 112.977 -1.92 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.617 ' CG ' ' HG1' ' A' ' 98' ' ' THR . 0.0 OUTLIER -104.65 171.39 7.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.11 149.73 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.0 m -77.45 97.42 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--O 1.219 -0.54 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.646 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.45 94.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.41 141.64 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.556 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.4 75.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.506 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 44.1 t -61.88 -43.82 98.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.684 0.278 . . . . 0.0 110.715 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 5' ' ' SER . 1.2 p 52.96 168.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' NH1' ' CZ ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -40.72 165.08 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.859 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 7' ' ' ARG . 96.6 Cg_exo -33.01 105.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.434 2.089 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.91 144.59 17.17 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.327 2.018 . . . . 0.0 112.928 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.1 mtm -127.05 -40.3 1.87 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.874 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.29 115.13 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -90.88 111.8 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 110.195 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.8 pp -107.67 122.71 47.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.47 163.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.665 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.493 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 57.9 m -107.63 101.5 40.18 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HG3' ' HE ' ' A' ' 21' ' ' ARG . 64.6 Cg_exo -50.04 178.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.193 1.929 . . . . 0.0 112.801 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.72 77.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.6 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -94.95 3.41 54.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.906 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 59.6 66.47 1.0 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.55 18.9 15.7 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' HE ' ' HG3' ' A' ' 16' ' ' PRO . 87.4 mtm180 -149.96 55.8 0.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.313 . . . . 0.0 110.229 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.67 22.08 6.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.242 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' GLY . 98.7 mt-10 54.57 167.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 23' ' ' GLU . . . -47.01 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.18 134.14 47.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -89.47 -179.51 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 40' ' ' SER . 5.5 t 59.01 -169.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.9 p -81.51 176.73 9.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.53 95.86 2.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.554 ' C ' ' H ' ' A' ' 32' ' ' GLN . 27.7 p -133.06 154.3 50.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.775 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 m -60.27 7.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.715 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 pt20 -105.72 -43.11 4.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 111.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 36' ' ' LEU . 22.8 p30 -108.27 -6.52 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.391 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 63' ' ' LEU . 77.8 t80 -44.43 -54.81 5.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.809 0.337 . . . . 0.0 110.588 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.75 -4.87 24.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 33' ' ' ASN . 62.8 mt -114.37 169.75 8.81 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.111 0.481 . . . . 0.0 111.029 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -41.89 159.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.15 170.96 8.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.668 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -83.82 -7.25 59.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.489 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 33.8 p -159.68 160.37 34.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 ttt -101.14 -54.58 2.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.62 -178.72 42.36 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -80.62 158.38 25.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.6 p -157.77 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' VAL . 5.8 t 15.77 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.19 161.54 29.15 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.887 0.715 . . . . 0.0 111.536 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.64 99.8 7.2 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.2 -173.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.881 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 174.87 4.55 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.18 167.32 17.86 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.014 1.809 . . . . 0.0 112.936 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -54.23 147.47 45.11 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.237 1.958 . . . . 0.0 112.372 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.34 -17.85 40.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.29 148.55 32.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.27 140.27 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.559 ' CZ ' ' NH1' ' A' ' 7' ' ' ARG . 66.0 mtp180 -72.6 122.69 21.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.287 0.565 . . . . 0.0 110.583 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.84 117.91 19.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 70.7 mm-40 51.1 35.0 11.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.9 m120 79.01 11.58 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.624 0.577 . . . . 0.0 110.985 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -122.91 148.91 44.91 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.36 129.98 44.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.676 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.63 154.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.125 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 153.22 41.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.23 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 34' ' ' TYR . 2.9 mm? -49.78 -55.64 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.855 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -57.82 -17.4 15.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.47 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.66 -3.48 32.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.9 t -54.4 116.89 11.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.413 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -48.86 153.55 3.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.259 1.973 . . . . 0.0 112.429 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -103.18 163.95 11.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.412 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 21.1 m-85 -137.06 129.3 29.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.071 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.542 ' NE2' HD11 ' A' ' 83' ' ' ILE . 9.4 t-80 -144.48 127.82 16.83 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 55.47 39.57 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.497 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 -5.91 37.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -100.54 144.43 29.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.39 127.18 43.14 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.997 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 31.7 m-85 -120.28 178.41 4.65 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.314 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.04 172.35 3.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.508 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.443 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.6 Cg_exo -63.33 138.79 68.03 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.339 2.026 . . . . 0.0 111.566 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.63 -1.6 71.69 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -79.35 133.25 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.6 144.51 31.6 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.82 0.819 . . . . 0.0 111.993 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.95 152.89 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.53 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -99.18 129.93 45.46 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.542 HD11 ' NE2' ' A' ' 70' ' ' HIS . 59.9 mt -129.17 107.85 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.094 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.64 -115.15 7.62 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.74 1.18 31.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.738 0.304 . . . . 0.0 110.454 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.504 ' HA ' ' CE1' ' A' ' 100' ' ' HIS . 19.2 p30 -127.16 159.84 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.428 0.632 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.31 151.87 35.0 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.54 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.29 147.92 52.42 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.346 -178.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.33 138.85 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.564 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.22 107.76 3.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.416 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -137.45 121.62 17.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.422 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 65.34 51.41 1.58 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.654 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.785 HH11 HD12 ' A' ' 63' ' ' LEU . 35.5 mtm180 56.61 9.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.621 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -133.48 163.29 29.7 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -96.96 133.49 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.908 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.436 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 5.5 m120 -111.58 106.57 15.45 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.621 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 62.9 m -86.42 137.03 32.88 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 112.063 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.579 HG21 ' CD2' ' A' ' 100' ' ' HIS . 54.2 m -58.04 -48.8 78.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.116 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 98' ' ' THR . 2.2 m-20 80.02 11.49 1.15 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.286 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.579 ' CD2' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -78.76 157.91 28.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -86.14 132.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.53 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 103' ' ' ASP . 10.5 p -67.47 -53.0 32.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.442 0.639 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 98.2 m-20 . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.28 86.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.59 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.2 ttp -147.69 116.28 6.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -94.91 -177.91 37.87 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.45 ' C ' ' SG ' ' A' ' 6' ' ' CYS . 88.3 p -54.91 117.77 3.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 19.2 m -151.48 101.96 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 9.9 mpt_? -89.4 -66.36 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.092 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 56.0 Cg_endo -69.5 169.45 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.133 1.888 . . . . 0.0 111.108 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.99 96.39 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 119.033 0.69 . . . . 0.0 111.629 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.602 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 40.6 mmm -91.92 2.38 56.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.018 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 10' ' ' MET . 0.2 OUTLIER 56.74 128.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.53 178.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -86.52 132.6 33.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.154 0.502 . . . . 0.0 110.05 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 pp -123.78 135.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.2 159.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 16' ' ' PRO . 35.8 m -70.02 114.36 24.68 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.633 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 15' ' ' CYS . 77.5 Cg_exo -46.17 178.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.743 1.629 . . . . 0.0 112.755 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.51 -46.36 90.32 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.807 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -98.2 5.0 48.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.634 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 57.81 66.43 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.72 14.44 17.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -149.11 51.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.08 0.467 . . . . 0.0 109.874 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.24 125.11 40.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.526 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -177.17 34.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.39 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.72 -4.11 90.22 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 44' ' ' VAL . 32.6 mt -64.55 135.03 55.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.821 0.343 . . . . 0.0 110.381 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' CYS . 95.2 mt-10 -42.84 166.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.454 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 1.1 t 82.74 10.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 p -49.55 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.106 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 11.9 ptmt -147.32 105.51 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.39 0.614 . . . . 0.0 109.347 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -143.12 159.59 41.99 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 67.5 m -40.91 -25.76 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.508 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' THR . 6.6 pt20 -76.62 -44.5 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 27' ' ' CYS . 2.7 p-10 -114.4 0.08 13.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.11 0.481 . . . . 0.0 110.834 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 30' ' ' THR . 64.2 t80 -47.5 -51.85 19.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.012 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -103.43 -2.28 27.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.027 0.441 . . . . 0.0 109.829 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 37' ' ' GLU . 1.7 tp -113.33 127.48 56.15 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 36' ' ' LEU . 79.2 mm-40 -61.04 149.4 37.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -155.21 140.47 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.236 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 39' ' ' MET . 2.0 mpt? -79.88 138.79 37.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.793 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 p -174.53 85.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.23 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 96.1 mtp -134.9 137.52 43.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.347 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.12 148.74 4.81 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.39 101.57 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 0.0 110.343 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 25' ' ' LEU . 71.8 t -142.04 107.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.702 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -73.67 140.88 46.38 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.341 0.401 . . . . 0.0 111.264 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 -171.96 45.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.07 39.67 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 49' ' ' CYS . 4.3 pp -119.45 -173.34 2.5 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.688 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.4 t -110.78 128.18 25.73 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.29 171.76 7.41 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.257 1.304 . . . . 0.0 113.197 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.21 152.23 73.45 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.392 2.061 . . . . 0.0 112.503 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.75 -21.06 4.87 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.538 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 85.7 mmm -111.86 150.03 30.98 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.44 141.5 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.117 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 30' ' ' THR . 69.8 ttt180 -72.92 120.14 18.13 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -133.87 120.29 20.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 52.27 37.47 22.21 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.268 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 76.37 10.88 2.88 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.879 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -123.4 153.01 40.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.602 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 18.6 m -103.04 124.7 49.03 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.102 0.477 . . . . 0.0 110.135 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.07 159.74 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.314 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 145.01 51.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.625 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 tp -51.49 -53.48 36.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.66 -20.0 4.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.977 0.417 . . . . 0.0 110.442 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -98.02 -4.25 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 110.27 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.439 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 6.3 t -53.86 126.54 50.69 Favored Pre-proline 0 C--N 1.32 -0.704 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.891 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.03 154.95 9.4 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.914 1.743 . . . . 0.0 112.419 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -99.16 165.63 11.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.133 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 22.1 m-85 -137.1 122.58 19.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.534 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.8 t-80 -147.26 133.7 19.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.233 0.54 . . . . 0.0 110.426 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 54.11 35.44 22.34 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.708 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.02 -5.65 52.94 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.145 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.8 156.88 17.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -106.48 130.92 54.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.071 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 4.8 m-85 -120.84 177.52 5.06 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.89 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.65 175.46 1.94 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.198 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.1 Cg_exo -64.66 135.07 43.59 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.235 1.957 . . . . 0.0 111.688 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.56 -2.76 84.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -77.85 136.68 38.11 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.71 152.05 23.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.08 0.466 . . . . 0.0 111.126 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.0 m -145.88 151.2 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.549 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -103.31 135.09 45.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.413 0.625 . . . . 0.0 110.254 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.534 HD11 ' NE2' ' A' ' 70' ' ' HIS . 49.6 mt -134.42 84.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 49.97 85.01 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.89 -33.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.753 HD22 ' HB3' ' A' ' 97' ' ' CYS . 15.2 t30 -90.17 136.94 32.74 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.86 152.97 37.77 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.05 0.452 . . . . 0.0 110.973 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 83' ' ' ILE . 4.0 m -140.57 154.77 46.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.346 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.88 139.68 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.393 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 24.1 t -71.78 109.64 5.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.288 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -140.07 122.78 16.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.67 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 62.55 51.37 3.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.286 0.565 . . . . 0.0 109.871 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 54.8 ttt-85 51.23 19.11 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.129 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -136.76 153.63 50.78 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 109.978 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -90.18 130.81 36.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.451 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -105.09 94.43 5.23 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.753 ' HB3' HD22 ' A' ' 86' ' ' ASN . 85.1 m -79.98 133.15 36.15 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.635 0.731 . . . . 0.0 111.79 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.431 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 65.4 m -63.89 -52.53 59.51 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 60.25 31.54 20.5 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.44 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER -96.54 170.15 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.047 178.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.33 144.43 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.5 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 t -65.38 95.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.9 t0 . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.659 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.06 93.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.607 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.2 mmm -65.37 -42.58 92.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.568 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.56 -171.95 39.86 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -60.89 -42.9 98.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 25.9 p -63.89 123.31 18.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 7.0 mtp180 -82.85 -65.4 0.23 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 29.2 Cg_endo -60.71 110.09 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.269 1.98 . . . . 0.0 111.367 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' C ' ' SD ' ' A' ' 10' ' ' MET . 92.0 Cg_endo -85.83 113.97 1.36 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 121.807 1.672 . . . . 0.0 113.208 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 10' ' ' MET . 4.4 mpp? -120.29 -58.33 1.86 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' CYS . 2.4 t -122.05 122.58 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' NZ ' ' CG1' ' A' ' 14' ' ' VAL . 64.1 tttm -89.91 125.15 35.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.071 0.462 . . . . 0.0 111.013 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.0 pp -123.55 122.61 38.63 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.602 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' CG1' ' NZ ' ' A' ' 12' ' ' LYS . 34.1 m -111.11 160.48 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.705 0.288 . . . . 0.0 110.273 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' SG ' ' OD1' ' A' ' 19' ' ' ASN . 10.0 t -73.26 114.7 33.78 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 77.9 Cg_exo -47.85 -179.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.078 1.852 . . . . 0.0 112.61 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.66 96.42 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -116.96 21.6 13.16 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.427 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' OD1' ' SG ' ' A' ' 15' ' ' CYS . 9.4 m-20 58.78 57.16 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.119 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' H ' ' HB2' ' A' ' 16' ' ' PRO . 4.5 mm? -64.38 -42.09 96.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.805 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.469 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 65.6 ttp85 -139.17 57.31 1.66 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.814 0.34 . . . . 0.0 110.09 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.75 96.69 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.579 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -172.81 171.55 4.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' MET . . . 72.34 68.83 1.51 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.0 mp 54.67 163.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.647 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.6 pm0 -88.21 147.66 24.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.13 0.491 . . . . 0.0 111.704 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -160.04 -153.87 0.36 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.272 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 29' ' ' LYS . 10.2 t -154.62 -154.39 0.51 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.41 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.9 ttpm? -144.74 99.7 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.487 ' C ' ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -132.28 157.32 44.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.93 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' HB2' ' HE ' ' A' ' 93' ' ' ARG . 1.7 p -47.83 -13.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.487 ' N ' ' C ' ' A' ' 30' ' ' THR . 1.6 pt20 -85.49 -40.95 15.79 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 18.9 m-20 -108.9 -5.94 15.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' HD21 ' A' ' 63' ' ' LEU . 18.7 t80 -49.61 -49.71 45.76 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.108 -0.37 . . . . 0.0 110.243 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -99.93 -3.33 32.57 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 33' ' ' ASN . 3.2 tp -116.2 122.25 44.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 36' ' ' LEU . 11.4 pt-20 -62.7 136.47 57.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.342 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.625 ' SG ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 p -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.872 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 38' ' ' CYS . 72.9 mtm 30.17 35.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.901 0.381 . . . . 0.0 111.513 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 38' ' ' CYS . 11.0 m 39.21 -108.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 95.6 mtp -141.85 -23.7 0.7 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . 74.95 159.87 7.51 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 43.9 t -96.03 54.5 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.0 110.3 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.4 154.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.111 0.481 . . . . 0.0 110.803 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -69.06 138.54 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.634 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.04 164.99 33.06 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 12.7 p -122.19 111.81 17.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.126 0.489 . . . . 0.0 110.963 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.28 165.41 17.0 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.889 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.78 47.95 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.51 157.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.787 2.325 . . . . 0.0 112.171 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.87 -18.79 63.39 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.602 2.201 . . . . 0.0 111.887 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.92 -17.24 44.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 mtp -111.14 149.71 30.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.909 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.01 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.484 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 55' ' ' ARG . 7.5 ptm180 -74.17 122.5 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.719 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -135.55 124.04 23.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 60.0 tt0 51.97 33.46 11.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.472 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.1 m120 79.51 14.24 1.02 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.019 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -124.77 148.04 48.34 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -103.95 113.81 27.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 0.0 111.176 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 m -123.81 161.02 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.001 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.4 144.6 53.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.46 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 34' ' ' TYR . 14.4 mt -48.96 -51.11 32.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.273 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -60.74 -17.41 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -102.5 -8.99 20.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.533 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.4 138.45 67.93 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.552 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.76 158.43 53.65 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.147 1.898 . . . . 0.0 112.418 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.03 165.63 11.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.454 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.22 128.39 35.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.932 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 83' ' ' ILE . 7.2 t60 -141.3 118.56 11.39 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 60.55 45.57 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.03 -6.22 28.71 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.256 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -102.78 149.14 24.78 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.849 0.357 . . . . 0.0 110.276 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 74' ' ' GLU . 7.2 tm-20 -103.89 129.64 51.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.652 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 11.4 m-85 -118.53 178.33 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.461 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.66 165.55 13.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.443 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 21.0 Cg_endo -60.18 134.56 56.66 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.617 2.212 . . . . 0.0 111.454 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.93 80.79 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -78.64 134.29 37.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.43 151.15 23.87 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.837 0.827 . . . . 0.0 111.645 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 151.79 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.592 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -99.81 131.86 45.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.807 0.337 . . . . 0.0 110.592 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 70' ' ' HIS . 76.8 mt -129.9 119.44 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.866 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.11 -110.53 1.18 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.16 4.09 20.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.047 0.451 . . . . 0.0 110.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ILE . 4.2 p30 -126.02 155.9 40.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.773 0.797 . . . . 0.0 110.306 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -114.95 152.24 32.7 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.235 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -133.57 157.03 46.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.222 -178.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.85 144.72 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.564 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.683 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 76.6 m -69.47 107.55 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.742 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -139.52 120.73 14.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.94 51.71 3.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.469 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HE ' ' HB2' ' A' ' 31' ' ' CYS . 45.0 mtp180 55.68 9.83 0.46 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.008 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -133.1 156.49 47.33 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.683 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 96.2 m95 -88.06 132.96 34.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.438 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 1.8 t30 -106.64 102.29 11.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 57.8 m -88.1 134.79 33.68 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.26 0.553 . . . . 0.0 111.61 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.1 t -60.67 -52.47 64.99 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.501 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.685 ' N ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER 77.35 -0.51 2.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.07 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 1.4 p80 -42.6 170.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 103' ' ' ASP . 14.6 t -62.02 133.81 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.127 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.9 m -60.59 74.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . 68.3 t0 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.491 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 10' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.46 0.066 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.62 124.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.256 0.55 . . . . 0.0 110.81 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 51' ' ' PRO . 6.5 ttpt . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -137.12 156.65 48.1 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.6 t -46.46 -17.05 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.33 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 30' ' ' THR . 12.6 pt20 -84.97 -42.75 14.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.4 m-20 -109.31 -2.44 17.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.284 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.5 t80 -44.27 -53.0 7.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -105.74 -3.63 21.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASN . 31.4 mt . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.087 0.47 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 p . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.699 0.285 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.0 mt -123.73 -174.59 3.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 50' ' ' PRO . 69.1 m -92.48 149.76 38.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.301 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 99.6 Cg_exo -38.47 165.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.745 2.297 . . . . 0.0 112.62 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 53.2 Cg_exo -53.87 -48.17 23.2 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.052 1.835 . . . . 0.0 112.926 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.15 -6.24 82.61 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.516 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.9 mtp -112.83 154.38 26.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 111.023 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 61' ' ' VAL . 3.0 m -125.91 152.25 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -86.72 117.61 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.289 0.566 . . . . 0.0 110.887 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -138.55 126.45 22.44 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.349 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 46.83 45.56 15.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.261 0.553 . . . . 0.0 110.352 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER 63.04 8.44 3.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.978 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -120.43 149.24 42.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -97.34 128.08 43.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.516 . . . . 0.0 110.385 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.3 m -135.59 155.17 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.582 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 148.33 47.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.588 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 93' ' ' ARG . 10.5 mp -52.01 -52.22 52.15 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.024 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.62 -15.58 29.69 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.533 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -104.25 -4.9 22.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.473 0.177 . . . . 0.0 111.45 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -53.79 151.78 11.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.438 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 92.4 Cg_endo -74.51 156.66 45.2 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 110.99 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -116.25 151.69 35.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.069 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 3.5 m-85 -120.94 130.85 54.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.087 0.47 . . . . 0.0 110.58 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.506 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.5 t60 -152.79 98.54 2.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.033 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 30.8 tt0 87.81 36.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.963 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.17 -5.59 48.78 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.0 148.45 26.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 110.522 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.88 125.39 41.28 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.988 0.423 . . . . 0.0 110.966 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 26.5 m-85 -114.53 177.06 4.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -117.8 173.58 3.15 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.695 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.437 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.8 Cg_exo -64.56 139.12 62.6 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.248 1.965 . . . . 0.0 111.472 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.7 0.16 67.36 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -81.73 129.22 34.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.35 145.07 30.77 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.112 0.958 . . . . 0.0 112.313 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.08 153.78 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.17 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.72 130.42 48.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.756 0.312 . . . . 0.0 110.159 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.14 98.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.3 -116.68 7.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 3.6 40.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.115 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.75 159.01 35.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -123.25 153.29 40.36 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.691 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -134.51 151.1 50.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.432 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.26 138.86 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.36 116.01 12.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.346 0.593 . . . . 0.0 111.124 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -144.0 118.78 9.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.325 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.29 51.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.426 ' CZ ' HD23 ' A' ' 63' ' ' LEU . 89.7 mtm180 54.23 12.24 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 157.54 44.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.68 133.48 36.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.8 m-80 -112.86 109.36 18.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.609 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 65.2 m -89.21 134.6 33.97 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.384 0.612 . . . . 0.0 111.792 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.797 HG22 ' H ' ' A' ' 100' ' ' HIS . 0.8 OUTLIER -71.68 -37.04 70.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.913 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.52 32.65 19.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.797 ' H ' HG22 ' A' ' 98' ' ' THR . 15.0 p80 -61.04 171.26 1.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.576 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.305 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.439 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 44.5 mtm . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.549 0.214 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.06 115.36 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp . . . . . 0 C--N 1.319 -0.748 0 CA-C-O 121.181 0.515 . . . . 0.0 111.026 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 3.7 tttp . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -135.64 156.08 49.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.991 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.465 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 1.5 t -52.12 -4.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.9 pt20 -100.4 -42.36 6.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.302 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.2 m-20 -113.74 -2.8 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.027 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 30' ' ' THR . 15.1 t80 -51.88 -45.47 64.14 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -102.17 -3.8 26.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.636 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 33' ' ' ASN . 50.5 mt . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.944 0.402 . . . . 0.0 111.052 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.947 0.403 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.08 -172.96 2.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -103.28 173.39 3.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.12 157.11 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.544 2.163 . . . . 0.0 112.344 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 32.1 Cg_endo -62.15 -27.97 79.28 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.602 2.201 . . . . 0.0 112.198 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 -8.79 75.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.11 153.0 31.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.002 0.429 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.96 135.05 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.945 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -73.84 129.75 38.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 59' ' ' ARG . 3.5 t60 -139.11 130.33 26.78 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.052 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 22.1 tp10 45.72 26.64 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 40.9 t30 88.56 10.27 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.916 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 56' ' ' HIS . 2.1 ptm180 -126.92 151.94 47.78 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.8 m -99.42 131.56 45.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.301 0.572 . . . . 0.0 110.539 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.03 157.17 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.574 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.04 148.8 48.37 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.456 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.8 mm? -52.17 -46.21 65.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.176 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.75 -13.42 62.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.441 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -102.07 -6.9 22.79 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 110.987 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.15 148.9 49.44 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.34 162.26 40.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.624 2.216 . . . . 0.0 111.83 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.6 m -103.41 166.19 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 17.8 m-85 -132.23 123.12 26.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.948 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 83' ' ' ILE . 13.4 t60 -142.67 126.92 17.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 110.049 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.6 42.15 29.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.62 -3.38 49.47 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.353 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -104.31 151.33 23.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.975 0.417 . . . . 0.0 110.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -104.63 129.14 52.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.654 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 10.4 m-85 -117.53 176.51 5.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.486 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.74 162.55 24.73 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.765 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 20.4 Cg_endo -59.6 136.06 68.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.411 2.074 . . . . 0.0 111.522 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.42 -2.62 86.9 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE1' ' C ' ' A' ' 79' ' ' GLU . 9.5 tm-20 -82.78 137.46 34.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -104.9 149.69 25.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.789 0.804 . . . . 0.0 111.966 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.16 146.07 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.399 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 84' ' ' GLY . 6.0 tmtt? -101.82 129.43 48.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 70' ' ' HIS . 81.4 mt -129.52 117.31 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . . . 56.41 -117.83 10.12 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.438 ' C ' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -102.19 1.98 36.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.328 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 6.7 p30 -125.81 162.38 25.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.397 0.617 . . . . 0.0 111.044 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -127.88 157.57 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.909 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.38 163.01 33.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.29 142.41 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.19 105.55 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.426 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -137.7 122.42 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.593 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 60.14 51.94 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.37 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 62.7 mtp180 54.47 12.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.157 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -132.91 158.07 43.52 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -92.86 133.73 35.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -105.53 94.21 5.08 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.7 m -82.0 135.03 35.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.187 0.518 . . . . 0.0 111.226 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.0 t -63.46 -52.57 60.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.281 1.039 . . . . 0.0 110.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.697 ' N ' HG23 ' A' ' 98' ' ' THR . 27.7 t0 68.74 18.76 8.64 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.929 -1.941 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 3.6 p80 -59.6 171.27 0.88 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 62.0 t . . . . . 0 CA--C 1.52 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.248 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.555 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.52 107.58 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 121.285 0.564 . . . . 0.0 111.241 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.72 ' HZ3' ' HA ' ' A' ' 51' ' ' PRO . 35.0 mtpt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 55' ' ' ARG . 36.4 p -131.25 152.57 50.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.832 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -50.42 -4.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.742 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.566 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.6 pt20 -104.31 -54.43 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.655 0.264 . . . . 0.0 111.618 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.49 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 27.7 p30 -93.3 -7.11 45.85 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.687 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.47 ' CD1' HD11 ' A' ' 63' ' ' LEU . 67.8 t80 -44.29 -47.5 9.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.248 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 17.1 p-10 -102.02 -0.63 33.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 32' ' ' GLN . 4.5 mt . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.29 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.726 0.298 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' O ' ' SD ' ' A' ' 10' ' ' MET . 95.6 mt -136.68 -173.41 3.42 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.172 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 50' ' ' PRO . 93.2 m -96.35 150.6 37.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.944 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 49' ' ' CYS . 84.4 Cg_exo -34.2 158.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.72 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 19.3 Cg_endo -58.14 -26.68 77.02 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.791 2.327 . . . . 0.0 112.179 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.5 -1.32 60.59 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtp -122.95 164.34 18.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.31 -0.445 . . . . 0.0 111.23 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.11 148.79 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.609 ' O ' HG22 ' A' ' 30' ' ' THR . 78.9 ttt-85 -76.26 123.05 25.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.153 0.501 . . . . 0.0 110.712 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.95 127.95 22.19 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 55.2 tt0 47.42 35.07 3.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.6 m-20 76.31 9.39 3.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.745 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -127.1 152.1 47.76 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.66 126.95 40.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 0.0 109.992 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.42 156.98 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.942 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.97 41.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.464 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.3 mm? -48.05 -50.24 28.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.111 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -59.67 -14.34 13.48 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.188 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -99.95 -6.58 26.38 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.471 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.9 m -55.11 138.87 65.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.197 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.79 159.99 47.2 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.593 2.195 . . . . 0.0 112.138 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.76 167.07 10.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.812 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.98 129.71 32.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -142.72 122.73 13.62 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 58.86 42.8 19.17 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.617 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.09 -3.98 34.65 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.119 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -101.79 142.02 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -96.23 129.08 43.63 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.194 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 39.0 m-85 -118.95 176.91 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.003 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.89 164.51 16.44 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 19.2 Cg_endo -59.34 133.96 55.76 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.519 2.146 . . . . 0.0 111.529 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.92 86.51 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 80' ' ' THR . 11.1 tm-20 -80.74 138.67 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.423 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -110.66 154.9 23.17 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.622 0.725 . . . . 0.0 111.696 -177.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.9 150.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.61 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -99.71 131.55 45.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASN . 55.6 mt -135.26 99.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.687 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 41.34 78.23 0.07 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 63.35 -29.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.667 0.27 . . . . 0.0 110.918 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 84' ' ' GLY . 23.4 t-20 -89.92 128.62 36.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.229 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.28 148.02 33.8 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.804 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.61 153.55 51.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.168 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.93 146.27 29.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.515 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.649 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 77.1 m -71.31 108.66 4.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -139.84 114.63 9.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.363 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 68.92 50.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.407 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 55.99 11.93 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.53 161.02 34.84 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.649 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 95.3 m95 -93.34 130.41 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.115 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.0 t-20 -105.88 105.41 15.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.728 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 53.3 m -87.92 132.62 34.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.627 0.727 . . . . 0.0 112.808 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.456 HG21 ' ND1' ' A' ' 100' ' ' HIS . 52.5 m -61.58 -47.9 83.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.359 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' THR . 14.6 t0 79.04 11.06 1.51 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.952 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.592 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.91 151.38 45.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.032 0.444 . . . . 0.0 110.486 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.578 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 58.9 mtm . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.63 120.29 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.551 -179.466 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.738 ' NZ ' ' H ' ' A' ' 52' ' ' GLY . 77.6 tttt . . . . . 0 CA--C 1.515 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' TYR . 6.4 m -136.78 155.84 49.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.872 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 3.7 t -59.15 1.37 0.07 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.017 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.0 pt20 -104.06 -44.0 5.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.622 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' LEU . 96.5 m-20 -111.81 -7.14 14.21 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.9 t80 -48.52 -47.13 39.24 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.935 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 48.8 t0 -101.45 -5.2 25.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 110.463 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 33' ' ' ASN . 45.0 mt . . . . . 0 N--CA 1.468 0.443 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.603 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -120.23 -172.66 2.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -90.44 171.75 7.97 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.617 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' CD ' ' SG ' ' A' ' 49' ' ' CYS . 25.6 Cg_exo -61.55 -179.84 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.298 1.999 . . . . 0.0 112.673 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.53 151.43 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.791 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.738 ' H ' ' NZ ' ' A' ' 29' ' ' LYS . . . 79.76 -9.57 43.58 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mtp -116.68 152.23 34.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.214 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.8 139.6 50.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.257 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -73.55 126.35 30.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.385 0.612 . . . . 0.0 110.516 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 67' ' ' PRO . 1.9 t60 -133.88 122.83 23.73 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.905 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 80.9 mt-10 46.99 31.68 1.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.788 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.4 m120 83.71 11.43 0.43 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.553 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -125.79 149.02 48.92 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.0 m -97.5 133.44 42.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.899 -0.5 . . . . 0.0 110.589 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.62 157.73 24.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.288 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.31 150.45 45.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.297 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.9 mm? -49.16 -46.61 45.54 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.52 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.99 -14.38 61.52 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.868 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -101.39 -8.98 21.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.801 0.334 . . . . 0.0 110.952 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 147.02 30.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.615 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 56' ' ' HIS . 71.8 Cg_endo -72.55 163.73 37.7 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.692 2.262 . . . . 0.0 111.582 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.41 158.48 22.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.921 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -127.89 128.11 44.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.398 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 83' ' ' ILE . 84.4 t60 -144.82 126.18 14.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 59.24 37.88 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.502 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.95 -5.2 50.2 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.096 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -102.2 145.7 29.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 0.0 109.875 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -100.73 129.31 46.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 29.0 m-85 -118.96 177.31 4.91 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.316 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.79 175.11 2.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.736 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.519 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.5 Cg_exo -63.37 138.75 67.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.429 2.086 . . . . 0.0 111.605 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.97 -0.86 61.19 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.29 134.0 36.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.85 151.6 24.32 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.029 0.443 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.72 148.52 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.656 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -96.52 129.14 43.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 86' ' ' ASN . 97.9 mt -136.78 127.06 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.961 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 86' ' ' ASN . . . 32.52 83.97 0.01 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 1.6 p 41.48 13.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.627 0.251 . . . . 0.0 111.441 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 84' ' ' GLY . 8.8 m120 -128.04 161.1 29.97 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.97 149.68 52.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.165 0.507 . . . . 0.0 111.006 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 m -137.33 157.65 46.13 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.707 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.86 144.09 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.658 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 71.2 m -67.01 107.11 2.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -137.71 118.61 14.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 63.48 50.73 2.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.584 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 58.1 mtp180 55.92 11.95 0.8 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.3 160.86 35.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 110.054 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.658 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 93.5 m95 -93.1 131.94 37.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.101 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -106.26 94.29 5.07 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 95.2 m -78.26 135.24 37.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.605 0.717 . . . . 0.0 111.576 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 m -59.62 -45.48 91.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 59.47 28.0 17.28 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.559 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -76.78 170.53 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.827 177.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.647 -179.416 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' ' SG ' ' A' ' 49' ' ' CYS . 64.7 mtm . . . . . 0 C--O 1.234 0.246 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.44 118.98 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 pttm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.504 179.363 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' TYR . 10.6 m -128.27 165.28 20.82 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.831 ' SG ' HG21 ' A' ' 54' ' ' VAL . 80.9 m -55.08 -13.11 1.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.154 -0.341 . . . . 0.0 110.663 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -96.87 -38.01 10.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.492 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 36' ' ' LEU . 6.2 m120 -106.0 -4.96 19.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.918 ' CD2' HD11 ' A' ' 63' ' ' LEU . 22.2 t80 -44.36 -53.88 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.228 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -102.8 -0.2 31.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.421 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' ASN . 55.4 mt . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.694 0.283 . . . . 0.0 110.681 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 121.0 0.429 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -118.68 -174.58 2.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.73 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' SG ' ' CE ' ' A' ' 10' ' ' MET . 0.4 OUTLIER -86.98 161.41 47.04 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.064 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.42 168.11 23.37 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.651 2.234 . . . . 0.0 112.622 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.39 145.99 53.86 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.035 1.824 . . . . 0.0 112.163 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.54 -23.02 24.51 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 96.2 mmm -116.43 155.71 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 109.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.831 HG21 ' SG ' ' A' ' 31' ' ' CYS . 34.3 m -131.21 -167.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.85 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -120.7 118.07 29.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.54 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 67' ' ' PRO . 4.9 t60 -135.97 126.53 27.0 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 110.795 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 44.74 45.07 8.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.213 0.53 . . . . 0.0 110.102 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.9 m120 68.21 10.41 7.82 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -126.46 152.95 45.75 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -100.26 134.04 43.77 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.704 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 54' ' ' VAL . 11.5 m -137.84 155.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.18 153.11 44.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.473 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 34' ' ' TYR . 3.8 mm? -52.46 -50.81 61.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.41 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -56.62 -15.57 4.66 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.88 -1.52 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.091 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -55.22 115.61 9.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' HIS . 50.5 Cg_exo -50.45 159.47 2.07 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.737 1.625 . . . . 0.0 112.406 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.01 166.62 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -136.39 130.75 33.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.416 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.4 t60 -150.94 104.21 3.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.247 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 32.0 tt0 83.1 37.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.34 48.67 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -104.07 145.45 30.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -97.83 127.22 43.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 37.9 m-85 -115.11 177.24 4.73 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.127 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.73 170.12 6.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.37 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.34 138.28 65.19 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.969 1.779 . . . . 0.0 111.306 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.25 -1.23 76.8 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.51 128.47 34.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.48 145.74 29.85 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.688 0.756 . . . . 0.0 111.886 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.22 154.37 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -101.08 130.24 47.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 77.2 mt -128.45 106.61 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.87 -116.78 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' NE2' ' A' ' 100' ' ' HIS . 7.6 p -103.99 3.94 33.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.03 0.443 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 17.3 p30 -126.27 164.72 20.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.393 0.615 . . . . 0.0 110.61 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.32 152.07 41.81 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.879 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.76 150.62 52.14 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.2 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.55 140.85 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.52 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 t -71.11 110.26 5.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.74 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -140.9 118.93 11.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.794 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.5 t0 63.96 50.52 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.317 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 55.59 9.27 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.296 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -129.71 155.91 45.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -94.63 134.42 37.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.437 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 98.5 m-20 -111.67 104.44 12.8 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.632 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 78.4 m -86.94 137.92 31.96 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.913 0.863 . . . . 0.0 112.175 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 100' ' ' HIS . 2.8 m -61.03 -44.78 96.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t0 55.0 29.61 12.63 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.074 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.646 ' H ' HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -70.6 172.21 8.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.705 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.39 117.01 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.029 0.443 . . . . 0.0 110.843 179.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? . . . . . 0 CA--C 1.522 -0.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -140.82 162.56 35.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.105 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.0 t -59.26 6.45 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.081 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.9 pt20 -105.13 -46.14 4.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.057 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.449 ' N ' ' CG ' ' A' ' 32' ' ' GLN . 99.2 m-20 -115.83 -3.16 12.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.014 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -50.46 -46.59 56.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.926 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 58.2 t0 -106.82 -8.51 16.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ASN . 52.8 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.538 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 20.0 p . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 62.3 mt -123.75 -177.17 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.972 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -98.07 159.09 31.61 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' CYS . 87.5 Cg_exo -42.11 173.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.754 2.303 . . . . 0.0 112.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.03 154.72 57.72 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.507 2.138 . . . . 0.0 111.974 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 -4.37 58.71 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.1 mtp -110.54 150.22 29.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.061 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.59 137.3 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -72.31 118.59 15.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.262 0.553 . . . . 0.0 110.442 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.24 117.88 20.52 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 56.4 mm-40 53.19 35.1 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.0 m-80 77.94 10.79 2.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.745 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -123.01 151.89 41.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.7 m -98.98 128.25 45.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 0.0 110.644 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.699 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.09 143.83 57.58 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.398 0.618 . . . . 0.0 109.86 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 93' ' ' ARG . 57.2 tp -51.27 -52.34 45.9 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.43 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.16 -12.92 31.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.01 0.434 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -103.29 -3.72 25.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.403 0.621 . . . . 0.0 110.464 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -54.2 149.02 20.45 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.143 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 67.4 Cg_endo -71.41 159.38 51.7 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.452 2.101 . . . . 0.0 111.132 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.06 148.98 29.97 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.188 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 7.3 m-85 -114.48 122.87 47.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.25 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.528 ' NE2' HD11 ' A' ' 83' ' ' ILE . 6.1 t-80 -137.07 121.08 17.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 58.84 43.02 18.88 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.798 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.63 -4.79 33.76 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.699 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.12 150.52 24.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.2 mp0 -103.2 129.72 50.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.794 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 12.8 m-85 -118.16 175.53 5.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.096 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.11 167.77 9.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.201 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 29.4 Cg_endo -62.19 128.29 23.52 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.561 2.174 . . . . 0.0 111.869 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.28 83.89 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -78.14 132.81 37.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.58 152.37 21.81 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.444 0.64 . . . . 0.0 110.931 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.44 150.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.179 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 14.9 tptp -98.72 131.48 44.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 86' ' ' ASN . 56.6 mt -135.01 114.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 34.68 66.09 0.34 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.56 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 70.78 -29.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.958 0.409 . . . . 0.0 110.909 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 83' ' ' ILE . 59.8 t-20 -87.58 133.82 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.358 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.78 148.92 29.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.63 151.76 50.56 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.53 144.29 35.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.4 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.628 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 87.2 m -70.37 111.48 5.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -142.15 121.35 13.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.348 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 61.74 50.62 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.263 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.526 HH11 HD11 ' A' ' 63' ' ' LEU . 32.1 ttp180 57.63 10.14 0.97 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.285 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -133.89 152.78 51.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.326 0.584 . . . . 0.0 110.055 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.628 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 94.9 m95 -83.39 133.5 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.108 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.442 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.2 t-20 -108.58 104.53 13.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.781 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 55.8 m -86.97 132.88 33.66 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.014 0.911 . . . . 0.0 112.235 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.451 HG21 ' ND1' ' A' ' 100' ' ' HIS . 54.1 m -58.07 -45.63 86.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.068 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.86 13.55 3.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.047 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.611 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.03 141.93 58.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.374 178.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.639 179.74 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 10' ' ' MET . 5.1 mpp? . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.54 120.31 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 0.0 110.904 179.562 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 11.6 ttpt . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -132.14 152.05 51.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.648 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -49.45 -13.22 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.263 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 30' ' ' THR . 5.0 pt20 -82.33 -38.63 23.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.265 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' LEU . 99.3 m-20 -113.17 -4.39 13.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.581 0.353 . . . . 0.0 111.016 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' THR . 11.9 t80 -48.56 -48.25 38.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -105.18 -7.27 19.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.021 0.438 . . . . 0.0 110.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.04 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 21.8 p . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 120.577 0.227 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.9 mt -130.47 162.19 29.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.21 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -73.64 156.6 88.43 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.333 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.14 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.655 2.237 . . . . 0.0 112.16 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.7 Cg_endo -56.06 -37.74 95.84 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.518 2.145 . . . . 0.0 112.546 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.01 -0.72 86.33 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.3 mmm -118.51 160.22 22.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.523 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 61' ' ' VAL . 16.6 m -130.37 -169.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.719 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 30' ' ' THR . 22.3 mtp-105 -122.13 117.58 26.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.292 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -133.16 124.45 27.51 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 44.47 49.25 8.31 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.269 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 29.1 t-20 66.89 5.22 3.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -123.31 151.08 42.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.8 m -103.02 131.69 49.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.337 0.589 . . . . 0.0 110.944 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.4 m -135.48 155.94 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.421 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.29 150.1 48.82 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.452 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' SG ' ' A' ' 31' ' ' CYS . 4.3 mm? -47.04 -50.65 19.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.862 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -66.89 -14.72 63.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -95.86 -6.18 39.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 110.439 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' HG21 ' A' ' 54' ' ' VAL . 57.9 m -56.38 150.5 33.01 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.34 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.36 157.6 37.04 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.52 2.147 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -109.47 148.25 31.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.739 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.83 127.61 50.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.971 0.415 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.451 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.0 t-80 -145.44 134.4 22.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.099 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 53.01 33.82 15.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.119 -0.363 . . . . 0.0 111.935 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.25 -5.83 58.59 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.224 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.68 148.85 25.07 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -101.08 127.15 47.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 9.9 m-85 -118.17 178.71 4.34 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.152 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.68 173.58 2.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 22.9 Cg_exo -64.5 137.02 53.12 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.184 1.923 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.18 82.07 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -81.98 134.37 35.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.63 148.92 24.97 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.846 0.831 . . . . 0.0 112.366 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -141.0 149.83 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.759 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -106.39 132.2 52.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.451 HD11 ' NE2' ' A' ' 70' ' ' HIS . 54.9 mt -130.98 86.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.228 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 51.41 85.95 0.02 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.76 -37.42 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.771 0.32 . . . . 0.0 111.374 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 84' ' ' GLY . 36.2 t-20 -88.88 140.76 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.123 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.566 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -126.99 152.61 46.99 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.042 0.448 . . . . 0.0 110.221 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.19 156.73 46.89 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.007 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 p -128.9 138.33 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.98 112.81 6.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -141.66 123.32 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.029 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 62.03 51.46 3.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.33 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.517 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 77.2 mtp180 53.36 15.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.289 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.25 161.15 35.25 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -98.36 132.09 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.92 95.83 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.425 ' HB3' HD21 ' A' ' 86' ' ' ASN . 86.6 m -80.56 138.74 36.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.052 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 99' ' ' ASP . 3.0 t -60.28 -53.17 60.81 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.356 1.074 . . . . 0.0 110.867 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.654 ' H ' HG23 ' A' ' 98' ' ' THR . 57.3 t0 60.79 26.44 16.27 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 112.977 -1.92 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.525 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.65 171.39 7.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.53 0.181 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.1 mtm . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.29 115.13 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.1 tttp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 110.195 179.605 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.827 ' H ' HD21 ' A' ' 33' ' ' ASN . 27.7 p -133.06 154.3 50.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.775 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 m -60.27 7.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.715 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 pt20 -105.72 -43.11 4.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 111.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.827 HD21 ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -108.27 -6.52 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.391 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 63' ' ' LEU . 77.8 t80 -44.43 -54.81 5.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.809 0.337 . . . . 0.0 110.588 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.75 -4.87 24.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 33' ' ' ASN . 62.8 mt . . . . . 0 N--CA 1.472 0.627 0 CA-C-O 121.111 0.481 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.2 -173.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.881 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 174.87 4.55 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.18 167.32 17.86 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.014 1.809 . . . . 0.0 112.936 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -54.23 147.47 45.11 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.237 1.958 . . . . 0.0 112.372 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.34 -17.85 40.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.29 148.55 32.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.27 140.27 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -72.6 122.69 21.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.287 0.565 . . . . 0.0 110.583 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.84 117.91 19.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 70.7 mm-40 51.1 35.0 11.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.2 m-80 79.01 11.58 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.624 0.577 . . . . 0.0 110.985 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -122.91 148.91 44.91 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.36 129.98 44.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.676 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.63 154.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.125 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 153.22 41.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.23 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 34' ' ' TYR . 2.9 mm? -49.78 -55.64 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.855 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -57.82 -17.4 15.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.47 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.66 -3.48 32.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.9 t -54.4 116.89 11.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.413 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -48.86 153.55 3.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.259 1.973 . . . . 0.0 112.429 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -103.18 163.95 11.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.412 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 21.1 m-85 -137.06 129.3 29.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.071 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.542 ' NE2' HD11 ' A' ' 83' ' ' ILE . 9.4 t-80 -144.48 127.82 16.83 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 55.47 39.57 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.497 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 -5.91 37.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -100.54 144.43 29.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.39 127.18 43.14 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.997 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 31.7 m-85 -120.28 178.41 4.65 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.314 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.04 172.35 3.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.508 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.443 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.6 Cg_exo -63.33 138.79 68.03 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.339 2.026 . . . . 0.0 111.566 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.63 -1.6 71.69 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -79.35 133.25 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.6 144.51 31.6 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.82 0.819 . . . . 0.0 111.993 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.95 152.89 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.53 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -99.18 129.93 45.46 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.542 HD11 ' NE2' ' A' ' 70' ' ' HIS . 59.9 mt -129.17 107.85 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.094 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.64 -115.15 7.62 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.74 1.18 31.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.738 0.304 . . . . 0.0 110.454 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 19.2 p30 -127.16 159.84 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.428 0.632 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.31 151.87 35.0 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.54 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.29 147.92 52.42 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.346 -178.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.33 138.85 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.564 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.22 107.76 3.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.416 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -137.45 121.62 17.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.422 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 65.34 51.41 1.58 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.654 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.785 HH11 HD12 ' A' ' 63' ' ' LEU . 35.5 mtm180 56.61 9.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.621 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -133.48 163.29 29.7 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -96.96 133.49 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.908 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.436 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.7 m-80 -111.58 106.57 15.45 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.621 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 62.9 m -86.42 137.03 32.88 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 112.063 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.442 HG21 ' CG ' ' A' ' 100' ' ' HIS . 54.2 m -58.04 -48.8 78.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.116 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 98' ' ' THR . 2.2 m-20 80.02 11.49 1.15 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.286 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.554 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.3 OUTLIER -78.76 157.91 28.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.53 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.602 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 40.6 mmm . . . . . 0 CA--C 1.517 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 10' ' ' MET . 0.2 OUTLIER 56.74 128.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.53 178.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.154 0.502 . . . . 0.0 110.05 179.071 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 11.9 ptmt . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -143.12 159.59 41.99 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 67.5 m -40.91 -25.76 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.508 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' THR . 6.6 pt20 -76.62 -44.5 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 36' ' ' LEU . 2.7 p-10 -114.4 0.08 13.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.11 0.481 . . . . 0.0 110.834 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 30' ' ' THR . 64.2 t80 -47.5 -51.85 19.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.012 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -103.43 -2.28 27.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.027 0.441 . . . . 0.0 109.829 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 33' ' ' ASN . 1.7 tp . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 49' ' ' CYS . 4.3 pp -119.45 -173.34 2.5 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.688 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.4 t -110.78 128.18 25.73 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.29 171.76 7.41 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.257 1.304 . . . . 0.0 113.197 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.21 152.23 73.45 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.392 2.061 . . . . 0.0 112.503 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.75 -21.06 4.87 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.538 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 85.7 mmm -111.86 150.03 30.98 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.44 141.5 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.117 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 30' ' ' THR . 69.8 ttt180 -72.92 120.14 18.13 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -133.87 120.29 20.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 52.27 37.47 22.21 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.268 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 76.37 10.88 2.88 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.879 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -123.4 153.01 40.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.602 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 18.6 m -103.04 124.7 49.03 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.102 0.477 . . . . 0.0 110.135 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.07 159.74 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.314 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 145.01 51.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.625 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 tp -51.49 -53.48 36.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.66 -20.0 4.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.977 0.417 . . . . 0.0 110.442 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -98.02 -4.25 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 110.27 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.439 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 6.3 t -53.86 126.54 50.69 Favored Pre-proline 0 C--N 1.32 -0.704 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.891 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.03 154.95 9.4 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.914 1.743 . . . . 0.0 112.419 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -99.16 165.63 11.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.133 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 22.1 m-85 -137.1 122.58 19.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.534 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.8 t-80 -147.26 133.7 19.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.233 0.54 . . . . 0.0 110.426 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 54.11 35.44 22.34 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.708 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.02 -5.65 52.94 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.145 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.8 156.88 17.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -106.48 130.92 54.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.071 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 4.8 m-85 -120.84 177.52 5.06 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.89 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.65 175.46 1.94 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.198 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.528 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.1 Cg_exo -64.66 135.07 43.59 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.235 1.957 . . . . 0.0 111.688 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.56 -2.76 84.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -77.85 136.68 38.11 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.71 152.05 23.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.08 0.466 . . . . 0.0 111.126 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.0 m -145.88 151.2 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.549 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -103.31 135.09 45.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.413 0.625 . . . . 0.0 110.254 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.534 HD11 ' NE2' ' A' ' 70' ' ' HIS . 49.6 mt -134.42 84.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 49.97 85.01 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.89 -33.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 99' ' ' ASP . 2.0 t-20 -90.17 136.94 32.74 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.446 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -120.86 152.97 37.77 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.05 0.452 . . . . 0.0 110.973 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 83' ' ' ILE . 4.0 m -140.57 154.77 46.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.346 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.88 139.68 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.393 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 24.1 t -71.78 109.64 5.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.288 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -140.07 122.78 16.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.67 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 62.55 51.37 3.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.286 0.565 . . . . 0.0 109.871 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 54.8 ttt-85 51.23 19.11 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.129 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -136.76 153.63 50.78 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 109.978 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -90.18 130.81 36.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.451 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -105.09 94.43 5.23 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.98 133.15 36.15 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.635 0.731 . . . . 0.0 111.79 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.431 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 65.4 m -63.89 -52.53 59.51 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.737 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 95.1 m-20 60.25 31.54 20.5 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.44 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -96.54 170.15 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.047 178.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.5 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.557 ' SD ' ' N ' ' A' ' 10' ' ' MET . 4.4 mpp? . . . . . 0 CA--C 1.524 -0.037 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' CYS . 2.4 t -122.05 122.58 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.071 0.462 . . . . 0.0 111.013 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.487 ' C ' ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -132.28 157.32 44.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.93 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' HB2' ' HE ' ' A' ' 93' ' ' ARG . 1.7 p -47.83 -13.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.576 ' C ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -85.49 -40.95 15.79 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.338 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.576 HD22 ' C ' ' A' ' 32' ' ' GLN . 2.0 m120 -108.9 -5.94 15.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' HD21 ' A' ' 63' ' ' LEU . 18.7 t80 -49.61 -49.71 45.76 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.108 -0.37 . . . . 0.0 110.243 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -99.93 -3.33 32.57 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 33' ' ' ASN . 3.2 tp . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.779 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.566 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 12.7 p . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.126 0.489 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.28 165.41 17.0 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.889 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.78 47.95 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.51 157.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.787 2.325 . . . . 0.0 112.171 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.87 -18.79 63.39 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.602 2.201 . . . . 0.0 111.887 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.92 -17.24 44.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 mtp -111.14 149.71 30.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.909 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.01 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.484 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 55' ' ' ARG . 7.5 ptm180 -74.17 122.5 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.719 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -135.55 124.04 23.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 60.0 tt0 51.97 33.46 11.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.472 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.1 m120 79.51 14.24 1.02 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.019 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -124.77 148.04 48.34 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -103.95 113.81 27.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 0.0 111.176 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 m -123.81 161.02 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.001 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.4 144.6 53.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.46 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 34' ' ' TYR . 14.4 mt -48.96 -51.11 32.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.273 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -60.74 -17.41 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -102.5 -8.99 20.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.533 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.4 138.45 67.93 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.552 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.76 158.43 53.65 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.147 1.898 . . . . 0.0 112.418 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.03 165.63 11.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.454 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.22 128.39 35.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.932 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 83' ' ' ILE . 7.2 t60 -141.3 118.56 11.39 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 60.55 45.57 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.03 -6.22 28.71 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.256 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -102.78 149.14 24.78 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.849 0.357 . . . . 0.0 110.276 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 74' ' ' GLU . 7.2 tm-20 -103.89 129.64 51.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.652 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 11.4 m-85 -118.53 178.33 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.461 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.66 165.55 13.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.443 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 21.0 Cg_endo -60.18 134.56 56.66 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.617 2.212 . . . . 0.0 111.454 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.93 80.79 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -78.64 134.29 37.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.43 151.15 23.87 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.837 0.827 . . . . 0.0 111.645 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 151.79 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.592 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -99.81 131.86 45.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.807 0.337 . . . . 0.0 110.592 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 70' ' ' HIS . 76.8 mt -129.9 119.44 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.866 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.11 -110.53 1.18 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.16 4.09 20.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.047 0.451 . . . . 0.0 110.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ILE . 4.2 p30 -126.02 155.9 40.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.773 0.797 . . . . 0.0 110.306 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -114.95 152.24 32.7 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.235 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -133.57 157.03 46.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.222 -178.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.85 144.72 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.564 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.683 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 76.6 m -69.47 107.55 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.742 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.594 HH21 ' ND2' ' A' ' 96' ' ' ASN . 67.3 ttp85 -139.52 120.73 14.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.94 51.71 3.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.469 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HE ' ' HB2' ' A' ' 31' ' ' CYS . 45.0 mtp180 55.68 9.83 0.46 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.008 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -133.1 156.49 47.33 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.683 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 96.2 m95 -88.06 132.96 34.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.594 ' ND2' HH21 ' A' ' 91' ' ' ARG . 5.3 t-20 -106.64 102.29 11.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 57.8 m -88.1 134.79 33.68 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.26 0.553 . . . . 0.0 111.61 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.1 t -60.67 -52.47 64.99 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.501 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.685 ' N ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER 77.35 -0.51 2.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.07 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.537 ' C ' ' ND1' ' A' ' 100' ' ' HIS . 1.4 p80 -42.6 170.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 14.6 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.127 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.42 38.62 18.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.748 0.308 . . . . 0.0 110.661 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.1 ttp -94.36 116.73 29.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 6' ' ' CYS . . . -63.75 -42.34 98.63 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 t 53.12 8.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 4' ' ' GLY . 7.7 p -84.25 64.37 8.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.692 ' HE ' ' NH2' ' A' ' 55' ' ' ARG . 2.1 mtt-85 49.42 178.05 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.314 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.89 105.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.977 1.785 . . . . 0.0 110.64 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' C ' ' SD ' ' A' ' 10' ' ' MET . 88.3 Cg_endo -83.61 145.72 11.77 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.839 1.693 . . . . 0.0 113.226 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 10' ' ' MET . 2.9 mpp? -114.25 -55.78 2.46 Favored 'General case' 0 N--CA 1.46 0.066 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.62 124.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.552 ' NZ ' ' CG1' ' A' ' 14' ' ' VAL . 64.3 tttm -86.8 132.76 33.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.256 0.55 . . . . 0.0 110.81 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 pp -132.42 124.45 28.67 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' CG1' ' NZ ' ' A' ' 12' ' ' LYS . 33.3 m -113.87 159.37 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 1.3 m -107.95 105.29 56.0 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.208 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 15' ' ' CYS . 82.4 Cg_exo -46.0 -179.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.957 1.771 . . . . 0.0 112.475 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.76 78.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -98.55 4.41 48.17 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 23' ' ' GLU . 1.9 m120 64.87 52.22 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.024 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.612 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.2 mm? -69.83 -40.3 75.94 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.528 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 63.3 ttm-85 -64.32 -43.3 95.1 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.531 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -95.63 -1.64 49.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.998 0.428 . . . . 0.0 110.709 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 19' ' ' ASN . 98.9 mt-10 51.17 11.8 0.11 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.439 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.83 -48.08 1.6 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.96 -43.54 98.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.958 0.409 . . . . 0.0 110.616 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -79.2 145.77 33.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.159 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.16 -48.56 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.606 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.472 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 71.5 p -134.14 159.95 39.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.383 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 51' ' ' PRO . 6.5 ttpt -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.685 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -137.12 156.65 48.1 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.6 t -46.46 -17.05 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.33 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 30' ' ' THR . 12.6 pt20 -84.97 -42.75 14.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.4 m-20 -109.31 -2.44 17.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.284 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.5 t80 -44.27 -53.0 7.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -105.74 -3.63 21.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASN . 31.4 mt -114.33 173.83 6.26 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.087 0.47 . . . . 0.0 110.695 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -48.7 152.94 0.89 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.308 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 39' ' ' MET . 8.0 t -103.91 159.35 15.72 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.956 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.558 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 97.1 mmm -78.78 146.66 33.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.185 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -60.4 -43.01 97.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttp -87.75 129.27 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.474 ' O ' HD11 ' A' ' 13' ' ' LEU . . . 150.23 -36.13 0.96 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -65.51 -39.94 92.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.08 0.467 . . . . 0.0 110.238 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 45' ' ' SER . 26.6 m -84.39 128.46 38.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.664 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 44' ' ' VAL . 5.8 t 20.32 92.57 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.649 1.218 . . . . 0.0 110.949 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.88 160.54 28.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 p -122.08 119.05 30.23 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.699 0.285 . . . . 0.0 110.565 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.0 mt -123.73 -174.59 3.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 50' ' ' PRO . 69.1 m -92.48 149.76 38.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.301 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 99.6 Cg_exo -38.47 165.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.745 2.297 . . . . 0.0 112.62 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 53.2 Cg_exo -53.87 -48.17 23.2 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.052 1.835 . . . . 0.0 112.926 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.15 -6.24 82.61 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.516 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.9 mtp -112.83 154.38 26.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 111.023 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 61' ' ' VAL . 3.0 m -125.91 152.25 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.692 ' NH2' ' HE ' ' A' ' 7' ' ' ARG . 80.1 ttt-85 -86.72 117.61 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.289 0.566 . . . . 0.0 110.887 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -138.55 126.45 22.44 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.349 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 46.83 45.56 15.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.261 0.553 . . . . 0.0 110.352 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER 63.04 8.44 3.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.978 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -120.43 149.24 42.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -97.34 128.08 43.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.516 . . . . 0.0 110.385 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.3 m -135.59 155.17 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.582 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 148.33 47.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.588 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 93' ' ' ARG . 10.5 mp -52.01 -52.22 52.15 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.024 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.62 -15.58 29.69 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.533 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -104.25 -4.9 22.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.473 0.177 . . . . 0.0 111.45 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -53.79 151.78 11.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.438 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 92.4 Cg_endo -74.51 156.66 45.2 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 110.99 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -116.25 151.69 35.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.069 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 3.5 m-85 -120.94 130.85 54.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.087 0.47 . . . . 0.0 110.58 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.506 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.5 t60 -152.79 98.54 2.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.033 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 30.8 tt0 87.81 36.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.963 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.17 -5.59 48.78 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.0 148.45 26.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 110.522 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -96.88 125.39 41.28 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.988 0.423 . . . . 0.0 110.966 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 26.5 m-85 -114.53 177.06 4.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.911 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -117.8 173.58 3.15 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.695 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.437 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.8 Cg_exo -64.56 139.12 62.6 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.248 1.965 . . . . 0.0 111.472 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.7 0.16 67.36 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -81.73 129.22 34.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.35 145.07 30.77 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.112 0.958 . . . . 0.0 112.313 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.08 153.78 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.17 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.72 130.42 48.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.756 0.312 . . . . 0.0 110.159 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.14 98.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.3 -116.68 7.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.5 3.6 40.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.881 0.372 . . . . 0.0 110.115 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -126.75 159.01 35.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 t -123.25 153.29 40.36 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.691 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -134.51 151.1 50.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.432 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.26 138.86 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.36 116.01 12.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.346 0.593 . . . . 0.0 111.124 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -144.0 118.78 9.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.325 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.29 51.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.25 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.426 ' CZ ' HD23 ' A' ' 63' ' ' LEU . 89.7 mtm180 54.23 12.24 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.792 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 157.54 44.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.68 133.48 36.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.8 m-80 -112.86 109.36 18.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.609 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 65.2 m -89.21 134.6 33.97 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.384 0.612 . . . . 0.0 111.792 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.797 HG22 ' H ' ' A' ' 100' ' ' HIS . 0.8 OUTLIER -71.68 -37.04 70.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.913 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 55.52 32.65 19.48 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.797 ' H ' HG22 ' A' ' 98' ' ' THR . 15.0 p80 -61.04 171.26 1.3 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.576 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 103' ' ' ASP . 62.7 t -55.05 135.44 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.305 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 34.8 t -66.82 69.46 0.07 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.665 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 101' ' ' VAL . 68.5 t0 . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.762 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.65 140.54 55.49 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 ttp -123.51 128.98 50.54 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.76 -178.28 39.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 7' ' ' ARG . 63.2 m -79.65 -12.22 59.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.365 . . . . 0.0 110.577 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.541 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 8.3 t -60.24 81.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.241 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.582 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.4 ttm-85 -66.83 -43.96 50.61 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 7' ' ' ARG . 58.1 Cg_endo -90.86 108.37 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 123.014 2.476 . . . . 0.0 110.793 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.01 116.79 2.49 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.568 1.512 . . . . 0.0 111.946 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.439 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 44.5 mtm -122.32 -58.79 1.68 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.264 -0.273 . . . . 0.0 110.589 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.06 115.36 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.2 137.05 34.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.181 0.515 . . . . 0.0 111.026 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -137.4 128.57 27.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.771 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.77 122.6 69.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.431 0.634 . . . . 0.0 110.144 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OD1' ' A' ' 19' ' ' ASN . 2.3 t -100.21 105.17 34.28 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' CYS . 86.7 Cg_exo -46.32 179.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.105 1.87 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -47.69 84.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.671 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -95.9 5.41 51.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.42 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.521 ' OD1' ' SG ' ' A' ' 15' ' ' CYS . 52.0 m-20 59.45 57.04 3.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.064 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -106.48 20.0 19.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -149.77 52.29 0.93 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.045 0.45 . . . . 0.0 110.112 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.88 158.67 23.91 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.08 0.466 . . . . 0.0 110.283 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' OE2' HD12 ' A' ' 25' ' ' LEU . 15.3 pt-20 -64.86 -35.74 82.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.575 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.29 -12.85 0.6 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD12 ' OE2' ' A' ' 23' ' ' GLU . 87.6 mt -92.34 135.1 34.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.837 0.351 . . . . 0.0 110.324 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.74 -37.82 88.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 p -154.61 -124.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.38 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.467 ' OG1' ' SG ' ' A' ' 38' ' ' CYS . 66.6 p -84.84 168.27 15.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.481 0.182 . . . . 0.0 110.66 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 3.7 tttp -147.05 89.94 1.85 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -135.64 156.08 49.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.991 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.465 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 1.5 t -52.12 -4.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.9 pt20 -100.4 -42.36 6.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.302 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 36' ' ' LEU . 98.2 m-20 -113.74 -2.8 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.027 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 30' ' ' THR . 15.1 t80 -51.88 -45.47 64.14 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.156 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -102.17 -3.8 26.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.636 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 33' ' ' ASN . 50.5 mt -120.38 174.88 6.26 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.944 0.402 . . . . 0.0 111.052 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.07 149.16 45.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.012 0.434 . . . . 0.0 110.994 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.467 ' SG ' ' OG1' ' A' ' 28' ' ' THR . 90.5 m -82.98 145.86 29.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 41' ' ' MET . 4.7 ptp -66.06 -178.88 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.198 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 m -47.31 88.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.53 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 39' ' ' MET . 7.5 tpp -149.23 124.72 10.32 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.92 37.51 3.78 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t 52.99 100.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.844 0.354 . . . . 0.0 110.143 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.85 159.77 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.775 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.3 t -55.95 134.16 52.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.087 0.47 . . . . 0.0 110.76 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.92 -175.19 45.76 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.541 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 1.6 p -123.16 129.63 51.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.947 0.403 . . . . 0.0 111.134 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.08 -172.96 2.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -103.28 173.39 3.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.12 157.11 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.544 2.163 . . . . 0.0 112.344 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 32.1 Cg_endo -62.15 -27.97 79.28 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.602 2.201 . . . . 0.0 112.198 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.89 -8.79 75.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.11 153.0 31.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.002 0.429 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.96 135.05 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.945 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -73.84 129.75 38.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.149 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 59' ' ' ARG . 3.5 t60 -139.11 130.33 26.78 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.052 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 22.1 tp10 45.72 26.64 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 40.9 t30 88.56 10.27 0.11 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.916 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 56' ' ' HIS . 2.1 ptm180 -126.92 151.94 47.78 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.8 m -99.42 131.56 45.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.301 0.572 . . . . 0.0 110.539 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.03 157.17 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.574 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.04 148.8 48.37 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.456 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.8 mm? -52.17 -46.21 65.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.176 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.75 -13.42 62.38 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.441 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -102.07 -6.9 22.79 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.72 0.295 . . . . 0.0 110.987 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.15 148.9 49.44 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.866 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.34 162.26 40.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.624 2.216 . . . . 0.0 111.83 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 7.6 m -103.41 166.19 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 17.8 m-85 -132.23 123.12 26.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.948 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.533 ' CE1' HD11 ' A' ' 83' ' ' ILE . 13.4 t60 -142.67 126.92 17.57 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.104 0.478 . . . . 0.0 110.049 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.6 42.15 29.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.62 -3.38 49.47 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.353 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -104.31 151.33 23.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.975 0.417 . . . . 0.0 110.658 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -104.63 129.14 52.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.654 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 10.4 m-85 -117.53 176.51 5.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.486 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.74 162.55 24.73 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.765 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 20.4 Cg_endo -59.6 136.06 68.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.411 2.074 . . . . 0.0 111.522 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.42 -2.62 86.9 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE1' ' C ' ' A' ' 79' ' ' GLU . 9.5 tm-20 -82.78 137.46 34.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -104.9 149.69 25.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.789 0.804 . . . . 0.0 111.966 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.16 146.07 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.399 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 84' ' ' GLY . 6.0 tmtt? -101.82 129.43 48.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 70' ' ' HIS . 81.4 mt -129.52 117.31 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . . . 56.41 -117.83 10.12 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.438 ' C ' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -102.19 1.98 36.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.328 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 6.7 p30 -125.81 162.38 25.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.397 0.617 . . . . 0.0 111.044 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -127.88 157.57 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.909 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.38 163.01 33.93 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.718 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.29 142.41 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.03 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.19 105.55 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.426 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -137.7 122.42 18.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.593 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 60.14 51.94 5.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.37 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 62.7 mtp180 54.47 12.22 0.5 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.157 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -132.91 158.07 43.52 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -92.86 133.73 35.79 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -105.53 94.21 5.08 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.7 m -82.0 135.03 35.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.187 0.518 . . . . 0.0 111.226 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.697 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.0 t -63.46 -52.57 60.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.281 1.039 . . . . 0.0 110.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.697 ' N ' HG23 ' A' ' 98' ' ' THR . 27.7 t0 68.74 18.76 8.64 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.929 -1.941 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 101' ' ' VAL . 3.6 p80 -59.6 171.27 0.88 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' ND1' ' A' ' 100' ' ' HIS . 62.0 t -55.33 134.94 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 28.6 t -63.09 70.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . 67.6 t0 . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.534 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.01 140.53 57.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 110.577 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 ttp -102.2 121.77 42.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.565 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.95 -171.58 42.4 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 m -56.26 -173.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.71 0.29 . . . . 0.0 110.256 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 7.9 t 56.72 96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.676 ' NH2' HH22 ' A' ' 55' ' ' ARG . 2.3 mpp_? -72.41 -64.9 0.86 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.585 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' O ' ' SD ' ' A' ' 10' ' ' MET . 31.7 Cg_endo -62.06 110.73 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.312 2.008 . . . . 0.0 111.094 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -83.07 118.86 2.73 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.942 1.761 . . . . 0.0 112.588 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.555 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -128.96 -59.45 1.12 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.52 107.58 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -81.35 141.89 33.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.285 0.564 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.0 pp -140.34 122.54 15.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.671 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.98 160.9 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.13 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 26.9 m -108.04 115.06 59.15 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -46.31 177.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.93 1.753 . . . . 0.0 112.845 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.86 90.19 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.78 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 94.8 m-20 -104.08 21.46 16.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.003 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 13.4 p30 44.0 62.18 2.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.235 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.01 21.1 15.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -142.26 55.52 1.45 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.996 0.427 . . . . 0.0 110.153 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.62 157.25 36.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.574 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -142.36 173.57 11.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.61 94.09 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.8 mm? -64.51 -39.7 94.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.769 0.319 . . . . 0.0 110.503 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -61.79 -34.42 75.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.9 t -40.32 -76.13 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.544 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 29' ' ' LYS . 13.6 m -149.77 160.39 43.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.406 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.72 ' HZ3' ' HA ' ' A' ' 51' ' ' PRO . 35.0 mtpt -147.72 91.39 1.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 55' ' ' ARG . 36.4 p -131.25 152.57 50.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.832 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -50.42 -4.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.742 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.566 ' H ' ' C ' ' A' ' 30' ' ' THR . 17.6 pt20 -104.31 -54.43 2.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.655 0.264 . . . . 0.0 111.618 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.49 ' ND2' ' OG1' ' A' ' 30' ' ' THR . 27.7 p30 -93.3 -7.11 45.85 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.687 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' CD1' HD11 ' A' ' 63' ' ' LEU . 67.8 t80 -44.29 -47.5 9.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.248 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 17.1 p-10 -102.02 -0.63 33.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.034 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 32' ' ' GLN . 4.5 mt -117.82 174.66 6.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.29 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -77.86 142.64 38.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.748 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.6 p -83.12 165.22 19.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 41' ' ' MET . 98.6 mtp -60.27 166.01 3.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.313 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 m -68.3 61.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.806 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 39' ' ' MET . 93.2 mmm -63.75 -41.6 97.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.687 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 21.39 74.67 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 6.9 t 65.47 96.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.559 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.45 156.88 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.496 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -61.36 132.33 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.375 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.32 175.57 46.69 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.533 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 4.8 p -117.25 146.48 43.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 110.511 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' O ' ' SD ' ' A' ' 10' ' ' MET . 95.6 mt -136.68 -173.41 3.42 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.172 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' O ' ' O ' ' A' ' 50' ' ' PRO . 93.2 m -96.35 150.6 37.33 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.944 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 49' ' ' CYS . 84.4 Cg_exo -34.2 158.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.876 2.384 . . . . 0.0 112.043 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.72 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 19.3 Cg_endo -58.14 -26.68 77.02 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.791 2.327 . . . . 0.0 112.179 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.5 -1.32 60.59 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.6 mtp -122.95 164.34 18.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.31 -0.445 . . . . 0.0 111.23 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.11 148.79 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.676 HH22 ' NH2' ' A' ' 7' ' ' ARG . 78.9 ttt-85 -76.26 123.05 25.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.153 0.501 . . . . 0.0 110.712 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.95 127.95 22.19 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 55.2 tt0 47.42 35.07 3.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.384 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.6 m-20 76.31 9.39 3.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.745 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -127.1 152.1 47.76 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.66 126.95 40.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 0.0 109.992 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.42 156.98 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.942 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.72 146.97 41.81 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.464 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.3 mm? -48.05 -50.24 28.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.111 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -59.67 -14.34 13.48 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.188 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -99.95 -6.58 26.38 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.471 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.9 m -55.11 138.87 65.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.197 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.79 159.99 47.2 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.593 2.195 . . . . 0.0 112.138 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.76 167.07 10.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.812 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.98 129.71 32.52 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -142.72 122.73 13.62 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 58.86 42.8 19.17 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.617 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.09 -3.98 34.65 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.119 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -101.79 142.02 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -96.23 129.08 43.63 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.194 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 39.0 m-85 -118.95 176.91 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.003 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.89 164.51 16.44 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 19.2 Cg_endo -59.34 133.96 55.76 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.519 2.146 . . . . 0.0 111.529 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.83 -3.92 86.51 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 80' ' ' THR . 11.1 tm-20 -80.74 138.67 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.423 ' O ' ' OE2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -110.66 154.9 23.17 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.622 0.725 . . . . 0.0 111.696 -177.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.9 150.22 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.61 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -99.71 131.55 45.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASN . 55.6 mt -135.26 99.61 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.687 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 41.34 78.23 0.07 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER 63.35 -29.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.667 0.27 . . . . 0.0 110.918 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 84' ' ' GLY . 23.4 t-20 -89.92 128.62 36.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.229 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.28 148.02 33.8 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.804 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.61 153.55 51.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.168 -178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.93 146.27 29.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.515 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.649 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 77.1 m -71.31 108.66 4.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -139.84 114.63 9.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.363 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 68.92 50.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.407 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 55.99 11.93 0.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.53 161.02 34.84 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.649 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 95.3 m95 -93.34 130.41 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.115 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.446 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.0 t-20 -105.88 105.41 15.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.728 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 53.3 m -87.92 132.62 34.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.627 0.727 . . . . 0.0 112.808 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.456 HG21 ' ND1' ' A' ' 100' ' ' HIS . 52.5 m -61.58 -47.9 83.39 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.359 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' THR . 14.6 t0 79.04 11.06 1.51 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.952 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.592 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.91 151.38 45.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.98 130.42 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.032 0.444 . . . . 0.0 110.486 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -149.49 5.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.444 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' GLY . . . -71.09 145.3 49.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 110.429 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.0 mtt 46.18 21.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.79 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 2' ' ' ALA . . . -72.45 171.18 49.73 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 m -71.38 144.9 49.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 110.487 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 7' ' ' ARG . 26.4 p -159.95 148.88 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.586 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.633 ' CD ' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -38.83 162.3 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.163 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' C ' ' O ' ' A' ' 7' ' ' ARG . 84.2 Cg_exo -31.51 104.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.769 2.313 . . . . 0.0 111.438 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -55.3 110.97 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.994 1.796 . . . . 0.0 113.68 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.578 ' SD ' ' SG ' ' A' ' 49' ' ' CYS . 58.9 mtm -124.06 -46.59 1.94 Allowed 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.63 120.29 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.68 111.23 22.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.551 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pp -110.64 129.62 55.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.604 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' CG2' ' NH2' ' A' ' 21' ' ' ARG . 3.6 m -124.39 164.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' SG ' ' CG ' ' A' ' 19' ' ' ASN . 41.4 t -103.16 104.49 40.78 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.792 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -47.27 178.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.009 1.806 . . . . 0.0 112.692 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.39 94.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.986 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.16 1.4 44.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.17 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 65.42 61.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.978 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.61 21.75 13.71 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' NH2' ' CG2' ' A' ' 14' ' ' VAL . 63.0 ttp85 -150.38 56.07 0.93 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.384 . . . . 0.0 110.092 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' GLY . . . -75.16 -13.25 60.45 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 38.4 29.47 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.334 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 22' ' ' ALA . . . -170.38 172.48 44.05 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' CYS . 67.9 mt -76.58 80.76 3.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.861 0.362 . . . . 0.0 110.368 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 57.16 -78.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.598 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LEU . 3.7 m -78.43 -144.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.366 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.5 p -86.69 -157.16 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.259 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.738 ' NZ ' ' H ' ' A' ' 52' ' ' GLY . 77.6 tttt -147.69 94.45 2.36 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 110.448 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 34' ' ' TYR . 6.4 m -136.78 155.84 49.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.872 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 3.7 t -59.15 1.37 0.07 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.017 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' THR . 8.0 pt20 -104.06 -44.0 5.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.622 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' LEU . 96.5 m-20 -111.81 -7.14 14.21 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 30' ' ' THR . 19.9 t80 -48.52 -47.13 39.24 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.935 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 48.8 t0 -101.45 -5.2 25.58 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 110.463 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 33' ' ' ASN . 45.0 mt -120.67 130.09 53.96 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.603 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 56.1 mp0 -54.05 138.02 38.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 40' ' ' SER . 26.7 p -67.77 161.42 26.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.614 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.1 ttm -61.31 -40.22 93.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.098 0.475 . . . . 0.0 110.581 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 32.3 t -115.5 104.62 11.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.361 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 27' ' ' CYS . 82.8 mmm -77.84 143.74 37.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.463 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.61 156.71 7.14 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 22.1 p -76.54 112.51 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.085 0.469 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.55 127.17 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.23 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.2 t -62.1 145.55 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.49 172.34 44.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.42 102.05 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -120.23 -172.66 2.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -90.44 171.75 7.97 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.617 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' CD ' ' SG ' ' A' ' 49' ' ' CYS . 25.6 Cg_exo -61.55 -179.84 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.298 1.999 . . . . 0.0 112.673 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.53 151.43 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.791 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.738 ' H ' ' NZ ' ' A' ' 29' ' ' LYS . . . 79.76 -9.57 43.58 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.5 mtp -116.68 152.23 34.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.214 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.8 139.6 50.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.257 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.474 ' NH1' ' CZ ' ' A' ' 7' ' ' ARG . 36.5 ptt180 -73.55 126.35 30.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.385 0.612 . . . . 0.0 110.516 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 67' ' ' PRO . 1.9 t60 -133.88 122.83 23.73 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.905 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 80.9 mt-10 46.99 31.68 1.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.788 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.4 m120 83.71 11.43 0.43 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.553 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -125.79 149.02 48.92 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.0 m -97.5 133.44 42.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.899 -0.5 . . . . 0.0 110.589 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.62 157.73 24.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.288 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.31 150.45 45.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.297 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.9 mm? -49.16 -46.61 45.54 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.52 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.99 -14.38 61.52 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.868 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -101.39 -8.98 21.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.801 0.334 . . . . 0.0 110.952 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 147.02 30.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.615 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 56' ' ' HIS . 71.8 Cg_endo -72.55 163.73 37.7 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.692 2.262 . . . . 0.0 111.582 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.41 158.48 22.43 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.921 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -127.89 128.11 44.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.398 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 83' ' ' ILE . 84.4 t60 -144.82 126.18 14.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.705 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 59.24 37.88 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.502 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.95 -5.2 50.2 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.096 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -102.2 145.7 29.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 0.0 109.875 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -100.73 129.31 46.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.226 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 29.0 m-85 -118.96 177.31 4.91 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.316 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.79 175.11 2.1 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.736 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.519 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.5 Cg_exo -63.37 138.75 67.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.429 2.086 . . . . 0.0 111.605 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.97 -0.86 61.19 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.29 134.0 36.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.85 151.6 24.32 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.029 0.443 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.72 148.52 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.656 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -96.52 129.14 43.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 110.169 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 86' ' ' ASN . 97.9 mt -136.78 127.06 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.961 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 86' ' ' ASN . . . 32.52 83.97 0.01 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.533 ' SG ' ' C ' ' A' ' 84' ' ' GLY . 1.6 p 41.48 13.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.627 0.251 . . . . 0.0 111.441 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 84' ' ' GLY . 8.8 m120 -128.04 161.1 29.97 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.97 149.68 52.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.165 0.507 . . . . 0.0 111.006 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 m -137.33 157.65 46.13 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.707 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.86 144.09 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.91 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.658 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 71.2 m -67.01 107.11 2.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.607 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -137.71 118.61 14.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 63.48 50.73 2.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.657 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.584 ' NE ' ' SG ' ' A' ' 31' ' ' CYS . 58.1 mtp180 55.92 11.95 0.8 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -132.3 160.86 35.02 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 110.054 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.658 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 93.5 m95 -93.1 131.94 37.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.101 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -106.26 94.29 5.07 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 95.2 m -78.26 135.24 37.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.605 0.717 . . . . 0.0 111.576 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.7 m -59.62 -45.48 91.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 59.47 28.0 17.28 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.559 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -76.78 170.53 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.827 177.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.1 t -40.74 122.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.647 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 7.3 t -79.93 74.34 6.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.072 0.463 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.7 t0 . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.519 179.753 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.31 93.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.569 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.6 mtp -95.02 137.34 34.19 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.0 165.63 38.81 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 m -83.35 -5.47 59.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.337 . . . . 0.0 110.31 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 7' ' ' ARG . 19.3 p -40.73 153.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.655 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.584 ' CZ ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -40.04 163.97 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.093 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' A' ' 7' ' ' ARG . 93.2 Cg_exo -31.02 107.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.169 0 C-N-CA 122.938 2.425 . . . . 0.0 111.464 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.62 121.76 4.77 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.642 1.561 . . . . 0.0 113.325 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' ' SG ' ' A' ' 49' ' ' CYS . 64.7 mtm -128.43 -41.85 1.52 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.44 118.98 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -86.8 133.87 33.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.504 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.1 pp -133.52 118.59 18.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.669 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 14' ' ' VAL . 5.7 m -101.57 116.67 45.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.909 0.385 . . . . 0.0 110.476 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.497 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -49.8 123.83 15.47 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 -179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 73.5 Cg_exo -45.26 -179.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.845 1.697 . . . . 0.0 112.922 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.15 91.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.383 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -108.59 15.03 24.11 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.28 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 22' ' ' ALA . 5.5 m120 62.56 58.08 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.785 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' H ' ' HB2' ' A' ' 16' ' ' PRO . 4.4 mm? -65.81 -41.5 91.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.438 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 70.2 ttt180 -66.84 -43.24 84.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.422 . . . . 0.0 110.799 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ASN . . . -95.67 168.38 10.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.804 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 54.3 26.2 6.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -159.48 -85.24 0.05 OUTLIER Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.5 tp -71.58 -88.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -147.88 98.66 2.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.3 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 p -60.44 -25.33 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.438 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' NH2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -138.88 170.26 16.32 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -149.67 90.27 1.69 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' TYR . 10.6 m -128.27 165.28 20.82 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.831 ' SG ' HG21 ' A' ' 54' ' ' VAL . 80.9 m -55.08 -13.11 1.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.154 -0.341 . . . . 0.0 110.663 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -96.87 -38.01 10.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.492 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 36' ' ' LEU . 6.2 m120 -106.0 -4.96 19.93 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.918 ' CD2' HD11 ' A' ' 63' ' ' LEU . 22.2 t80 -44.36 -53.88 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.228 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -102.8 -0.2 31.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.421 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 33' ' ' ASN . 55.4 mt -120.06 165.89 14.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.694 0.283 . . . . 0.0 110.681 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.97 139.13 52.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.773 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 p -88.31 135.25 33.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 41' ' ' MET . 66.9 mtt -79.91 146.81 31.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.197 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -61.82 71.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.536 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 39' ' ' MET . 89.9 mmm -65.06 -39.99 94.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.214 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.64 92.65 0.09 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 38.7 t -73.59 49.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.082 0.468 . . . . 0.0 110.323 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 45' ' ' SER . 10.3 p -159.39 138.48 3.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 44' ' ' VAL . 29.0 p 20.34 98.82 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.594 1.184 . . . . 0.0 111.228 -177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.27 145.62 16.18 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 95.51 5.02 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.917 -0.642 . . . . 0.0 110.142 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -118.68 -174.58 2.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.73 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' SG ' ' CE ' ' A' ' 10' ' ' MET . 0.4 OUTLIER -86.98 161.41 47.04 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.064 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.42 168.11 23.37 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.651 2.234 . . . . 0.0 112.622 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.39 145.99 53.86 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.035 1.824 . . . . 0.0 112.163 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.54 -23.02 24.51 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 96.2 mmm -116.43 155.71 28.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 109.893 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.831 HG21 ' SG ' ' A' ' 31' ' ' CYS . 34.3 m -131.21 -167.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.85 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 7' ' ' ARG . 68.7 mtm180 -120.7 118.07 29.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.54 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 67' ' ' PRO . 4.9 t60 -135.97 126.53 27.0 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.178 0.513 . . . . 0.0 110.795 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 44.74 45.07 8.06 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.213 0.53 . . . . 0.0 110.102 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.9 m120 68.21 10.41 7.82 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -126.46 152.95 45.75 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.2 m -100.26 134.04 43.77 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.704 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 54' ' ' VAL . 11.5 m -137.84 155.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.18 153.11 44.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.473 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.918 HD11 ' CD2' ' A' ' 34' ' ' TYR . 3.8 mm? -52.46 -50.81 61.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.41 -177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -56.62 -15.57 4.66 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -101.88 -1.52 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.091 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -55.22 115.61 9.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' HIS . 50.5 Cg_exo -50.45 159.47 2.07 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.737 1.625 . . . . 0.0 112.406 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.01 166.62 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -136.39 130.75 33.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.416 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 71' ' ' GLN . 80.4 t60 -150.94 104.21 3.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.247 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' HIS . 32.0 tt0 83.1 37.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.34 48.67 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -104.07 145.45 30.16 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -97.83 127.22 43.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 37.9 m-85 -115.11 177.24 4.73 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.127 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.73 170.12 6.34 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.37 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.34 138.28 65.19 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.969 1.779 . . . . 0.0 111.306 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.25 -1.23 76.8 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -82.51 128.47 34.31 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.48 145.74 29.85 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.688 0.756 . . . . 0.0 111.886 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.22 154.37 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -101.08 130.24 47.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 77.2 mt -128.45 106.61 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.87 -116.78 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' NE2' ' A' ' 100' ' ' HIS . 7.6 p -103.99 3.94 33.99 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.03 0.443 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 17.3 p30 -126.27 164.72 20.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.393 0.615 . . . . 0.0 110.61 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.32 152.07 41.81 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.879 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.632 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.76 150.62 52.14 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.2 -178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.55 140.85 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.52 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 18.2 t -71.11 110.26 5.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.74 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -140.9 118.93 11.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.794 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.5 t0 63.96 50.52 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.317 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 55.59 9.27 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.296 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -129.71 155.91 45.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -94.63 134.42 37.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.437 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 98.5 m-20 -111.67 104.44 12.8 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.632 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 78.4 m -86.94 137.92 31.96 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.913 0.863 . . . . 0.0 112.175 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.646 HG22 ' H ' ' A' ' 100' ' ' HIS . 2.8 m -61.03 -44.78 96.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t0 55.0 29.61 12.63 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.074 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.646 ' H ' HG22 ' A' ' 98' ' ' THR . 0.3 OUTLIER -70.6 172.21 8.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -38.24 126.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.705 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 7.2 t -80.95 72.41 7.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.698 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.429 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.34 140.45 54.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.476 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -139.15 145.18 39.08 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.67 84.22 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 p 44.2 89.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.705 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 30.3 p -82.87 40.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.623 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 56.26 159.93 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' O ' ' CE ' ' A' ' 10' ' ' MET . 80.1 Cg_exo -31.17 105.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.696 2.264 . . . . 0.0 111.308 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.28 141.47 20.47 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.907 1.738 . . . . 0.0 112.701 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -124.42 -42.91 2.07 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.39 117.01 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -85.1 131.12 34.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.029 0.443 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 pp -130.94 122.92 27.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.776 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.37 162.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.838 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 85.4 m -106.52 102.15 39.69 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.484 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 15' ' ' CYS . 61.7 Cg_exo -46.17 179.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.037 1.825 . . . . 0.0 112.601 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.52 82.38 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.756 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -98.42 5.15 48.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.998 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 58.65 63.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.883 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.73 21.58 14.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -100.25 -41.84 6.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.883 0.373 . . . . 0.0 110.012 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.72 138.76 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.732 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 25' ' ' LEU . 22.2 pt-20 -167.86 135.08 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.643 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.43 -30.16 0.58 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 23' ' ' GLU . 91.4 mt -125.13 145.06 50.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 0.0 110.282 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 95.6 mt-10 -138.83 153.52 48.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 28' ' ' THR . 17.1 p 40.0 -138.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.724 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.597 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 63.3 p -86.02 167.16 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.95 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -147.24 99.74 3.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 32' ' ' GLN . 0.5 OUTLIER -140.82 162.56 35.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.105 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.0 t -59.26 6.45 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.081 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 30' ' ' THR . 5.9 pt20 -105.13 -46.14 4.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.057 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' N ' ' CG ' ' A' ' 32' ' ' GLN . 99.2 m-20 -115.83 -3.16 12.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.014 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -50.46 -46.59 56.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.926 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 58.2 t0 -106.82 -8.51 16.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 33' ' ' ASN . 52.8 mt -111.56 172.32 6.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.538 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -41.63 153.41 0.05 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.046 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 t -121.57 168.55 11.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.822 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 78.2 mtm -75.29 144.42 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.554 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.8 m -68.7 62.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 44.7 ttm -64.9 -40.27 94.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.31 31.62 77.61 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.6 t 66.16 92.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.688 0.28 . . . . 0.0 110.475 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.6 154.41 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -62.16 129.76 42.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.56 168.38 37.45 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 20.0 p -119.38 125.62 49.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 62.3 mt -123.75 -177.17 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.972 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -98.07 159.09 31.61 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' CYS . 87.5 Cg_exo -42.11 173.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.754 2.303 . . . . 0.0 112.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.03 154.72 57.72 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.507 2.138 . . . . 0.0 111.974 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 -4.37 58.71 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.1 mtp -110.54 150.22 29.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.195 0.521 . . . . 0.0 110.061 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.59 137.3 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -72.31 118.59 15.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.262 0.553 . . . . 0.0 110.442 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.24 117.88 20.52 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 56.4 mm-40 53.19 35.1 19.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.962 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.0 m-80 77.94 10.79 2.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.745 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -123.01 151.89 41.44 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.7 m -98.98 128.25 45.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 0.0 110.644 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.699 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.09 143.83 57.58 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.398 0.618 . . . . 0.0 109.86 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 93' ' ' ARG . 57.2 tp -51.27 -52.34 45.9 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.43 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.16 -12.92 31.25 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.01 0.434 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -103.29 -3.72 25.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.403 0.621 . . . . 0.0 110.464 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -54.2 149.02 20.45 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.143 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 67.4 Cg_endo -71.41 159.38 51.7 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.452 2.101 . . . . 0.0 111.132 178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.06 148.98 29.97 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.188 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 7.3 m-85 -114.48 122.87 47.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.25 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' NE2' HD11 ' A' ' 83' ' ' ILE . 6.1 t-80 -137.07 121.08 17.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 58.84 43.02 18.88 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.798 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.63 -4.79 33.76 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.699 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -104.12 150.52 24.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 56.2 mp0 -103.2 129.72 50.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.794 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 12.8 m-85 -118.16 175.53 5.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.096 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -115.11 167.77 9.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.201 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 29.4 Cg_endo -62.19 128.29 23.52 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.561 2.174 . . . . 0.0 111.869 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.28 83.89 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -78.14 132.81 37.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.58 152.37 21.81 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.444 0.64 . . . . 0.0 110.931 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.44 150.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.179 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 85' ' ' CYS . 14.9 tptp -98.72 131.48 44.84 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 86' ' ' ASN . 56.6 mt -135.01 114.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.564 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 34.68 66.09 0.34 Allowed Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.56 ' O ' ' NZ ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 70.78 -29.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.958 0.409 . . . . 0.0 110.909 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 83' ' ' ILE . 59.8 t-20 -87.58 133.82 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.358 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.78 148.92 29.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -135.63 151.76 50.56 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.422 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.53 144.29 35.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.4 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.628 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 87.2 m -70.37 111.48 5.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -142.15 121.35 13.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.348 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 61.74 50.62 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.263 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.526 HH11 HD11 ' A' ' 63' ' ' LEU . 32.1 ttp180 57.63 10.14 0.97 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.285 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -133.89 152.78 51.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.326 0.584 . . . . 0.0 110.055 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.628 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 94.9 m95 -83.39 133.5 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.108 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.442 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 6.2 t-20 -108.58 104.53 13.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.781 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 55.8 m -86.97 132.88 33.66 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.014 0.911 . . . . 0.0 112.235 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.451 HG21 ' ND1' ' A' ' 100' ' ' HIS . 54.1 m -58.07 -45.63 86.78 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.068 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.86 13.55 3.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.047 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.611 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.1 OUTLIER -64.03 141.93 58.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.374 178.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.6 p -52.2 146.29 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.639 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.8 m -74.76 92.47 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.617 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.506 179.744 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.02 143.09 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.723 0.297 . . . . 0.0 110.51 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.7 tpp -97.01 122.54 40.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.391 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.43 175.94 34.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 t -72.79 145.77 46.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 110.576 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 21.2 p -140.93 37.58 1.78 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' PRO . 30.9 mtm-85 57.96 159.25 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' O ' ' SD ' ' A' ' 10' ' ' MET . 87.4 Cg_exo -30.05 104.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 122.764 2.309 . . . . 0.0 111.174 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.42 134.09 5.62 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.063 1.842 . . . . 0.0 113.1 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 8' ' ' PRO . 5.1 mpp? -116.64 -45.69 2.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.54 120.31 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -84.84 135.32 34.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 0.0 110.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD11 ' SD ' ' A' ' 41' ' ' MET . 1.9 pp -131.67 132.7 44.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.351 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.49 160.92 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.588 ' SG ' ' ND2' ' A' ' 19' ' ' ASN . 36.8 t -92.77 111.98 53.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.391 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 85.2 Cg_exo -46.42 179.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.27 -46.58 86.15 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.806 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.452 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.5 t0 -99.74 6.83 45.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.851 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.588 ' ND2' ' SG ' ' A' ' 15' ' ' CYS . 3.4 t-20 61.08 66.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.025 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.602 ' N ' HD22 ' A' ' 20' ' ' LEU . 1.1 mm? -95.71 -15.72 22.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.246 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 63.4 ttm-85 -70.12 -43.0 71.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 19' ' ' ASN . . . -85.81 161.43 19.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.949 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -145.12 -35.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.384 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.85 -162.04 36.62 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -79.42 -159.55 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.533 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -69.03 -3.64 13.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' N ' ' OE2' ' A' ' 26' ' ' GLU . 54.4 m -71.7 146.68 48.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.619 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 29' ' ' LYS . 33.5 p -98.72 -122.9 0.14 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 51' ' ' PRO . 11.6 ttpt -147.63 97.92 2.9 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -132.14 152.05 51.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.648 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -49.45 -13.22 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.263 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.456 ' N ' ' C ' ' A' ' 30' ' ' THR . 5.0 pt20 -82.33 -38.63 23.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.265 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' LEU . 99.3 m-20 -113.17 -4.39 13.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.581 0.353 . . . . 0.0 111.016 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 30' ' ' THR . 11.9 t80 -48.56 -48.25 38.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -105.18 -7.27 19.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.021 0.438 . . . . 0.0 110.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -101.19 139.46 36.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.04 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.999 ' N ' HD12 ' A' ' 36' ' ' LEU . 97.4 mt-10 -42.49 164.28 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.806 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 1.8 t 78.48 103.05 0.07 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.091 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.3 ptt? -161.35 -167.73 1.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.552 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 39' ' ' MET . 5.5 t 49.77 97.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.915 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 42' ' ' GLY . 5.6 ttt -43.95 125.74 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.33 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 41' ' ' MET . . . -55.4 -160.91 0.01 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 53.7 t -71.3 44.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.528 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 42' ' ' GLY . 72.3 t -122.87 127.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.077 0.465 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.5 p -75.34 153.82 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.699 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 -175.7 47.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.802 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 21.8 p -122.45 126.18 47.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.712 -0.244 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.9 mt -130.47 162.19 29.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.21 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -73.64 156.6 88.43 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.333 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.14 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.655 2.237 . . . . 0.0 112.16 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 19.7 Cg_endo -56.06 -37.74 95.84 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.518 2.145 . . . . 0.0 112.546 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.01 -0.72 86.33 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.3 mmm -118.51 160.22 22.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.523 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 61' ' ' VAL . 16.6 m -130.37 -169.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.719 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 30' ' ' THR . 22.3 mtp-105 -122.13 117.58 26.61 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.292 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -133.16 124.45 27.51 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 44.47 49.25 8.31 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.269 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 29.1 t-20 66.89 5.22 3.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -123.31 151.08 42.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.8 m -103.02 131.69 49.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.337 0.589 . . . . 0.0 110.944 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 54' ' ' VAL . 4.4 m -135.48 155.94 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.421 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.29 150.1 48.82 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.452 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' SG ' ' A' ' 31' ' ' CYS . 4.3 mm? -47.04 -50.65 19.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.862 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -66.89 -14.72 63.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.563 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -95.86 -6.18 39.92 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.875 0.369 . . . . 0.0 110.439 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' HG21 ' A' ' 54' ' ' VAL . 57.9 m -56.38 150.5 33.01 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.34 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.36 157.6 37.04 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.52 2.147 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.6 m -109.47 148.25 31.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.739 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.83 127.61 50.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.971 0.415 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.451 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.0 t-80 -145.44 134.4 22.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.099 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 53.01 33.82 15.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.119 -0.363 . . . . 0.0 111.935 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.25 -5.83 58.59 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.224 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -102.68 148.85 25.07 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -101.08 127.15 47.75 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 9.9 m-85 -118.17 178.71 4.34 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.152 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.68 173.58 2.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 22.9 Cg_exo -64.5 137.02 53.12 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.184 1.923 . . . . 0.0 111.737 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.55 -0.18 82.07 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -81.98 134.37 35.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.63 148.92 24.97 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.846 0.831 . . . . 0.0 112.366 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -141.0 149.83 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.759 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -106.39 132.2 52.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.451 HD11 ' NE2' ' A' ' 70' ' ' HIS . 54.9 mt -130.98 86.75 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.228 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 51.41 85.95 0.02 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.76 -37.42 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.771 0.32 . . . . 0.0 111.374 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 84' ' ' GLY . 36.2 t-20 -88.88 140.76 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.123 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.566 ' H ' HG22 ' A' ' 98' ' ' THR . 1.3 t -126.99 152.61 46.99 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.042 0.448 . . . . 0.0 110.221 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.19 156.73 46.89 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.007 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 p -128.9 138.33 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.98 112.81 6.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -141.66 123.32 15.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.029 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 62.03 51.46 3.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.33 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.517 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 77.2 mtp180 53.36 15.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.289 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.25 161.15 35.25 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -98.36 132.09 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.92 95.83 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.425 ' HB3' HD21 ' A' ' 86' ' ' ASN . 86.6 m -80.56 138.74 36.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.052 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 99' ' ' ASP . 3.0 t -60.28 -53.17 60.81 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.356 1.074 . . . . 0.0 110.867 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.654 ' H ' HG23 ' A' ' 98' ' ' THR . 57.3 t0 60.79 26.44 16.27 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 112.977 -1.92 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.525 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.3 OUTLIER -104.65 171.39 7.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.648 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.11 149.73 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.0 m -77.45 97.42 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--O 1.219 -0.54 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.646 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.45 94.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.41 141.64 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.556 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.4 75.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.506 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 44.1 t -61.88 -43.82 98.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.684 0.278 . . . . 0.0 110.715 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 5' ' ' SER . 1.2 p 52.96 168.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' NH1' ' CZ ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -40.72 165.08 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.859 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 7' ' ' ARG . 96.6 Cg_exo -33.01 105.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.434 2.089 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.91 144.59 17.17 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.327 2.018 . . . . 0.0 112.928 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.1 mtm -127.05 -40.3 1.87 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.874 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.29 115.13 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -90.88 111.8 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 110.195 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.8 pp -107.67 122.71 47.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.877 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.47 163.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.665 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.493 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 57.9 m -107.63 101.5 40.18 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HG3' ' HE ' ' A' ' 21' ' ' ARG . 64.6 Cg_exo -50.04 178.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.193 1.929 . . . . 0.0 112.801 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.72 77.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.6 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -94.95 3.41 54.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.906 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 59.6 66.47 1.0 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.55 18.9 15.7 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.709 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' HE ' ' HG3' ' A' ' 16' ' ' PRO . 87.4 mtm180 -149.96 55.8 0.95 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.313 . . . . 0.0 110.229 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.67 22.08 6.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.242 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' GLY . 98.7 mt-10 54.57 167.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 23' ' ' GLU . . . -47.01 -97.27 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.18 134.14 47.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -89.47 -179.51 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 40' ' ' SER . 5.5 t 59.01 -169.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.9 p -81.51 176.73 9.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.53 95.86 2.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.827 ' H ' HD21 ' A' ' 33' ' ' ASN . 27.7 p -133.06 154.3 50.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.775 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 m -60.27 7.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.715 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 30' ' ' THR . 10.2 pt20 -105.72 -43.11 4.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 111.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.827 HD21 ' H ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -108.27 -6.52 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.391 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 63' ' ' LEU . 77.8 t80 -44.43 -54.81 5.56 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.809 0.337 . . . . 0.0 110.588 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.75 -4.87 24.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.009 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 33' ' ' ASN . 62.8 mt -114.37 169.75 8.81 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.111 0.481 . . . . 0.0 111.029 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -41.89 159.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.15 170.96 8.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.668 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 39' ' ' MET . 0.0 OUTLIER -83.82 -7.25 59.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.489 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 33.8 p -159.68 160.37 34.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 ttt -101.14 -54.58 2.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.783 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.62 -178.72 42.36 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 28.6 p -80.62 158.38 25.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.6 p -157.77 86.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' VAL . 5.8 t 15.77 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.19 161.54 29.15 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.887 0.715 . . . . 0.0 111.536 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.64 99.8 7.2 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.2 -173.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.881 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 174.87 4.55 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.353 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.18 167.32 17.86 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 122.014 1.809 . . . . 0.0 112.936 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -54.23 147.47 45.11 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.237 1.958 . . . . 0.0 112.372 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.34 -17.85 40.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.29 148.55 32.68 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.295 0.569 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.27 140.27 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.559 ' CZ ' ' NH1' ' A' ' 7' ' ' ARG . 66.0 mtp180 -72.6 122.69 21.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.287 0.565 . . . . 0.0 110.583 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.84 117.91 19.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 70.7 mm-40 51.1 35.0 11.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 4.2 m-80 79.01 11.58 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.624 0.577 . . . . 0.0 110.985 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -122.91 148.91 44.91 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 70.8 m -97.36 129.98 44.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.231 0.539 . . . . 0.0 110.676 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.63 154.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.125 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 153.22 41.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.23 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 34' ' ' TYR . 2.9 mm? -49.78 -55.64 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.855 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -57.82 -17.4 15.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.47 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.66 -3.48 32.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 12.9 t -54.4 116.89 11.7 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.413 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -48.86 153.55 3.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.259 1.973 . . . . 0.0 112.429 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -103.18 163.95 11.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.412 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 21.1 m-85 -137.06 129.3 29.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.071 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.542 ' NE2' HD11 ' A' ' 83' ' ' ILE . 9.4 t-80 -144.48 127.82 16.83 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 55.47 39.57 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.497 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 -5.91 37.64 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -100.54 144.43 29.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -97.39 127.18 43.14 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.997 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 31.7 m-85 -120.28 178.41 4.65 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.314 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -115.04 172.35 3.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.508 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.443 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 24.6 Cg_exo -63.33 138.79 68.03 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.339 2.026 . . . . 0.0 111.566 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.63 -1.6 71.69 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -79.35 133.25 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.6 144.51 31.6 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.82 0.819 . . . . 0.0 111.993 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.95 152.89 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.53 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -99.18 129.93 45.46 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.542 HD11 ' NE2' ' A' ' 70' ' ' HIS . 59.9 mt -129.17 107.85 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.094 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.64 -115.15 7.62 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.1 m -103.74 1.18 31.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.738 0.304 . . . . 0.0 110.454 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 83' ' ' ILE . 19.2 p30 -127.16 159.84 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.428 0.632 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.31 151.87 35.0 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.54 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -132.29 147.92 52.42 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.346 -178.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.33 138.85 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.564 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 45.2 t -70.22 107.76 3.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.416 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -137.45 121.62 17.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.422 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 65.34 51.41 1.58 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.654 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.785 HH11 HD12 ' A' ' 63' ' ' LEU . 35.5 mtm180 56.61 9.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.621 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -133.48 163.29 29.7 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -96.96 133.49 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.908 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.436 ' C ' ' SG ' ' A' ' 88' ' ' CYS . 3.7 m-80 -111.58 106.57 15.45 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.621 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 62.9 m -86.42 137.03 32.88 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 112.063 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.442 HG21 ' CG ' ' A' ' 100' ' ' HIS . 54.2 m -58.04 -48.8 78.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.116 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 98' ' ' THR . 2.2 m-20 80.02 11.49 1.15 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.286 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.554 ' CD2' ' H ' ' A' ' 100' ' ' HIS . 0.3 OUTLIER -78.76 157.91 28.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -86.14 132.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.53 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 103' ' ' ASP . 10.5 p -67.47 -53.0 32.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.442 0.639 . . . . 0.0 110.836 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 98.2 m-20 . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.28 86.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.59 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.2 ttp -147.69 116.28 6.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.483 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -94.91 -177.91 37.87 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.45 ' C ' ' SG ' ' A' ' 6' ' ' CYS . 88.3 p -54.91 117.77 3.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 19.2 m -151.48 101.96 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 9.9 mpt_? -89.4 -66.36 0.15 Allowed Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.092 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 56.0 Cg_endo -69.5 169.45 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.133 1.888 . . . . 0.0 111.108 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.99 96.39 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 119.033 0.69 . . . . 0.0 111.629 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.602 ' SD ' ' SG ' ' A' ' 60' ' ' CYS . 40.6 mmm -91.92 2.38 56.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.018 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 10' ' ' MET . 0.2 OUTLIER 56.74 128.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.53 178.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -86.52 132.6 33.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.154 0.502 . . . . 0.0 110.05 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 pp -123.78 135.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.2 159.75 42.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.154 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 16' ' ' PRO . 35.8 m -70.02 114.36 24.68 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.633 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 15' ' ' CYS . 77.5 Cg_exo -46.17 178.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.743 1.629 . . . . 0.0 112.755 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.51 -46.36 90.32 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.807 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -98.2 5.0 48.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.634 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 57.81 66.43 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.802 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.72 14.44 17.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -149.11 51.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.08 0.467 . . . . 0.0 109.874 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.24 125.11 40.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.526 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -177.17 34.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.39 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.72 -4.11 90.22 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 44' ' ' VAL . 32.6 mt -64.55 135.03 55.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.821 0.343 . . . . 0.0 110.381 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' CYS . 95.2 mt-10 -42.84 166.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.454 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 1.1 t 82.74 10.11 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.616 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 p -49.55 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.106 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 53' ' ' MET . 11.9 ptmt -147.32 105.51 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.39 0.614 . . . . 0.0 109.347 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -143.12 159.59 41.99 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 179.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 67.5 m -40.91 -25.76 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.508 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' THR . 6.6 pt20 -76.62 -44.5 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 27' ' ' CYS . 2.7 p-10 -114.4 0.08 13.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.11 0.481 . . . . 0.0 110.834 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 30' ' ' THR . 64.2 t80 -47.5 -51.85 19.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.012 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -103.43 -2.28 27.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.027 0.441 . . . . 0.0 109.829 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 37' ' ' GLU . 1.7 tp -113.33 127.48 56.15 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 36' ' ' LEU . 79.2 mm-40 -61.04 149.4 37.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.636 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -155.21 140.47 17.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.236 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 39' ' ' MET . 2.0 mpt? -79.88 138.79 37.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.793 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.6 p -174.53 85.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.23 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 96.1 mtp -134.9 137.52 43.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.347 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.12 148.74 4.81 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.39 101.57 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 0.0 110.343 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 25' ' ' LEU . 71.8 t -142.04 107.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.702 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -73.67 140.88 46.38 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.341 0.401 . . . . 0.0 111.264 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.98 -171.96 45.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.07 39.67 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 49' ' ' CYS . 4.3 pp -119.45 -173.34 2.5 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.688 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.4 t -110.78 128.18 25.73 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.29 171.76 7.41 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.257 1.304 . . . . 0.0 113.197 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.21 152.23 73.45 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.392 2.061 . . . . 0.0 112.503 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.75 -21.06 4.87 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.538 ' O ' ' NZ ' ' A' ' 29' ' ' LYS . 85.7 mmm -111.86 150.03 30.98 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.44 141.5 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.117 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 30' ' ' THR . 69.8 ttt180 -72.92 120.14 18.13 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -133.87 120.29 20.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 52.27 37.47 22.21 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.268 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 76.37 10.88 2.88 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.879 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -123.4 153.01 40.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.602 ' SG ' ' SD ' ' A' ' 10' ' ' MET . 18.6 m -103.04 124.7 49.03 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.102 0.477 . . . . 0.0 110.135 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.07 159.74 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.314 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 145.01 51.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.625 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.5 tp -51.49 -53.48 36.96 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.66 -20.0 4.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.977 0.417 . . . . 0.0 110.442 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -98.02 -4.25 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 110.27 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.439 ' SG ' ' NE ' ' A' ' 93' ' ' ARG . 6.3 t -53.86 126.54 50.69 Favored Pre-proline 0 C--N 1.32 -0.704 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.891 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.03 154.95 9.4 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.914 1.743 . . . . 0.0 112.419 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -99.16 165.63 11.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.133 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 22.1 m-85 -137.1 122.58 19.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.534 ' NE2' HD11 ' A' ' 83' ' ' ILE . 4.8 t-80 -147.26 133.7 19.68 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.233 0.54 . . . . 0.0 110.426 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 54.11 35.44 22.34 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.708 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.02 -5.65 52.94 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.145 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.8 156.88 17.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -106.48 130.92 54.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.071 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 4.8 m-85 -120.84 177.52 5.06 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.89 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' A' ' 77' ' ' PRO . . . -116.65 175.46 1.94 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.198 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' CD ' ' HB1' ' A' ' 76' ' ' ALA . 21.1 Cg_exo -64.66 135.07 43.59 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.235 1.957 . . . . 0.0 111.688 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.56 -2.76 84.83 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -77.85 136.68 38.11 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.71 152.05 23.65 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.08 0.466 . . . . 0.0 111.126 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.0 m -145.88 151.2 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.549 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -103.31 135.09 45.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.413 0.625 . . . . 0.0 110.254 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.534 HD11 ' NE2' ' A' ' 70' ' ' HIS . 49.6 mt -134.42 84.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 86' ' ' ASN . . . 49.97 85.01 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.89 -33.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 99' ' ' ASP . 2.0 t-20 -90.17 136.94 32.74 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.446 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -120.86 152.97 37.77 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.05 0.452 . . . . 0.0 110.973 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 83' ' ' ILE . 4.0 m -140.57 154.77 46.64 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.346 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.88 139.68 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.393 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 24.1 t -71.78 109.64 5.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.288 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -140.07 122.78 16.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.67 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 62.55 51.37 3.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.286 0.565 . . . . 0.0 109.871 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 31' ' ' CYS . 54.8 ttt-85 51.23 19.11 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.129 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -136.76 153.63 50.78 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 109.978 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -90.18 130.81 36.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.451 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -105.09 94.43 5.23 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.98 133.15 36.15 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.635 0.731 . . . . 0.0 111.79 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.431 ' CG2' ' CG ' ' A' ' 100' ' ' HIS . 65.4 m -63.89 -52.53 59.51 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.885 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.737 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 95.1 m-20 60.25 31.54 20.5 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.44 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -96.54 170.15 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.047 178.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.33 144.43 9.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.5 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 t -65.38 95.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.9 t0 . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.659 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.06 93.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.607 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.2 mmm -65.37 -42.58 92.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.568 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.56 -171.95 39.86 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -60.89 -42.9 98.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.421 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 47' ' ' CYS . 25.9 p -63.89 123.31 18.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 7.0 mtp180 -82.85 -65.4 0.23 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' O ' ' SD ' ' A' ' 10' ' ' MET . 29.2 Cg_endo -60.71 110.09 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.269 1.98 . . . . 0.0 111.367 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' C ' ' SD ' ' A' ' 10' ' ' MET . 92.0 Cg_endo -85.83 113.97 1.36 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 121.807 1.672 . . . . 0.0 113.208 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.557 ' SD ' ' N ' ' A' ' 10' ' ' MET . 4.4 mpp? -120.29 -58.33 1.86 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' CYS . 2.4 t -122.05 122.58 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' NZ ' ' CG1' ' A' ' 14' ' ' VAL . 64.1 tttm -89.91 125.15 35.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.071 0.462 . . . . 0.0 111.013 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.0 pp -123.55 122.61 38.63 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.602 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' CG1' ' NZ ' ' A' ' 12' ' ' LYS . 34.1 m -111.11 160.48 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.705 0.288 . . . . 0.0 110.273 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.596 ' SG ' ' ND2' ' A' ' 19' ' ' ASN . 10.0 t -73.26 114.7 33.78 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.61 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 77.9 Cg_exo -47.85 -179.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.078 1.852 . . . . 0.0 112.61 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.66 96.42 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -116.96 21.6 13.16 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.427 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.596 ' ND2' ' SG ' ' A' ' 15' ' ' CYS . 1.8 m120 58.78 57.16 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.119 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' H ' ' HB2' ' A' ' 16' ' ' PRO . 4.5 mm? -64.38 -42.09 96.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.805 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.469 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 65.6 ttp85 -139.17 57.31 1.66 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.814 0.34 . . . . 0.0 110.09 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.75 96.69 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.579 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -172.81 171.55 4.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' MET . . . 72.34 68.83 1.51 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.0 mp 54.67 163.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.74 0.305 . . . . 0.0 110.195 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.647 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -88.21 147.66 24.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.13 0.491 . . . . 0.0 111.704 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -160.04 -153.87 0.36 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.272 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 29' ' ' LYS . 10.2 t -154.62 -154.39 0.51 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.41 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.9 ttpm? -144.74 99.7 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.487 ' C ' ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -132.28 157.32 44.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.93 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' HB2' ' HE ' ' A' ' 93' ' ' ARG . 1.7 p -47.83 -13.5 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.576 ' C ' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -85.49 -40.95 15.79 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.338 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.576 HD22 ' C ' ' A' ' 32' ' ' GLN . 2.0 m120 -108.9 -5.94 15.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 110.885 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' HD21 ' A' ' 63' ' ' LEU . 18.7 t80 -49.61 -49.71 45.76 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.108 -0.37 . . . . 0.0 110.243 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -99.93 -3.33 32.57 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 33' ' ' ASN . 3.2 tp -116.2 122.25 44.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 36' ' ' LEU . 11.4 pt-20 -62.7 136.47 57.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.342 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 2.6 p -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.872 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.472 ' C ' ' O ' ' A' ' 38' ' ' CYS . 72.9 mtm 30.17 35.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.901 0.381 . . . . 0.0 111.513 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 38' ' ' CYS . 11.0 m 39.21 -108.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 95.6 mtp -141.85 -23.7 0.7 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.705 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . 74.95 159.87 7.51 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 43' ' ' CYS . 43.9 t -96.03 54.5 1.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.0 110.3 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.4 154.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.111 0.481 . . . . 0.0 110.803 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -69.06 138.54 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.634 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.04 164.99 33.06 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.566 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 12.7 p -122.19 111.81 17.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.126 0.489 . . . . 0.0 110.963 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.28 165.41 17.0 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.889 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.78 47.95 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.51 157.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.787 2.325 . . . . 0.0 112.171 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.87 -18.79 63.39 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.602 2.201 . . . . 0.0 111.887 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.92 -17.24 44.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.9 mtp -111.14 149.71 30.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.352 0.596 . . . . 0.0 110.909 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.01 134.14 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.484 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 55' ' ' ARG . 7.5 ptm180 -74.17 122.5 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.719 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -135.55 124.04 23.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 60.0 tt0 51.97 33.46 11.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.472 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 2.1 m120 79.51 14.24 1.02 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.019 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -124.77 148.04 48.34 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 86.3 m -103.95 113.81 27.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 0.0 111.176 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 m -123.81 161.02 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.001 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.4 144.6 53.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.46 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 34' ' ' TYR . 14.4 mt -48.96 -51.11 32.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.273 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -60.74 -17.41 48.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -102.5 -8.99 20.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.533 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.4 138.45 67.93 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.552 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.76 158.43 53.65 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.147 1.898 . . . . 0.0 112.418 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.03 165.63 11.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.454 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.22 128.39 35.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.932 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 83' ' ' ILE . 7.2 t60 -141.3 118.56 11.39 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 60.55 45.57 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.03 -6.22 28.71 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.394 -0.431 . . . . 0.0 112.256 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -102.78 149.14 24.78 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.849 0.357 . . . . 0.0 110.276 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 74' ' ' GLU . 7.2 tm-20 -103.89 129.64 51.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.652 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 11.4 m-85 -118.53 178.33 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.461 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -114.66 165.55 13.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.443 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 21.0 Cg_endo -60.18 134.56 56.66 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.617 2.212 . . . . 0.0 111.454 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.51 -2.93 80.79 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -78.64 134.29 37.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.43 151.15 23.87 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.837 0.827 . . . . 0.0 111.645 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.66 151.79 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.592 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -99.81 131.86 45.52 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.807 0.337 . . . . 0.0 110.592 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 70' ' ' HIS . 76.8 mt -129.9 119.44 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.866 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.11 -110.53 1.18 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.16 4.09 20.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.047 0.451 . . . . 0.0 110.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ILE . 4.2 p30 -126.02 155.9 40.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.773 0.797 . . . . 0.0 110.306 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.4 t -114.95 152.24 32.7 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.235 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -133.57 157.03 46.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.222 -178.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.85 144.72 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.564 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.683 ' SG ' ' CH2' ' A' ' 95' ' ' TRP . 76.6 m -69.47 107.55 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.742 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.594 HH21 ' ND2' ' A' ' 96' ' ' ASN . 67.3 ttp85 -139.52 120.73 14.81 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.94 51.71 3.63 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.469 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HE ' ' HB2' ' A' ' 31' ' ' CYS . 45.0 mtp180 55.68 9.83 0.46 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.008 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -133.1 156.49 47.33 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.683 ' CH2' ' SG ' ' A' ' 90' ' ' CYS . 96.2 m95 -88.06 132.96 34.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.594 ' ND2' HH21 ' A' ' 91' ' ' ARG . 5.3 t-20 -106.64 102.29 11.68 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 88' ' ' CYS . 57.8 m -88.1 134.79 33.68 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.26 0.553 . . . . 0.0 111.61 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.685 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.1 t -60.67 -52.47 64.99 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.501 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.685 ' N ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER 77.35 -0.51 2.85 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.07 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.537 ' C ' ' ND1' ' A' ' 100' ' ' HIS . 1.4 p80 -42.6 170.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 103' ' ' ASP . 14.6 t -62.02 133.81 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.127 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.9 m -60.59 74.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.809 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . 68.3 t0 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.491 179.956 . . . . . . . . 1 1 . 1 stop_ save_